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Patterns of Mutation in the Human Genome 
 
Summary 
 
The processes that underlie point mutations in the human genome are largely unknown.  
However, the cumulative effect of these processes have a large impact on how mutation 
rates vary across a number of different scales and contexts, and consequently guide our 
understanding of human disease and evolution.  Although variation in the mutation rate 
has been characterized on many different levels, it is not fully understood the extent to 
which the rate of mutation can vary outside of the general patterns already observed.  
Beginning with the human genome project, many studies have produced large unbiased 
sequence datasets within a number of human populations.  To that end, we analysed a 
number of sequence datasets in an attempt to better understand the patterns and causes 
of variation in the rate of mutation that exists across the genome.  Firstly, we find that 
the mutation rates of single sites vary by more than is currently understood, and that this 
variation is not associated with any specific process or feature on either a local or 
genomic scale.  Although we have been unable to uncover the source of such variation, 
understanding the range of mutability at sites in the human genome is important since it 
may point to functional regions, disease phenotypes and prompt further ideas on the 
underlying mechanisms associated with such a result.  Furthermore, we find evidence 
that a mutational process that can generate the simultaneous production of two new 
alleles within the same individual during a single, or tightly linked series of mutation 
events increases the number of tri-allelic sites in the human genome.  There are a 
number of potential mechanisms that may drive this process, and the consequences of 
such an event may be far reaching, as the generation of two new alleles at a single site 
in functional regions may allow a more rapid exploration of evolutionary space.  
Furthermore, this process appears to make a reasonable contribution to variation in the 
human genome, thus providing a substrate for evolutionary change.  Finally, we observe 
significant variation in the mutation rate over all scales in cancer genomes.  Part of this 
 11 
result can be explained by the actions of specific carcinogens, however it is striking that 
patterns of mutation can be both consistent across different cancer types, but also very 
different between individuals with the same type of cancer over different scales.  This 
result points to the idea that the patterns of mutation may vary widely between different 
genomes under different conditions, and the identification of general patterns in a small 
number of samples may not fully describe the extent to which mutation rates can vary.  
Taken together, these conclusions suggest that the patterns and processes underlying 
mutation are highly complex, and require further analysis if they are to be fully 
understood.  
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1. General Introduction 
 
Mutation is arguably the most fundamental of all genetic processes, generating, as it 
does, the genetic variation that contributes to genetic disease, and upon which natural 
and artificial selection can act.  Variation in the rate of mutation as a function of local 
context and genomic location has many important implications for the study of 
evolution and disease.  Primarily an understanding of the mutability of a site or region 
can give insight into the rate of evolution across species via phylogenetic trees inferred 
from molecular changes, within populations and amongst regions of the genome.  For 
example, distinguishing between the rates of change at synonymous and non-
synonymous sites has led to an understanding of the direction of selection (Mcdonald 
and Kreitman 1991; Nielsen et al. 2007).  Furthermore, considering the patterns of 
mutation is important for the identification of genes associated with disease and 
understanding the processes occurring at such sites (Antonarakis, Krawczak, and 
Cooper 2000; Kondrashov 2003; Stenson et al. 2009), as well as the identification of 
functional regions in the genome. 
 
 
1.1 Methods 
 
The analysis of sequence data has become an important tool in understanding mutation 
rates in mammalian and other genomes.  While initial studies relied on limited amounts 
of sequence data, large sequencing projects have allowed the use of more sophisticated 
and robust techniques to analyze patterns of mutation.  Whole genome sequences such 
as human (Lander et al. 2001; Venter et al. 2001), chimp (Mikkelsen et al. 2005) and 
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mouse (Waterston et al. 2002) have become available, and improvements in sequencing 
technology (for review see (Mardis 2008) have made large re-sequencing projects such 
as SeattleSNPs (www.pga.gs.washington.edu), the Environmental genome project 
(www.egp.gs.washington.edu/) and 1000 genomes project (www.1000genomes.org) 
more viable, generating a large amount of sequence data for analysis.  Robust analysis 
of mutation patterns relies heavily on the correct selection of sequence data and an 
appropriate methodological approach (Ellegren, Smith, and Webster 2003; Baer, 
Miyamoto, and Denver 2007; Kondrashov and Kondrashov 2010).  A common 
technique is to compare sequences between species and analyze divergence data (Wolfe 
and Sharp 1993; Hwang and Green 2004; Pink et al. 2009), however some studies focus 
on sequences within a species, utilizing the homologous nature of pseudogenes 
(Gojobori, Li, and Graur 1982; Blake, Hess, and Nicholsontuell 1992; Casane et al. 
1997; Li, Yi, and Makova 2002) or repetitive sequences (Gaffney and Keightley 2005; 
Walser, Ponger, and Furano 2008).  Furthermore, it is generally assumed that the sites 
being considered are neutral and hence that the pattern of substitution reflects the 
pattern of mutation; some analyses explicitly test for selection while others do not.  
Many early studies consider synonymous sites in coding sequences when estimating 
rates of mutation, and although synonymous sites do not lead to an alteration in the 
amino acid sequence, it has been questioned whether these sequences represent truly 
neutral sites (Gaffney and Keightley 2005; Eory, Halligan, and Keightley 2010).  For 
this reason, researchers must be cautious when interpreting results from such data.  
Other studies use intronic sequences that are thought to be largely unaffected by 
selection (Dermitzakis, Reymond, and Antonarakis 2005; Asthana et al. 2007; Eory, 
Halligan, and Keightley 2010) and similar patterns of mutation to those in intronic 
sequence have been observed in whole genome and intergenic data (Mikkelsen et al. 
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2005; Taylor et al. 2006), allowing for a consideration of consistency across these 
sequence types. 
 
In this introduction we consider what has been learned from sequence analysis about 
variation in mutation rates in the mammalian nuclear genome, and possible explanations 
for the patterns observed.  We focus entirely on point mutations, which occur roughly 
40 and 100 times more often than deletion and insertion events, respectively (Ophir and 
Graur 1997), and consider the patterns of mutation on a local, regional and 
chromosomal level.  Due to the considerations above, we also assume that substitution 
rates are equivalent to mutation rates.  
 
 
1.2 Variation in the Mutation rate 
 
1.2.1 Sequence Context Effects 
 
The mutation rate of single nucleotides is the smallest scale upon which variation can 
occur, and there is much disparity at this level.  Transition mutations, which change a 
purine (adenine and guanine) to another purine or a pyrimidine (cytosine and thymine) 
to another pyrimidine, occur roughly twice as often as transversions, which change a 
purine to a pyrimidine or vice versa, with estimates of the transition/transversion ratio 
ranging from 1.55 to 2.5 (Gojobori, Li, and Graur 1982; Li, Wu, and Luo 1984; Blake, 
Hess, and Nicholsontuell 1992; Hess, Blake, and Blake 1994; Krawczak, Ball, and 
Cooper 1998; Zhang et al. 2007); studies with the most comprehensive datasets estimate 
the ratio to be ~1.9 (Zhao and Boerwinkle 2002).  The excess of transitions is most 
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likely due to transitions only requiring one rare tautomeric form of a nucleotide to 
create a stable purine-pyrimidine mismatch that can avoid detection by repair enzymes, 
whereas transversions require two tautomeric forms to create a purine-purine mismatch 
(Topal and Fresco 1976).  However, although transitions are generally more common 
than transversions, there is considerable variation in the transition-transversion ratio, 
particularly within mitochondria (Belle et al. 2005), with some genomes even showing 
no excess of transitions (Keller, Bensasson, and Nichols 2007).  A bias in the direction 
of mutation has also been observed in many studies, with G:C→A:T mutations 
occurring more often than the reverse (Gojobori, Li, and Graur 1982; Li, Wu, and Luo 
1984; Blake, Hess, and Nicholsontuell 1992; Hess, Blake, and Blake 1994; Hwang and 
Green 2004).  More specifically, in the most comprehensive analysis of mutation rates, 
Hwang and Green (2004) estimated that the frequency of mutations in humans follow 
the order, C/G→T/A > T/A→C/G > C/G→A/T > G/C→C/G > A/T→C/G > T/A→A/T, 
which is similar to that suggested by Li, Wu and Luo (1984) and Ebersberger et al. 
(2002), who used different methods and types of sequence.   
 
Neighbouring nucleotides also have a large effect on the mutation rate of a particular 
site.  The most obvious example is that of transitions at CpG sites, which undergo 
mutation roughly 8-18 times more often than other sites in vertebrates (Coulondre et al. 
1978; Bird 1980; Blake, Hess, and Nicholsontuell 1992; Nachman and Crowell 2000; 
Hwang and Green 2004; Elango et al. 2008).  CpG dinucleotides are generally 
methylated in mammals and since methyl-cytosine is unstable it undergoes high rates of 
spontaneous deamination to thymine, which is repaired less efficiently than the usual 
product of cytosine transitions, uracil (Coulondre et al. 1978).  CpG transversions also 
mutate at a higher rate than other transversions (Cooper and Krawczak 1990; Blake, 
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Hess, and Nicholsontuell 1992; Nachman and Crowell 2000; Hwang and Green 2004), 
and it is thought that this might be due to error prone repair at altered guanines after 
methylation and deamination at cytosines (Blake, Hess, and Nicholsontuell 1992).   
 
It has been suggested that mutation rates can be broadly divided into four groups in 
humans: CpG transitions > CpG transversions ~ non-CpG transitions > non-CpG 
transversions (Zhang et al. 2007).  However, within each of the non-CpG groups there is 
variation in the rate of mutation (Hwang and Green 2004; Zhang et al. 2007), with 
Hwang and Green (2004) identifying 14 types of substitution that show similar rates 
across the mammalian phylogenetic tree.  The mutation rate associated with 
neighbouring nucleotides is estimated to vary over 52 to 72-fold (Hess, Blake, and 
Blake 1994; Hwang and Green 2004), which reduces to 10-fold when CpG transitions 
are excluded (Hwang and Green 2004).  More specifically, mutations appear to be more 
frequent in the presence of certain flanking nucleotides, with C>A>G>T being the order 
of prevalence at the 5’ flanking site (Zhao and Boerwinkle 2002); this is likely to be the 
most accurate ordering since Zhao and Boerwinkle (2002) performed the analysis using 
SNPs across the whole human genome, whereas contradictory predictions by Blake, 
Hess, and Nicholsontuell (1992) were generated using pseudogenes with a GC content 
of ~57%, which is much higher than the genome average of 41%.  One specific feature 
of these patterns is that there is an increased rate of mutation at alternating purines and 
pyrimidines (Blake, Hess, and Nicholsontuell 1992; Hess, Blake, and Blake 1994) – an 
effect that is also seen at CpG nucleotides with more mutable doublets being flanked by 
a 5’ pyrimidine and a 3’ purine (Krawczak, Ball, and Cooper 1998; Zhao and 
Boerwinkle 2002) – that is likely due to the more stable nature of alternating purines-
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pyrimidines, which form inter-base-pair hydrogen bonds resulting in mismatches being 
less detectable by repair machinery (Kennard and Hunter 1991). 
 
Finally, the effects of local context can be important beyond the neighbouring 
nucleotides.  Although it is thought that the impact of the surrounding sequence quickly 
diminishes beyond the flanking nucleotides, and possibly the next two or three positions 
(Krawczak, Ball, and Cooper 1998), it has been shown that there is significant 
heterogeneity in nucleotide composition up to as far as 200bp away for all classes of 
mutation (Zhao and Boerwinkle 2002; Elango et al. 2008).  One particularly well-
studied example is that of CpG dinucleotides, where an increase in AT content around 
CpGs results in a higher rate of mutation (Fryxell and Zuckerkandl 2000; Fryxell and 
Moon 2005; Elango et al. 2008).  Elango et al. (2008) have shown that this context 
dependence decays in an exponential fashion over about 1500bp either side of the CpG.  
It seems likely that the increased mutability of CpGs in AT rich sequences is caused by 
a process suggested by Fryxell and Zuckerkandl (2000) in which individual GC 
nucleotide pairs remain paired for ~3 times longer than AT pairs during DNA 
‘breathing’ that occurs regularly in the cell (Leroy et al. 1988).  Cytosine deamination 
occurs ~143 times more often on ssDNA than it does on dsDNA (Frederico, Kunkel, 
and Shaw 1990), thus the mutability of CpGs is closely linked to the melting 
temperature of the surrounding DNA.  A 10% decrease in GC content reduces the 
melting temperature of a sequence by 4.1oC, increasing the deamination of methylated 
cytosine by 2-fold (Fryxell and Zuckerkandl 2000).  It is unknown whether similar 
processes could have an impact on other types of mutation, although it seems unlikely 
as most other mutational classes seem to be a result of replication errors, rather than 
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methylation and deamination (see later). 
 
Whereas the CpG effect is well understood, the reason for other context effects is not so 
evident.  There are two types of general feature that may impact upon the rate and type 
of mutation in different contexts: exposure to exogenous factors and consequences of 
endogenous error prone processes such as replication and repair (Cooper and Krawczak 
1990).  Examples of exogenous factors include UV light, which increases the rate of 
mutation at pyrimidine dimers (Pfeifer, You, and Besaratinia 2005), and chemical 
mutagens such as those found in tobacco smoke, which increase the rate of C>A 
mutations (Pfeifer et al. 2002).  More generally, it appears that guanine is the most 
frequently attacked base, being preferentially alkylated by many chemicals (for review 
on this and many other mutation processes, see (Boulikas 1992).  However, although 
exogenous factors play a part in increasing and biasing patterns of somatic mutation, it 
seems unlikely that they have a large effect on germline mutations, since it is thought 
that most germ-line mutations are a consequence of DNA replication.  The evidence for 
this comes from several sources. First, the Y-chromosome appears to have a higher 
mutation rate than the autosomes, which have higher mutation rates than the X-
chromosome (Ebersberger et al. 2002; Malcom, Wyckoff, and Lahn 2003; Mikkelsen et 
al. 2005; Goetting-Minesky and Makova 2006); this is consistent with most mutations 
occurring through DNA replication, since more germ-line replications occur in the male 
germ-line, than in the female, and the Y-chromosome spends all of its time in the male 
germ-line (Miyata et al. 1987) (see discussion below).  Second, Cooper and Krawczak 
(1990) have noted that the pattern of mutation exhibited in vitro by the two main 
replication enzymes in mammals, DNA polymerase α and β, are similar to those 
observed in human disease mutations when proof-reading is no longer active.  This 
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implies that a substantial proportion of point mutations are caused by mis-incorporation 
of nucleotides during DNA replication.   
 
During the processes of replication and repair, there are many examples of physical and 
enzymatic processes that can bias the rate of mutation.  Transient misalignment is a 
process by which a single nucleotide (usually one that is part of repetitive DNA) can 
loop out from the double helix during misalignment, with the following mis-
incorporation and re-alignment of sequences resulting in a mismatch (Kunkel 1985).  
Indeed, some studies have reported an excess of mutations in which the newly inserted 
base is identical to one of the flanking nucleotides, a pattern consistent with transient 
misalignment process (Cooper and Krawczak 1990; Todorova and Danieli 1997; 
Krawczak, Ball, and Cooper 1998).  Similarly, the stability of local DNA context can 
vary (SantaLucia, Allawi, and Seneviratne 1996) and the mutability of particular 
nucleotide combinations significantly co-varies with this feature (Cooper and Krawczak 
1990; Krawczak, Ball, and Cooper 1998).  Furthermore, some mutations are more likely 
to be read through during replication, allowing the error to be reproduced in subsequent 
DNA.  For example, G.T mispairs can be accommodated with minimal distortion of the 
DNA helix, as many functional groups of the nucleotides can bind to the opposite base 
in much the same way as Watson-Crick pairings (Kennard and Hunter 1991).  It is also 
apparent that some repair enzymes show a bias in the direction of repair dependent on 
mutation type and local context (Brown and Jiricny 1988).  Similarly, adenine is 
preferentially inserted at apurinic sites (Loeb 1985).  Although this is not a 
comprehensive list of processes that bias mutation, it does give an indication of the 
types of process that can affect mutation rates on a local scale.  It seems likely that a 
combination of these factors leads to variation in the mutation rate on this scale and 
 20 
ultimately it is difficult to assess whether one process has more impact than any other 
by analyzing sequence data alone. 
 
Although the rates of mutation associated with particular types of mutation and their 
local context have been well characterized, it is unknown the extent to which these 
factors govern the overall mutability of a site.  It seems likely that there is variation in 
the mutation rate within a particular class of mutation and within a particular context.  
Other factors may impact on the mutability of a site outside of local primary sequence 
context, resulting in far more variation in the mutation rate of single sites than is 
currently understood.  Although it is difficult to identify general processes that may 
alter the mutability of particular sites, in chapter 2 we attempt to quantify the variation 
in the mutation rate that cannot be explained by known factors.  In this way, we can 
better understand the pattern and frequency of change in the human genome, for 
example the length of conserved regions we might expect to see by chance, or impact of 
hypermutation in disease phenotypes.  Understanding the variation in the rate of 
mutation is also important in evolutionary inference, particularly in the reconstruction 
of ancestral sites and phylogeny.  Furthermore, understanding variation in the mutation 
rate of single sites may lead to a greater understanding of why some single sites are 
more prone to mutation than others.  In chapter 3 we consider the spatial distribution of 
sites we suspect are undergoing higher rates of mutation, in attempt to answer such 
questions. 
 
1.2.2 Other mechanisms 
 
Some features of mammalian genomes imply that there are more complex processes 
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outside of the general effects mentioned above that lead to variation in the mutation 
rate.  There are many types of mutation hotspot that are associated with specific motifs, 
mostly driven by association with particular molecules (Rogozin and Pavlov 2003).  For 
example, Todorova and Danieli (1997) showed there to be a large excess of mutations at 
a specific motif, TG[A/G][A/G][G/T][A/C], associated with α-polymerase pause sites 
in the human dystrophin gene where the arrest of α-polymerase during the replication 
cycle is thought to reduce its accuracy of incorporation or repair, and this has also been 
observed in the human lioprotein lipase gene (Templeton et al. 2000). 
 
We have so far only considered single point mutations, however, it is has been shown 
that mutations can sometimes occur simultaneously at adjacent sites.  This was first 
elegantly demonstrated by Averof et al. (2000), who showed that the rate of substitution 
between TCN and AGY serine codons (where N is any nucleotide and Y is a 
pyrimidine) was faster than one would expect given the rate of single mutation. Averof 
et al. (2000) estimated the rate of doublet mutation to be ~2% of the rate of single 
nucleotide changes, averaging across diverse taxomonic groups.  In contrast, in 
mammals the rate has been estimated as 0 (i.e. no excess at all) (Silva and Kondrashov 
2002) and 0.1%-0.44% (Kondrashov 2003; Smith, Webster, and Ellegern 2003).  The 
rate of mutations occurring at adjacent sites is also considered in chapter 4 of this thesis.  
Doublet mutations may have a great impact if they occur in coding regions, as the 
number of steps required to move between different amino acids could be dramatically 
reduced via this process. 
 
It has recently been suggested that a similar process may also occur across DNA 
strands, with an error at one site increasing the rate of mutation at the site opposite 
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(Walser, Ponger, and Furano 2008).  Such a mechanism could explain why the rates of 
CpG and non-CpG substitution are correlated across genes (Walser, Ponger, and Furano 
2008); a C>T mutation at CpG sites may be preferentially preserved by DNA 
polymerase iota and the subsequent G/T mismatch may then be subject to error prone 
repair, leading to a mutation that would no longer be seen as a CpG site in sequence 
analysis.  It is unknown how frequent such a process might be and whether it could 
have far reaching impacts on the human genome in generating variation and thus 
providing a medium for evolutionary change.  In chapter 4, I consider whether a 
mechanism that generates two new alleles simultaneously can explain why there is an 
excess of tri-allelic SNP sites in the human genome, thus attempting to identify whether 
such a process can generate appreciable genetic variation. 
 
1.2.3 Regional patterns of mutation 
 
Neighbouring nucleotide effects generate variation in the mutation rate on a single 
nucleotide scale.  However, it is evident that the mutation rate also varies at larger 
scales.  At a small regional scale it has been shown that insertion/deletion events 
(indels) increase the rate of mutation in adjacent sequences, with the largest effects 
observed up to ~50bp from the indel, but reaching as far as ~400bp away.  This effect is 
thought to be caused by problems in the pairing of chromosomes in individuals 
heterozygous for an indel (Tian et al. 2008).   
 
Furthermore, it has been proposed that recombination itself may be mutagenic (Lercher 
and Hurst 2002; Hellmann et al. 2003; Hellmann et al. 2005), as primate and rodent 
divergence data correlates with recombination rates, and this may result in small-scale 
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regional variation in mutation rates.  Hellmann et al. (2005) also showed that nucleotide 
diversity within chimpanzee does not correlate with human recombination rates, which 
can be explained by the two species differing dramatically in patterns of recombination 
(Winckler et al. 2005); if the patterns were driven by selection one might expect human 
recombination rates to correlate with chimpanzee SNPs since the two species are almost 
identical in the locations of coding regions (Mikkelsen et al. 2005).  It is also unlikely 
that the process is driven entirely by biased gene conversion, a process in which 
mismatches are preferentially repaired to GC over AT around double strand breaks at 
recombination events (Marais 2003), as GC conserving and GC changing mutations 
both correlate with recombination (Lercher and Hurst 2002).  There is also some debate 
as to the strength of fixation bias in the direction of GC around recombination events, 
and some studies may have overestimated this effect as a consequence of mis-inferring 
the ancestral allele at a mutation event (Hernandez et al. 2007). 
 
Mutation rates also vary within chromosomes on a much larger regional scale.  The 
evidence for this comes from a number of mammalian species and sequence types. The 
earliest confirmation came from the demonstration that the rate of synonymous 
substitution (Ks) varied significantly across the genome and that it was correlated to GC 
content (Wolfe, Sharp, and Li 1989; Wolfe and Sharp 1993).  Subsequently, Matassi, 
Sharp, and Gautier (1999) showed that the differences in Ks between genes that were 
located close to each other on the human genome were significantly lower than values 
observed at random gene pairs using human-mouse divergence data.  The same pattern 
is also seen in rodents (Lercher, Williams, and Hurst 2001; Williams and Hurst 2002).  
Although these results must be treated with caution, since there is evidence that 
selection can act upon synonymous sites in mammals (Chamary, Parmley, and Hurst 
 24 
2006), subsequent analyses using non-coding sequences have confirmed that there is 
large scale variation in the mutation rate (Casane et al. 1997; Smith, Webster, and 
Ellegren 2002; Mikkelsen et al. 2005; Zhang et al. 2007), even when sequences likely to 
be subject to selection have been removed.  
 
The most extensive analysis of large-scale variation in the mutation rate has been 
performed by Gaffney and Keightley (2005).  They considered the scale over which the 
mutation rate varies by analyzing the spatial autocorrelation in the divergence between 
ancestral repeats found in mouse and rat.  They showed that the mutation rate varies 
little within 100kb, but that it then decays exponentially until there is little correlation 
between adjacent blocks at a scale of 10-15MB.  They further show that all the 
autocorrelation above 1MB can be explained in terms of the correlation between 1MB 
blocks, suggesting that the scale over which the mutation rate varies is less than 1MB 
but greater than 100KB.  Other studies have argued that variation within chromosomes 
can be found to act over many scales; blocks of 50kb show significant variation (Elango 
et al. 2008) and a non-random distribution of mutations have been observed in regions 
of between 1kb and 10kb (Silva and Kondrashov 2002).  However, it seems that the 
strongest effect within chromosomes occurs on a scale of 1MB (Silva and Kondrashov 
2002; Gaffney and Keightley 2005; Mikkelsen et al. 2005). 
 
Whatever is generating variation in the mutation rate over a scale of 1MB must be a 
factor that operates on this scale.  There are a number of possible candidates.  It has 
recently been shown that the rate of mutation is correlated to replication time 
(Stamatoyannopoulos et al. 2009) with late replicating regions of the genome having a 
mutation rate that is ~30% higher than early replicating regions.  This increase is 
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observed for both CpG and non-CpG mutations, although it is much more evident for 
the former.  Stamatoyannopoulos et al. (2009) suggest that this is due to accumulation 
of single stranded DNA late in the cell cycle, driven by stalling of DNA polymerase 
enzymes in late replicating regions due to heterochromatic DNA or by a full depletion 
of nucleotides pools.  Alternatively, there may be more mutations occurring in late 
replicating regions due to collisions between replication and transcription machinery 
(Mirkin and Mirkin 2007), however this seems unlikely since there is a negative 
correlation between the two events (Chen et al. 2010).  It has also been suggested that 
the activity and fidelity of repair enzymes may decrease throughout replication 
(Holmquist and Filipski 1994; Chen et al. 2010), although there is currently no evidence 
for this. 
 
The idea that replication time might influence the rate and pattern of mutation has a 
much older history; Wolfe, Sharp, and Li (1989) originally suggested that changes in 
the dNTP pools through the cell cycle might induce changes in the GC content and 
mutation rate based upon a correlation between GC content and the rate of synonymous 
substitution.  DNA precursor pools are very small, often only sufficient for only a few 
minutes of replication (Meuth 1989), thus small changes in nucleotide ratios may have a 
big impact on mutation rate.  Unfortunately, the direction and strength of the 
relationship between GC content and mutation rate is open to much debate, and 
different studies have shown positive (Matassi, Sharp, and Gautier 1999; Smith, 
Webster, and Ellegren 2002), negative (Filipski 1988; Hellmann et al. 2005), and other 
more complex (Wolfe, Sharp, and Li 1989; Wolfe and Sharp 1993; Eory, Halligan, and 
Keightley 2010) correlations.  However, although there is some debate about the nature 
of the relationship between the mutation rate and GC content, there is a consensus that 
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GC content explains relatively little of the variance in the mutation rate, and that there is 
significant variation in the mutation rate when GC content is controlled for (Matassi, 
Sharp, and Gautier 1999; Hellmann et al. 2005).  For example, Smith, Webster, and 
Ellegren (2002) showed that GC content only explained 10% of the variation in 
substitution rates, and so other factors are clearly involved.  It is perhaps surprising that 
mutation rates are not more strongly correlated to GC content since there is a general 
bias towards GC>AT mutations, however the variance in GC content across human 
chromosomes is not that large; 75% of 1MB regions of the genome lie within ~36-46% 
GC content (Venter et al. 2001).  It is worth noting that the mutation rate still correlates 
significantly to the timing of DNA replication when GC content is controlled for (Chen 
et al. 2010).  
 
Another feature that correlates with mutation rates is chromatin structure, with more 
mutations occurring in closed chromatin rather than open chromatin (Prendergast et al. 
2007; Ying et al. 2010).  This may be explained by varying repair efficiencies of 
different enzymes in closed and open chromatin (Filipski 1988; Sueoka 1992; Matassi, 
Sharp, and Gautier 1999; Gaffney and Keightley 2005).  However, some doubt over a 
direct causal relationship between the two factors has arisen since Chen et al. (2010) 
showed that the correlation is no longer significant when controlling for replication 
timing.  There are also various anomalies, such as the high rate of substitution on 
chromosome 19 despite the chromosome being particularly enriched with open 
chromatin (Prendergast et al. 2007), which would need to be explained under this 
model. 
 
Although it is understood that the rate of mutation varies on a regional scale, it is not 
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fully understood which mechanism is driving the affect and whether other currently 
undiscovered factors may also play a part.  It seems that replication timing has some 
effect on regional variation in the mutation rate, however since the level of variation on 
this scale is small compared to more local effects, these processes may ultimately have 
little effect on mutation rates genome wide.  It is also not known how regional patterns 
of mutation might vary among different individuals and between different cell types, 
and other factors such as chromatin structure may become more important in different 
scenarios.  In chapter 5 we consider the regional patterns of mutation in four cancer 
genomes in an attempt to understand whether this level of variation in the mutation rate 
becomes more important in disease phenotypes.  We also consider whether regional 
variation in the mutation rate can play an important role as we consider the extent to 
which it might be driving changes in disease genes themselves.  
 
1.2.4 Chromosomal variation in the mutation rate 
 
Mutation rates are also known to vary between chromosomes.  The strongest differences 
exist between the sex chromosomes and the autosomes, with the Y-chromosome having 
a higher mutation rate than the autosomes, which has a higher mutation rate than the X-
chromosome.  This pattern has been shown in primates (Ebersberger et al. 2002; 
Malcom, Wyckoff, and Lahn 2003; Mikkelsen et al. 2005; Goetting-Minesky and 
Makova 2006), rodents (Wolfe and Sharp 1993; McVean and Hurst 1997; Lercher and 
Hurst 2002; Malcom, Wyckoff, and Lahn 2003; Gaffney and Keightley 2005) and the 
perissodactyls (horses and rhinos) (Goetting-Minesky and Makova 2006).   
 
Two hypotheses have been proposed to explain this pattern.  First, It has been suggested 
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that it is due to males having a higher mutation rate than females because they undergo 
more cell divisions in their germ-line (Haldane 1947).  It has also been proposed that 
the male-driven bias is a consequence of mature sperm lacking in certain repair 
enzymes that leads to a higher rate of mutation (Boulikas 1992) or varying levels of 
methylation during the perigametic interval causing higher levels of mutation in males 
(Russell 1999), however a dependency on the number of cell divisions is by far the most 
supported theory.  Since the Y-chromosome is only transmitted through the male germ-
line, whereas an autosome spends 1/2 its time and the X-chromosome 1/3 of its time in 
the male, we would expect the Y-chromosome to have a higher mutation rate than the 
autosomes, which in turn should have a higher mutation rate than the X, if most 
mutations are generated by DNA replication (Miyata et al. 1987).  Several lines of 
evidence support this model.  First, the male-to-female mutation rate, α, has been 
estimated from the divergence of the Y, Z and autosomes to be between ~2 and ~7 in 
primates (Bohossian, Skaletsky, and Page 2000; Makova and Li 2002; Mikkelsen et al. 
2005; Goetting-Minesky and Makova 2006; Taylor et al. 2006), with the most reliable 
estimate in the 6-7 range (Taylor et al. 2006), and ~2 in rodents (Chang et al. 1994; 
Makova, Yang, and Chiaromonte 2004).  These predictions are reasonably consistent 
with estimates of the ratio of the numbers of male to female germ-line cell divisions; in 
humans it has been estimated that males have undergone ~6 times as many germ-line as 
females when they are 20 years old, ~10 times as many at 25 years and ~27 times as 
many at 40 years (Crow 2000; Li, Yi, and Makova 2002).  In contrast, in mice it is 
estimated that the ratio of male to female of cell divisions is much lower than in humans 
at about 2 (Chang et al. 1994).  It is worth noting that the very lowest estimates of α in 
primates can be explained by methodological problems.  Predictions of α may vary 
when using limited datasets focused in small areas of the genome as mutation rates are 
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known to vary on a regional scale (McVean 2000; Li, Yi, and Makova 2002).  Indeed, 
Goetting-Minesky and Makova (2006) showed that estimates of α can vary over 16-fold 
using different genes within the same genome; part of this large variation in the range of 
predicted α values can be explained by sampling bias and part by regional variation in 
the mutation rate.   Similarly, the lowest prediction of α was obtained by a comparison 
between humans and chimpanzees (Bohossian, Skaletsky, and Page 2000), and here 
ancestral polymorphism becomes a problem since the Y-chromosome typically has very 
little diversity (Li, Yi, and Makova 2002).  Indeed, when levels of polymorphism are 
accounted for in the common ancestor of humans and chimps, α predictions are much 
more consistent across the chromosomal classes (Ebersberger et al. 2002) and estimates 
of α are much more reliable when using primate data between more distantly related 
species, probably due to the smaller influence of ancestral polymorphisms over a longer 
period of time (Makova and Li 2002). 
 
Second, it has been shown that there is much more variation in the non-CpG mutation 
rate between the sex chromosomes and the autosomes, than for CpG mutations (Taylor 
et al. 2006).  This is consistent with most non-CpG mutations being generated by DNA 
replication, while most CpG mutations are induced by deamination, a replication 
independent process.  Nevertheless, CpG sites show a male mutation bias of ~2-3 in 
humans (Mikkelsen et al. 2005; Taylor et al. 2006).  This could be due to replication 
through a mismatch at a CpG site before it has been repaired, or due to higher levels of 
methylation on the X chromosome compared to the autosomes, leading to a depletion of 
CpG dinucleotides on the X chromosome and thus a lower CpG transition rate 
(Krawczak, Ball, and Cooper 1998; McVean 2000). 
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Third, it has been shown in birds that the Z chromosome has a higher substitution rate 
than the autosomes, which have a higher substitution rate than the W chromosome; in 
birds the female is the heterogametic sex.  This is expected since the Z chromosome 
spends 2/3rds of its life being transmitted through the male germ-line, whereas the W 
chromosome is always transmitted through the female germ-line (Ellegren and 
Fridolfsson 1997). 
 
The second theory to explain the differences between the sex chromosomes and the 
autosomes stems from an observation that estimates of α are generally larger when they 
are estimated from comparisons of the X and autosomes, rather than the Y and 
autosomes (McVean and Hurst 1997); the X-chromosome appears to have a mutation 
rate that is lower than expected from the male mutation bias hypothesis.  It has been 
suggested that this might be due to strong selection to reduce the mutation rate on the 
X-chromosome since mutations are hemizygous, and so effectively dominant, in males 
and often effectively hemizygous in females because of dosage compensation.  
However, the theory has since been questioned by Malcom, Wyckoff and Lahn (2003), 
who showed that the substitution rate of the X chromosome is actually compatible with 
the male-driven mutation theory using a larger dataset. 
 
As well as the differences between sex chromosomes and the autosomes, there is also 
significant variation in the substitution rate amongst the autosomes (Ebersberger et al. 
2002; Lercher and Hurst 2002; Malcom, Wyckoff, and Lahn 2003; Gaffney and 
Keightley 2005; Mikkelsen et al. 2005), which implies that chromosomal differences 
are not entirely driven by male-driven mutation.  However, the variance between 
chromosomes is ~10-fold smaller than the variance between sub-chromosomal sections 
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at the 1MB scale (Wolfe and Sharp 1993).  The reasons for the between chromosomal 
differences remain obscure.  There is a strong positive correlation in rodents between 
the amount of rearrangement a chromosome has undergone and the rate of substitution 
(Pink et al. 2009); rearrangement explains 56% of the variance in chromosomal 
substitution rates.  This may be driven by a link between recombination and 
chromosomal rearrangements; recombination is thought to be mutagenic (Lercher and 
Hurst 2002; Hellmann et al. 2003; Hellmann et al. 2005), and thus chromosomes that 
undergo higher rates of recombination may contain more mutations and also contain 
more rearrangement events (Pink et al. 2009).  Furthermore, Pink and Hurst (2010) 
showed that substitution rates in rodents can partially be explained by differences in 
average replication timing between chromosomes; however this explains little of the 
variance as there is only about 4.5% difference in the rate of substitution between the 
earliest and latest replicating autosomes.  However, replication timing and chromosomal 
rearrangements make independently significant contributions to chromosomal mutation 
rates, and together it is estimated that they explain ~70% of the variance between 
chromosomes (Pink and Hurst 2010).  
 
Variation in the mutation rate between the sex chromosomes and the autosomes is a 
well-characterized phenomenon, and there is a lot of evidence to suggest that it is driven 
by male mutation bias.  However, the processes driving variation in the mutation rate 
among the autosomes are less clear and it is not certain whether patterns on this level 
are driven entirely by variation on a regional scale.  It is difficult to see why one 
autosome should have a higher mutation rate than any other, outside of processes 
occurring on smaller scales.  As with variation on a regional scale, it is also unknown 
whether chromosomal mutation rates might vary more widely under different conditions 
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and in different individuals.  Again, in chapter 5 we consider the rates of chromosomal 
mutation in cancer genomes in order to identify whether there is variation beyond that 
observed in the germ line. 
 
1.3 Concluding remarks 
 
There is significant variation in mutation rates across various scales in mammalian 
genomes, and analysis of sequence data has been an important tool in revealing and 
explaining those patterns.  However, there are many mutation patterns and molecular 
processes yet to be fully understood and further analysis may need to go beyond 
primary sequence context to higher orders of DNA conformation.  The ultimate causes 
of mutation rate variation appear complex and no single mechanism can explain the 
differences that exist over many scales.  However, it is interesting to consider how 
variation in the mutation rate is tolerated within a genome, and whether certain areas 
may have evolved to mutate at higher rates to increase the rate of evolution or lower 
rates to avoid harmful mutations (McVean and Hurst 1997; Ellegren, Smith, and 
Webster 2003).  Perhaps the biggest mystery is whether the patterns and processes 
outlined above can account for the majority, if not all, of the variation in the rate of 
mutation that occurs across the human genome, and indeed within the human 
population. 
 
In this thesis I consider other factors that can influence the rate of mutation, particularly 
at single sites in order to better understand how mutation rates can vary.  In chapters 2 
and 3, I consider whether the rate of mutation at single sites can vary independently of 
patterns associated with neighbouring nucleotides and other local contexts, and whether 
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any regional genomic feature can impact upon this.  In this way we may be able to make 
predictions on the impact of varying rates of mutation at single sites, which can affect 
our outlook on evolution and disease.  In chapter 4, I identify and seek to explain an 
excess of tri-allelic sites in the human genome by invoking a process by which two new 
alleles are generated at a single site in a single or tightly linked series of events.  Finally, 
in chapter 5, I look at how patterns of somatic mutations vary over a number of different 
scales in cancer genomes, in an attempt to better understand how the rate of mutation 
can vary under different conditions and in different individuals. 
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2. Cryptic Variation in the Human Mutation Rate 
 
 
2.1 Abstract 
 
The mutation rate is known to vary between adjacent sites within the human genome as 
a consequence of context, the most well studied example being the influence of CpG 
dinucelotides.  Here we investigate whether there is additional variation by testing 
whether there is an excess of sites at which both humans and chimpanzees have a single 
nucleotide polymorphism (SNP).  We find a highly significant excess of such sites and 
demonstrate that this excess is not due to neighbouring nucleotide effects or natural 
selection, and although we are unable to rule out a contribution from ancestral 
polymorphism and substitutions in paralogous sequences, it seems unlikely that these 
processes can explain much of the excess of coincident SNPs.  We therefore infer that 
there is cryptic variation in the mutation rate.  However, although this variation in the 
mutation rate is not associated with the adjacent nucleotides, we show that there are 
highly non-random patterns of nucleotides that extend ~80bp on either side of sites with 
coincident SNPs, suggesting that there are extensive and complex context effects.  
Finally, we estimate the level of variation needed to produce the excess of coincident 
SNPs and show that there is possibly at least as much variation in the mutation rate 
associated with this cryptic process as there is associated with adjacent nucleotides, 
including the CpG effect.  We conclude that there is substantial variation in the 
mutation rate that has, until now, been hidden from view. 
 
 
 35 
2.2 Introduction 
 
The mutation rate is thought to vary across the human genome on several different 
scales.  At the chromosomal level, the Y-chromosome evolves faster than the 
autosomes, which evolve faster than the X-chromosome (Miyata et al. 1987; Li, Yi, and 
Makova 2002).  This is thought to be due to males having a higher mutation rate than 
females.  The autosomes also appear to differ in their rates of mutation for reasons that 
are unclear (Lercher, Williams, and Hurst 2001; Gaffney and Keightley 2005).  At the 
next level down, there appears to be variation in the mutation rate over a scale of several 
hundred kilobases (Matassi, Sharp, and Gautier 1999; Gaffney and Keightley 2005), 
another pattern that remains unexplained.  However, the most dramatic variation in the 
mutation rate is observed over fine scales in which adjacent sites can have very different 
mutation rates.  In the nuclear genome, this variation has been shown to be associated 
with context, the best-known example being the CpG dinucleotide in mammals.  CpG 
dinucleotides are generally methylated in mammals and since methyl-cytosine is 
unstable, this leads to a high rate of C->T and G->A transitions at these sites, which is 
about ten- to twenty-fold higher than at other sites (Coulondre et al. 1978; Bird 1980).  
However, the CpG effect is not the only source of fine-scale variation in the mutation 
rate; the rate of mutation appears to vary by about two or three-fold as a function of 
other adjacent nucleotides (Blake, Hess, and Nicholsontuell 1992; Rogozin and Pavlov 
2003; Zhao et al. 2003; Hwang and Green 2004).  Furthermore, the pattern of mutation 
is known to differ between the two DNA strands due to repair biases that occur during 
transcription, leading to an excess of G/T over A/C on the coding strand of genes (Green 
et al. 2003; Gibbs et al. 2004).  
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Although variation in the mutation rate has been well characterised in terms of adjacent 
nucleotides (Blake, Hess, and Nicholsontuell 1992; Zhao et al. 2003; Hwang and Green 
2004), it is possible that there is other variation in the mutation rate that is associated 
with either distant or complex context effects, which has hitherto escaped detection.  
Here we investigate this question by testing whether human and chimpanzee single 
nucleotide polymorphisms (SNP) occur at orthologous sites in the genome.  If there is 
variation in the mutation rate we expect to see an excess of sites at which both humans 
and chimpanzees have a SNP. 
 
 
2.3 Materials and methods 
 
2.3.1 Data 
 
In order to consider the number of human and chimpanzee coincident SNPs we obtain 
polymorphism data from dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP/), which is 
a public repository for genetic variation.  It includes variation data for single nucleotide 
polymorphisms (SNPs), single base insertions and deletions, multi-base small scale 
insertions and deletions, retro-transposable element insertions and microsattelite repeats 
(Sherry et al. 2001).  In this study we focus on SNPs.  For humans, variant entries are 
submitted from the SNP consortium, the genomic sequence from the human genome 
project, various large-scale variant detection studies and individual lab contributions, 
obtained through a mixture of sequencing and other genotyping methods.  Chimpanzee 
SNPs are largely contributed by the chimpanzee genome sequencing project, but also 
from other individual lab contributions (Kitts and Sherry 2010).  Most SNPs included in 
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the database are from direct submission information, however some SNP entries are a 
result of computational calling based on originally submitted data, where new 
submissions match to the reference sequence and indicate a new variant.  Each SNP 
entry contains flanking sequence, which must be of a minimum length to increase the 
likelihood of a unique match to the reference sequence, population and sample sizes, a 
validation status, details on the detection method and may also include allele and 
genotype frequencies.  The genomic location of each SNP is given, which is obtained 
by BLASTing new submissions to the reference genome.  Repeats are masked during 
the BLAST process via the ‘Dust’ option and the locations of variants are only 
confirmed if there is a reasonable match to unmasked sequence; if this criteria is met, 
alignments are allowed to extend into masked regions (Kitts and Sherry 2010).  
Confirmed SNP entries are then linked to numerous other databases, which include 
PubMed (http://www.ncbi.nlm.nih.gov/pubmed) and the Online Mendelian Inheritance 
in Man website (http://www.ncbi.nlm.nih.gov/omim).  There has been much debate on 
the quality of data found in dbSNP, and some researchers have highlighted errors in 
sequencing and SNP calling.  Mitchell et al (2004) have suggested that ~15-17% of 
entries in dbSNP are sequencing errors, the majority of which arise from errors made by 
base calling software, particularly at heterozygous sites.  Furthermore, Musumeci et al 
(2010) have shown that ~8.32% of human SNP entries may be false positives due to 
substitutions in paralogous sequences being incorrectly called as SNPs.  
 
2.3.2 Coincident SNPs 
 
We downloaded human and chimpanzee SNPs from dbSNP build 126.  Dividing the 
data into chromosomes we BLASTed each chimpanzee SNP, along with 50bp of 
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flanking DNA on either side of the SNP, against a database of human SNPs. We set the 
BLAST parameters as follows; e-value = 1x10-30, mismatch score = -1 and simple 
sequence filter off.  We retained those alignments which were 101bp in length, and in 
which the human or chimpanzee sequence showed identity at 96 sites if the SNPs were 
coincident, or 94 sites if they were not coincident.  We adjusted the number of matches 
required to control for the fact that if the SNPs are not coincident then there must be two 
extra mismatches.  We randomly chose one alignment if a chimpanzee SNP matched 
more than one human SNP at the levels of identity we set; we obtained very similar 
results removing these cases from the analysis.  The alignments were trimmed to 40bp 
either side of the central chimpanzee SNP because there is a slight bias away from 
finding human SNPs at the edges of the chimpanzee query sequence.  This bias occurs 
because SNPs, being classified as mismatches, tend to cause BLAST to prematurely 
terminate the alignment.  To perform the analysis of triplet frequencies we downloaded 
an extended flanking sequence for the chimpanzee SNPs analysed. 
 
The macaque SNPs were kindly provided by Dr Ripan Malhi (2007). We repeated the 
analysis as we did for chimpanzee but we relaxed the criteria used to identify 
orthologous human sequences containing SNPs to 86 matches if there was a coincident 
SNP, and 84 if there was not, with the e-value adjusted to allow this level of similarity 
to be found. 
 
Sites were designated as CpG if the site, or any of the SNPs at the site, would yield a 
CpG dinucleotide. 
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2.3.3 Estimating the expected number of coincident SNPs 
 
To estimate the expected number of coincident SNPs under the null hypothesis, 
ignoring any context effects, we divided the total number of alignments that contained 
both a human and chimpanzee SNP by 81.  Since the chimpanzee SNP always occurs in 
the central position of the 81bp sequence, if the human SNP is distributed randomly 
across the alignment, it is expected to be in the central position once in every 81 
alignments at random. 
 
We estimated the expected number of coincident SNPs, taking into account the effects 
of adjacent nucleotides on the rate of mutation, what we term “simple” context effects, 
as follows.  Our data consists of a set of alignments in which we have both a human and 
a chimpanzee SNP.  We start by tabulating the numbers of each triplet, nxyz, where x, y 
and z can be T, C, A or G, in the chimpanzee sequence in the alignments, along with the 
number of chimp triplets that have a human SNP opposite the central nucleotide, 
nxyz.Hsnp. From these, we can estimate the probability of observing a human SNP 
opposite a chimpanzee triplet in our alignments: pxyz = nxyz.Hsnp / nxyz.  We can also 
calculate the frequency of each triplet in the chimpanzee sequences: fxyz = nxyz / Σ nxyz.  
To calculate the probability that the human and chimpanzee SNPs are coincident, we 
need to take into account that there are two chimpanzee alleles, and the triplets they are 
a part of will have different probabilities of having a human SNP opposite them.  If we 
knew the relative frequencies of the chimpanzee alleles we could calculate the chance of 
a coincident SNP as gy pxyz + (1- gy) pxy’z where y and y’ are the two chimpanzee alleles 
and gy is the frequency of the y allele.  However, we do not have allele frequency 
information, so we calculated the relative probabilities of each of the two ancestral 
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states for the chimpanzee SNP, since the ancestral allele is likely to be at higher 
frequency in the population.  For example, let us imagine we have a CYC SNP – i.e. a 
Y SNP surrounded by C on both sides.  The ancestral triplet could have been CCC or 
CTC.  The probability that it was CCC can be estimated as mCCC = fCCC rCCC.snp / (fCCC 
rCCC.snp + fCTC rCTC) where rxyz is the rate at which triplet XYZ generates a SNP in the 
central position of the triplet.  We estimate rxyz by orienting the chimp SNPs using the 
human sequence, excluding coincident SNPs and SNPs for which the human nucleotide 
is different to both chimp alleles; let sxyz.Csnp be the number of chimp triplets that are 
inferred to have generated a SNP, then rxyz.snp = sxyz,Csnp / nxyz.  The expected number of 
coincident SNPs in each alignment is then, using the above example, (mCCC pCCC + mCTC 
pCTC) / Σ pxyz, where the summation is across all the triplets in the alignment.  The total 
number of expected coincident SNPs was simply the sum across alignments.  
 
We used two methods to calculate the standard error for the ratio of the observed 
number of coincident SNPs over the expected number; we bootstrapped the data by 
alignment and then summed the observed and expected values across the bootstrapped 
datasets.  However, it turned out that this was very closely approximated by assuming 
that the observed number of coincident SNPs was Poisson distributed and the expected 
value was known with no error; these are the standard errors we present. 
 
2.3.4 Simulations 
 
We performed a number of simulations to check that the BLAST analysis was not 
biased and that our method to estimate the number of coincident SNPs under simple 
context effects worked well.  In each simulation we obtained 300MB of human 
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sequence data at random from the reference human genome (GRCh37) and then 
evolved the sequence under various mutation patterns, in which the mutation rate 
depended upon the adjacent nucleotides and the type of mutation, to generate simulated 
human and chimpanzee sequences.  Sequences were diverged by 0%, 0.5% or 1% from 
the reference sequence to generate human and chimp sequences that were 0%, 1% and 
2% divergent in total.  In the case of the 1% divergence simulations, we used three 
times as much data to improve the accuracy of our point estimate, since this level of 
divergence is the most realistic for the divergence between human and chimpanzee 
(Mikkelsen et al. 2005).  Into these sequences we then introduced SNPs according to the 
same mutation pattern as was used for the divergence step, at the density found in 
dbSNP – one SNP every 266bp in humans and every 2128bp in chimp.   Each SNP was 
extracted from the simulated human and chimp sequences; we constructed a BLAST 
database of ~1.1 million human SNPs with 100bp of flanking DNA sequence, and a 
query dataset of ~140,000 chimpanzee SNPs with 50bp of flanking DNA in each case 
(with ~3 times as many SNPs for 1% divergence simulations).  We ran the BLAST 
analysis and analysed the output exactly as we had the real data.  We performed 
simulations under four different mutation scenarios.  In the first we had no mutation 
bias for all sites and types of mutation, except for CpG transitions, which mutated at 1, 
10, 15, 20 and 30 times the average mutation rate of all other sites.  In the second we 
introduced a simple transition/transversion bias, where transition mutations occurred 
twice as frequently as transversions at all sites, except for CpG transitions, which again 
mutated at 1, 10, 15, 20 and 30 times the average mutation rate of all other sites.  This 
pattern of mutation is similar to the broad patterns suggested to occur in the human 
genome (Zhao and Boerwinkle 2002).  In the third model, we incorporated a more 
complex pattern of mutation as suggested by Zhang et al (2007) in which CpG 
 42 
transversions occur 2.5 times more frequently than non-CpG transversion and non-CpG 
transitions occur 4.5 times more frequently than non-CpG transversions.  Again, CpG 
transitions occured at 1, 10, 15, 20 and 30 times the average mutation rate of all other 
sites.  Finally, the fourth model incorporates the most complex pattern of mutation rates 
that are obtained from a study by Hwang and Green (2004).  In this model the mutation 
rate of each site is a function of it’s neighbouring nucleotides and the type of mutation, 
much as is expected to occur in the human genome, and CpG transitions occur ~16.7 
times more frequently than the average mutation rate at all other sites. 
 
2.3.5 Paralogous SNPs 
 
In order to rule out the effects of paralogous sequences in generating an excess of 
human and chimpanzee coincident SNPs we proceeded as follows.  We obtained the full 
fasta sequences for each coincident SNP from the dbSNP website 
(http://www.ncbi.nlm.nih.gov/projects/SNP/).  We then BLASTed these SNPs against 
the GRCh37 version of the reference human genome, using the parameters outlined in 
Musumeci et al (2010), except we increased the expected value to 0.1 to increase the 
likelihood that each SNP aligned to the reference sequence.  This approach is likely to 
be more conservative, since it tends to increase the number of genomic hits at 
coincident SNP sites.  Then, following the method in Musumeci et al (2010), we 
extracted only those alignments that contained the SNP position and where at least 20% 
of the full length SNP sequence had at least 90% sequence identity.  Coincident SNP 
sequences with single hits to the reference genome were considered genuine and 
therefore not a consequence of different nucleotides being present at the same position 
in paralogous sequences.  For sequences with multiple hits, if only one of the SNP 
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alleles was present at the SNP position across all alignments, the SNP was considered 
genuine; if both alleles were present the SNP was considered to be a consequence of 
substitutions in paralogous sequences and therefore a false positive.  Finally, if any of 
the alleles across matching alignments at the SNP site were not the same as those found 
in the original SNP, the site was defined as undetermined. 
 
2.3.6 Strand asymmetry 
 
To investigate strand asymmetry, we estimated the mutation rate of the central 
nucleotide in each triplet by tabulating the number of times each triplet contained a 
SNP.  The direction of mutation was inferred from the frequency; i.e. the minority allele 
was judged to be the new mutation.  We inferred mutation rates across 964 human 
genes from the Seattle SNPs (SeattleSNPs 2008) and Environmental Genome Projects 
(NIEHS-SNPs 2008).  To investigate which of these genes are expressed in the male 
germ-line we downloaded gene expression data from the human testis from the study of 
Ge et al. (2005).  We obtained raw CEL files of gene expression levels from the NCBI 
Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/projects/geo/).  We 
normalized the results from the mouse and rat arrays separately using the RMA 
algorithm (Irizarry et al. 2003) as implemented in Bioconductor (Gentleman et al. 
2004). We judged a gene to be expressed within the testis if its expression was above 
200 (Su et al. 2004). 
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2.3.7 Ancestral Polymorphism 
 
In order to model the possible contribution of neutral ancestral polymorphisms to 
coincident SNPs we proceeded as follows.  We started by simulating the coalescent 
process of a single site in a standard manner by summing random numbers from a series 
of exponential distributions, in which the mean time to coalescence of m to m-1 lineages 
is proportional to 1/(m(m-1)); this sum was multiplied by 4 so the sum would be the 
time to coalescence in Ne generations.  We assumed that the generation time of human 
and chimpanzee is 25 years (Eyre-Walker and Keightley 1999), that current human and 
chimpanzee nucleotide diversity levels are 0.001 (Sachidanandam et al. 2001; Venter et 
al. 2001) and 0.002 (Mikkelsen et al. 2005) respectively, and that the nucleotide 
diversity of the common ancestor is between 1 and 10 times larger than human diversity 
levels, consistent with current estimates that the common ancestor of human and 
chimpanzee may have had an effective population size 4-10 times larger than the 
current human effective population size (Wall 2003; Burgess and Yang 2008).  We also 
assumed that human and chimpanzee diverged 5 million years ago, which is likely to be 
conservative (Benton and Donoghue 2007).  Since the long-term average effective 
population size along the lineages leading from human and chimpanzee are unknown, 
we modeled three scenarios where the average effective population size of human and 
chimp were 10000, 20000 and 40000.  Furthermore, we assumed that the number of 
chromosomes sampled during the initial discovery of the SNP was 50 and 2 for humans 
and chimp respectively; the results are very similar if the number of chromosomes 
sampled varies over a realistic parameter range.  We performed each simulation 50,000 
times under each set of parameters and the likelihood of an ancestral polymorphism 
segregating in both species was found by multiplying the proportion of genealogies that 
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extend back far enough in human and chimpanzee, by the diversity in the common 
ancestor.  This is a slight overestimate of the likelihood that an ancestral polymorphism 
will be present and sampled in both species, since not all genealogies connecting two 
human and two chimp lineages will generate a polymorphism that will be inherited by 
both species. The expected number of ancestral polymorphisms surviving to the present 
in both species was then compared to half the observed number of coincident SNPs, 
since approximately one half of coincident SNPs are due to chance alone. 
 
2.3.8 Log-normal model 
 
We estimated the variation in the mutation rate as follows.  We start by assuming there 
is no divergence between humans and chimpanzees so a hypermutable site in humans 
will also be hypermutable in chimpanzees.  Let the average probability of detecting a 
SNP at a site in humans and chimpanzees be µh and µc respectively; if µh and µc are 
small, the probability at a particular site be γµh and γµc, where γ is the relative rate of 
mutation.  Let us assume that γ takes some distribution D(γ) which has a mean of one.  
The expected number of coincident SNPs is 
 
! 
P = D(")µhµc" 2d"#        (2.1) 
 
If there is no variation in the mutation rate then this reduces to  
 
! 
P0 = µhµc         (2.2) 
 
 46 
such that the ratio of the number of coincident SNPs, over the number expected with no 
variation, is 
 
! 
Z = PP0
= D(")" 2d"#        (2.3) 
 
an equation which only depends upon the distribution of γ.  We assume that γ is either 
log-normally distributed, or that it has a two state distribution in which sites can either 
be hypermutable or normal (see appendix 2.1).  We estimate the parameters of the 
distribution of γ by considering the ratio of the observed number of SNPs over the 
number expected with simple context effects (i.e. the number expected without cryptic 
variation in the mutation rate). 
 
This model is unrealistic because we assume that a site does not change its mutation 
rate; however, hypermutable sites are more likely to change, and this may lead them to 
become non-hypermutable.  Under the log-normal model we assume that once a site 
changes, its mutation rate is drawn randomly from the log-normal distribution. Let v be 
the average rate of mutation per unit time in both humans and chimpanzees.  Consider a 
site, in the ancestor of humans and chimpanzees, which currently has a mutation rate vγ.  
The probability that the site will remain unchanged along both the human and 
chimpanzee lineage is 
 
! 
Qu = e"2v#t         (2.4) 
 
where t is the time since humans and chimpanzees diverged.  The probability that such a 
site will produce a coincident SNP is 
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! 
Pu = µhµc D(")e#2v"t" 2d"$        (2.5) 
 
If the site changes in one of the lineages, then the mutation rates in the two lineages 
become independent of one another; since the mean of a product is the product of the 
means, when two random variables are independent, the probability of a coincident SNP 
at a site which has undergone at least one substitution is 
 
! 
Pd = µhµc D(")(1# e#2vt"$ )d"       (2.6) 
 
The expected number of SNPs with no variation in the mutation rate is still P0, as given 
by equation 2.2, so we can write the ratio of the expected number of coincident SNPs 
with variation over the expected number without variation in the mutation rate as 
 
! 
Z = Pu + PdP0
= D(")e#2v"t" 2d"$ + D(")(1# e#2vt"$ )d"     (2.7) 
 
This equation depends on the compound parameter 2vt, which is the average divergence 
between humans and chimpanzees and the distribution of γ.  Since we set the average of 
the log-normal distribution to one, we need only find the shape parameter of the log-
normal distribution. 
 
To estimate the variance associated with simple context effects we calculated the 
mutation rate of each triplet as above, when correcting simple context effects.  We then 
scaled the mutation rates so the mean across triplets, taking into account their 
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frequencies in the genome, had a mean of one. We then calculated the variance.  This 
can be compared directly to the variance of the log-normal distribution, which we had 
also constrained to have a mean of one.  We weighted the variance estimates from the 
CpG and non-CpG sites by the relative frequency of the sites. 
 
 
2.4 Results 
 
2.4.1 Excess of coincident SNPs 
 
To investigate whether human and chimpanzee SNPs tend to occur at the same sites in 
the genome, we BLASTed all chimpanzee SNPs against a dataset of human SNPs.  This 
yielded a dataset of 309,158 alignments of 81 base pairs (bp) with the chimpanzee SNP 
in the central position and a human SNP elsewhere within the alignment. Of these 
alignments, 11571 have the human and chimpanzee SNP at the same position (figure 
2.1); we refer to these as coincident SNPs.  This number of coincident SNPs is much 
greater than the 3817 we would expect if the human SNPs were distributed at random 
across the alignment, and also much greater than the 6592 we would expect taking into 
account the influence of the adjacent nucleotides on the mutation rate, henceforth 
known as “simple” context effects.  The observed excess of coincident SNPs is 
significantly greater than the expected number (ratio of observed over expected with 
simple context effects = 1.76 with a standard error of 0.02, p < 0.0001 under the null 
hypothesis that the ratio is 1).  
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a) 
  Chimpanzee 
  C/T G/A C/A G/T C/G A/T 
C/T 3840 11 181 98 197 73 
G/A 14 3708 95 171 189 101 
C/A 226 107 291 3 48 27 
G/T 114 254 0 304 48 16 
C/G 190 194 46 51 217 3 
H
um
an
 
A/T 81 89 33 19 0 532 
b) 
  C/T G/A C/A G/T C/G A/T 
C/T 1.91  1.04 1.19 1.21 0.96 
G/A  1.83 1.24 1.02 1.14 1.40 
C/A 1.23 1.08 4.81  1.28 1.39 
G/T 1.15 1.38  4.95 1.27 0.77 
C/G 1.09 1.14 1.24 1.4 2.79  
H
um
an
 
A/T 0.94 1.06 1.79 0.99  15.43 
 
 
Table 2.1. The pattern of coincident SNPs. a) Number of times a particular SNP in 
humans is found opposite a particular SNP in chimpanzees. b) The observed number of 
SNPs over the number expected with simple context effects; for clarity cells in which 
the observed number of SNPs were less than 20 have been removed because they 
generate ratios with very large variances. CpG sites are included; see appendix 2.2 for 
an equivalent table with CpG sites excluded.  
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This excess is not due to our inability to correct for CpG effects; if we remove CpG 
dinucleotides from the analysis we observe 5028 coincident SNPs but would only 
expect 2533 taking into account simple context effects (ratio = 1.98 (0.03); p < 0.0001).  
If we look at the pattern of coincident SNPs, it is evident that almost all the excess is 
due to the same SNP being present in both humans and chimpanzees, with A-T/A-T 
SNPs being dramatically over-represented (table 2.1; see appendix 2.2 for the analysis 
with CpG sites removed). 
 
Although the excess of coincident SNPs is consistent with variation in the mutation rate 
that is not associated with simple context, there are several other explanations that 
warrant consideration. 
 
2.4.2 Simulations 
 
In order to check that our method for estimating the expected number of coincident 
SNPs works well, we performed a number of simulations under various patterns of 
mutation and different levels of human and chimp divergence, in each case generating 
simulated SNP datasets that were analysed in the same way as the original analysis.  In 
the basic model all sites were assumed to mutate at the same rate, except for CpG 
transitions, which mutated at 1, 10, 15, 20 and 30 times the average rate of all other sites 
(results shown in table 2.2).  In the simple transition/transversion model, transition 
mutations occurred twice as frequently and transversions, except for CpG transitions, 
which mutated under the same conditions as in the basic model (table 2.3).  In the 
complex transition/transversion model, the patterns of mutation rate mirrored the broad 
categories as outlined in a study by Zhang et al (2007), except for CpG transitions 
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which again mutated at a rate as outlined in the basic model (table 2.4).  Finally, in the 
Hwang and Green model, sites mutated at a rate as observed in the study by Hwang and 
Green (2004), which are thought to be the same as those observed in the human genome 
(table 2.5).  
 
First, the results show that varying the rates of mutation for all mutation types except 
CpG transitions has little effect on the reliability of the method.  All models except the 
Hwang and Green model show very similar patterns; when all sites are considered there 
is a tendency to slightly underestimate the expected number of coincident SNPs – this 
bias increases with increasing CpG transition rate.  The bias appears to be maximal 
when the divergence is 1%.  The maximum level of underestimate is such that the 
observed over expected ratio is 1.14.  In contrast, if we consider non-CpG sites the 
method tends to slightly overestimate the expected number of coincident SNPs.  Under 
the Hwang and Green model, which fixes the rate of CpG transition at ~16.7 times the 
average rate of mutation at all other sites, results are consistent with other models as the 
method predicts an observed over expected coincident SNP ratio similar to those 
observed when the mutation rate for CpG transitions is 15-20 times higher than other 
sites; there is little or no bias for all sites and a slight overestimate for non-CpG sites.  
These results tell us that the model of mutation patterns is unlikely to affect the 
predictions made by our method. 
 
Second, our method works well at all divergences and under all mutation patterns, 
except when the CpG rate is very high, where the method tends to underestimate the 
expected number of coincident SNPs.  Surprisingly, in the majority of cases the method 
tends to slightly overestimate the expected number of coincident SNPs when CpG sites  
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All sites Non CpG sites Div 
(%) 
CpG 
rate Obs Exp Ratio 95% C.I. Obs Exp Ratio 95% C.I. 
0 1x 515 552 0.934 (0.853,1.014) 442 450 0.983 (0.891,1.074) 
0 10x 603 613 0.983 (0.905,1.062) 407 408 0.997 (0.900,1.094) 
0 15x 685 675 1.015 (0.939,1.091) 359 387 0.926 (0.831,1.022) 
0 20x 775 778 0.996 (0.926,1.066) 340 370 0.918 (0.820,1.016) 
0 30x 992 880 1.128 (1.058,1.198) 312 316 0.988 (0.878,1.097) 
1 1x 1592 1624 0.981 (0.932,1.029) 1282 1290 0.994 (0.940,1.048) 
1 10x 1782 1807 0.986 (0.941,1.032) 1163 1162 1.001 (0.944,1.059) 
1 15x 2007 1992 1.008 (0.963,1.052) 1083 1105 0.980 (0.922,1.039) 
1 20x 2345 2185 1.073 (1.029,1.117) 1073 1057 1.015 (0.955,1.076) 
1 30x 2996 2653 1.129 (1.089,1.170) 934 965 0.968 (0.906,1.030) 
2 1x 502 507 0.989 (0.903,1.076) 392 410 0.956 (0.861,1.050) 
2 10x 511 552 0.926 (0.846,1.007) 310 375 0.826 (0.734,0.918) 
2 15x 574 599 0.958 (0.879,1.036) 344 354 0.972 (0.869,1.075) 
2 20x 611 593 1.031 (0.949,1.113) 306 313 0.978 (0.869,1.088) 
2 30x 730 687 1.062 (0.985,1.139) 268 286 0.937 (0.825,1.049) 
 
Table 2.2:  Simulation results for the basic model.  Table gives the observed and 
expected number of coincident SNPs from simulations run with different levels of CpG 
hypermutability and divergence.  The ratio of observed over expected coincident SNPs 
is also given, together with a 95% confidence interval. 
 
 
 
All sites Non CpG sites Div 
(%) 
CpG 
rate Obs Exp Ratio 95% C.I. Obs Exp Ratio 95% C.I. 
0 1x 500 549 0.911 (0.831,0.991) 402 448 0.896 (0.809,0.984) 
0 10x 597 603 0.990 (0.910,1.069) 407 417 0.977 (0.882,1.072) 
0 15x 636 666 0.955 (0.881,1.029) 372 397 0.938 (0.842,1.033) 
0 20x 776 746 1.040 (0.967,1.114) 387 381 1.015 (0.913,1.116) 
0 30x 1061 929 1.142 (1.073,1.211) 346 349 0.991 (0.886,1.095) 
1 1x 1571 1624 0.967 (0.919,1.015) 1281 1289 0.993 (0.939,1.048) 
1 10x 1674 1767 0.948 (0.902,0.993) 1094 1182 0.925 (0.870,0.980) 
1 15x 2000 1951 1.025 (0.980,1.070) 1091 1123 0.972 (0.914,1.029) 
1 20x 2240 2141 1.046 (1.003,1.090) 1056 1082 0.976 (0.917,1.035) 
1 30x 2983 2613 1.142 (1.101,1.183) 1009 980 1.030 (0.966,1.094) 
2 1x 504 510 0.987 (0.901,1.074) 409 412 0.993 (0.897,1.090) 
2 10x 557 547 1.019 (0.934,1.104) 375 380 0.988 (0.888,1.088) 
2 15x 575 593 0.970 (0.890,1.049) 338 364 0.930 (0.830,1.029) 
2 20x 702 637 1.102 (1.020,1.183) 351 349 1.006 (0.900,1.111) 
2 30x 785 743 1.056 (0.983,1.130) 299 319 0.936 (0.830,1.042) 
 
Table 2.3:  Simulation results for the simple transition/transversion model.  Table gives 
the observed and expected number of coincident SNPs from simulations run with 
different levels of CpG hypermutability and divergence.  The ratio of observed over 
expected coincident SNPs is also given, together with a 95% confidence interval. 
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All sites Non CpG sites Div 
(%) 
CpG 
rate Obs Exp Ratio 95% C.I. Obs Exp Ratio 95% C.I. 
0 1x 534 557 0.958 (0.877,1.039) 447 446 1.003 (0.910,1.096) 
0 10x 612 616 0.994 (0.915,1.072) 426 419 1.018 (0.921,1.114) 
0 15x 719 695 1.035 (0.959,1.110) 402 402 0.999 (0.902,1.097) 
0 20x 806 776 1.039 (0.967,1.111) 348 379 0.919 (0.822,1.015) 
0 30x 1091 973 1.122 (1.055,1.188) 313 349 0.897 (0.798,0.997) 
1 1x 1529 1625 0.941 (0.894,0.988) 1205 1272 0.947 (0.894,1.000) 
1 10x 1796 1812 0.991 (0.945,1.037) 1168 1184 0.986 (0.930,1.043) 
1 15x 2071 1996 1.037 (0.993,1.082) 1114 1132 0.984 (0.926,1.042) 
1 20x 2390 2223 1.075 (1.032,1.118) 1078 1080 0.998 (0.939,1.058) 
1 30x 3046 2667 1.142 (1.101,1.183) 984 986 0.998 (0.936,1.061) 
2 1x 479 513 0.933 (0.849,1.016) 389 410 0.949 (0.855,1.043) 
2 10x 552 556 0.993 (0.910,1.076) 375 380 0.987 (0.887,1.087) 
2 15x 495 502 0.987 (0.900,1.074) 285 300 0.949 (0.839,1.059) 
2 20x 669 654 1.023 (0.946,1.101) 346 350 0.989 (0.885,1.093) 
2 30x 906 763 1.187 (1.110,1.265) 296 312 0.948 (0.840,1.056) 
 
Table 2.4: Simulation results for the complex transition/transversion model.  Table 
gives the observed and expected number of coincident SNPs from simulations run with 
different levels of CpG hypermutability and divergence.  The ratio of observed over 
expected coincident SNPs is also given, together with a 95% confidence interval. 
 
 
 
All sites Non CpG sites Div 
(%) Obs Exp Ratio 95% C.I. Obs Exp Ratio 95% C.I. 
0 839 812 1.033 (0.963,1.103) 401 428 0.936 (0.844,1.028) 
1 2419 2316 1.045 (1.003,1.086) 1182 1228 0.963 (0.908,1.018) 
2 681 685 0.995 (0.920,1.069) 374 400 0.935 (0.840,1.030) 
Table 2.5: Simulation results for the Hwang and Green model.  Table gives the 
observed and expected number of coincident SNPs from simulations run with different 
levels of CpG hypermutability and divergence.  The ratio of observed over expected 
coincident SNPs is also given, together with a 95% confidence interval. 
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are removed for reasons that are not clear.  CpG transitions have been estimated to 
occur 8-18 times the average rate of all other sites (Hess, Blake, and Blake 1994; 
Nachman and Crowell 2000; Hwang and Green 2004; Lunter and Hein 2004; Zhang et 
al. 2007; Elango et al. 2008), meaning that simulations where the CpG transition rate is 
between 10 and 20 are likely to be the most informative, although the 20 fold increase 
in CpG transition rate is slightly above the level found in most studies.  Furthermore, it 
has been shown that the level of human and chimp divergence is ~1% (Mikkelsen et al. 
2005).  Over this CpG transition parameter range and a 1% level of divergence, our 
method predicts that the observed over expected ratio for all coincident SNPs is 
between 0.948 and 1.075, and for non-CpG sites the prediction is between 0.925 and 
1.015, thus performing well under realistic mutation rates.  Perhaps the most realistic set 
of mutation rates is under the Hwang and Green model, as these rates were estimated 
using a large dataset and their method incorporates many other parameters such as 
sequence type and the physical location of substitutions (Hwang and Green 2004).  
Under this model, at the 1% divergence level our method predicts that the observed over 
expected ratio for all coincident SNPs is 1.045, and for non-CpG sites the prediction is 
0.963.  As a consequence, it appears that our method introduces a very slight bias when 
predicting the number of coincident SNPs, however in the case of non-CpG coincident 
SNPs the method appears to be conservative under the most realistic conditions. 
 
2.4.3 Errors in dbSNP 
 
In order to identify the number of human and chimpanzee SNPs that are coincident we 
used single nucleotide polymorphism data obtained from the online database dbSNP.  
The data quality of this resource has been questioned (Mitchell et al. 2004; Musumeci et 
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al. 2010) and under certain conditions it may be possible that the excess of coincident 
SNPs is a consequence of these errors.  First, it has been suggested that up to ~15-17% 
of the entries in dbSNP are false positives, occurring due to sequencing errors arising 
from base calling software, particularly at heterozygous sites (Mitchell et al. 2004).  
Should errors that arise due to base calling be more prevalent for coincident SNPs, we 
might expect the frequency of coincident SNPs that are confirmed only in heterozygous 
individuals to be higher than for other SNPs.  In order to test this we obtained genotype 
information from dbSNP for coincident SNPs and compared the proportion of cases 
where the minor allele of the SNP was only confirmed in heterozygous individuals with 
the same number of random SNPs from the same resource.  We were able to obtain 
genotype information for 7025 coincident SNPs; amongst these 0.355 were confirmed 
only in heterozygous individuals (95% confidence interval: (0.341,0.369), assuming the 
number of SNPs only confirmed in heterozygotes is Poisson distributed) and for the 
same number of random SNPs, this value is 0.398 (0.384,0.413).  Since the proportion 
of SNPs confirmed only in heterozygotes is significantly higher in random SNPs than 
coincident SNPs (p<0.05), there is no evidence to suggest that coincident SNPs are 
more prone to base calling errors than other SNPs.   
 
Second, it has been suggested that a proportion of SNPs in dbSNP may be false 
positives due to substitutions occurring within paralogous regions of the human genome 
(Fredman et al. 2004; Musumeci et al. 2010), and that this may account for ~8.32% of 
entries in the database (Musumeci et al. 2010).  False positive SNPs may occur in this 
fashion if researchers are unable to discriminate between two paralogous regions of the 
genome; substitutions in these regons would then be observed as a SNP during 
sequencing.  Paralogous sequences may be problem in our analysis if a substitution 
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occurred in a duplicated region prior to the split of human and chimpanzee, as a false 
positive SNP would then be called at the same site in both species.  In order to consider 
whether paralogous sequences contribute to the excess of coincident SNPs, we repeated 
the analysis of Musumeci et al (2010) and BLASTed all coincident SNP sequences 
against the human reference genome and examined all cases where there were multiple 
matches.  Single hit sequences were regarded as genuine SNPs.  If sequences with 
multiple matches contained both alleles called at the SNP site we categorized the 
coincident SNP as a potential false positive.  Alternatively, if an allele was present in 
one or more alignment that was not the same as one of the alleles in the original SNP, 
the SNP was categorized as undetermined.   
 
In total, out of the 11,571 coincident SNPs found between human and chimpanzee, 
9,611 had a single match to the reference genome, 233 had multiple matches but only a 
single allele was found at the SNP site across all alignments, 269 had multiple matches 
to the reference genome and both SNP alleles were found at the SNP site and 95 
coincident SNPs were undetermined.  Furthermore, we were unable to match 1,363 
coincident SNP sequences to the reference genome due to the parameters of the BLAST 
search; these sequences contained some low complexity or interspersed repeats that 
interrupted the BLAST extension.  Out of the coincident SNPs that had at least one 
match to the reference genome, ~3.6% are potential false positives due to variant alleles 
in paralogous sequences, which is lower than the ~8.32% found in the study by 
Musumeci et al (2010).  However, it may be the case that a high proportion of the 
coincident SNPs that we were unable to match to the reference genome are a 
consequence of substitutions in paralogous sequences.  It is worth noting that the vast 
majority of these SNPs have been mapped to single locations on the dbSNP website, by 
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using a less stringent BLAST criteria that allows seeding of shorter length sequences 
that then extent into repeat regions (Kitts and Sherry 2010).  Under a conservative 
approach, if we assume that all coincident SNPs that we have not matched to the 
reference genome are in fact a consequence of substitutions in paralogous sequences, 
and that false positives occur at non-coincident SNP sites at the same rate as found in 
the Musumeci et al analysis (2010), we estimate that the observed over expected ratio of 
coincident SNPs reduces to 1.63 (standard error 0.016) from 1.76.  Under the same 
criteria, the observed over expected ratio for non-CpG coincident SNPs reduces to 1.81 
(standard error 0.028) from 1.98. 
 
It may also be possible that some coincident SNPs are a consequence of substitutions 
occurring in paralogous regions that have not been identified in the reference genome, 
for example, in copy number variants.  It is not possible to determine the extent of this 
phenomenon using the method above, however if a high proportion of coincident SNPs 
are a consequence of substitutions in paralogous regions, we might expect the average 
minor allele frequency at coincident SNP sites in humans to be higher than other SNP 
sites since, for example, variant alleles picked up at two different positions in the 
genome would likely be at a minor allele frequency of ~0.5.  To investigate this 
possibility we obtained the minor allele frequencies at coincident SNP sites from 
dbSNP and compared these to the minor allele frequencies at the same number of 
randomly chosen SNPs from the same resource.  In total we were able to obtain allele 
frequency information for 7801 of the coincident SNPs, which have an average minor 
allele frequency of 0.274 (95% confidence interval: (0.270, 0.277)); the same number of 
randomly chosen SNPs have an average minor allele frequency of 0.271 (0.267,0.274), 
which is not significantly different to that observed at coincident SNPs (t-test, p=0.241).  
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As the average minor allele frequency of coincident SNPs is only slightly higher than 
that of the same number of randomly chosen SNPs, it seems unlikely that a high 
proportion of coincident SNPs are a consequence of undetected paralogous regions, or 
indeed detected paralogous regions, in the human genome. 
 
2.4.4 Strand asymmetry 
 
In correcting for simple context effects, we have also made two assumptions; we have 
assumed that the pattern of mutation is the same on the two strands of the DNA duplex, 
and we have assumed that context effects are the same across the genome.  As a 
consequence of these assumptions, we could be underestimating the expected number of 
coincident SNPs.  For example, let us imagine that the central nucleotide in the triplet 
AAA has a high mutation rate on one strand, say the transcribed strand, and a low 
mutation rate on the other strand, but that the pattern is the opposite for the triplet CCC 
(note that when we refer to the mutation of a triplet, we are referring to the mutation 
rate of the central nucleotide).  Because the relative mutation rates of AAA and CCC 
depend upon which strand we are considering, we would tend to underestimate the 
expected number of coincident SNPs.  
 
The pattern of mutation is known to differ between the two DNA strands in a manner 
that depends upon transcription (Green et al. 2003; Gibbs et al. 2004).  However, what 
is important for our analysis is whether the relative mutation rates of the triplets differs 
between strands; it is the relative, rather than the absolute rate that matters, because for 
each alignment we calculate the chance of a coincident SNP relative to the chance that 
the human SNP occurs at one of the other triplets in the sequence.  To investigate this, 
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we estimated the mutation rate of the central nucleotide in each triplet for a set of 
human genes for which we knew the direction of transcription; we also considered a 
subset of these genes known to be expressed in the testis. 
 
In agreement with Green et al. (2003), we observe a 25% excess of A->G transitions 
over T->C transitions; however, we did not observe an excess of G->A transitions over 
C->T transitions, even in our testes expressed genes.  Crucially for our analysis, the 
mutation rate of each triplet is highly correlated to its reverse-complement triplet for all 
genes (Pearson correlation coefficient r = 1.00 for all triplets, r = 0.85 without triplets 
containing CpGs; appendix 2.6a) and for genes expressed in the testes (r = 0.99 for all 
triplets, r = 0.75 without triplets containing CpGs; appendix 2.6b); genes expressed in 
the testes are expressed in the male germ-line, where any strand asymmetry in the 
pattern of mutation will have an evolutionary effect.  It therefore seems unlikely that 
strand asymmetry in the pattern of mutation is leading to an underestimate of the 
expected number of coincident SNPs. 
 
2.4.5 Patterns of mutation 
 
The excess of coincident SNPs could also be due to variation in the pattern of mutation 
across the genome for reasons similar to those given for strand asymmetry; if the 
relative rate at which each triplet mutates differs between genomic regions, we will 
underestimate the expected number of coincident SNPs.  Since such variation in the 
pattern of mutation might be expected to generate differences in base composition, we 
divided our dataset of alignments according to their GC content and estimated the 
mutation rate of the central nucleotide in each triplet in the chimpanzee sequence using 
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the human sequence to infer the ancestral sequence.  The relative rates of mutation 
inferred from the sequences in the upper and low GC content quartiles are highly 
correlated to each other (r = 0.99 using all triplets; r = 0.88 excluding triplets involving 
CpGs; appendix 2.7), which suggests that triplets that are highly mutable in high GC 
content sequences also tend to be highly mutable in the low GC content sequences.  It 
therefore seems unlikely that we are underestimating the expected number of coincident 
SNPs because of variation in the pattern of mutation.  As expected, we find a significant 
excess of coincident SNPs in both the upper and lower GC quartile datasets, although 
the excess of coincident SNPs appears to be slightly stronger in GC-poor DNA 
(appendix 2.3). 
 
2.4.6 Ancestral polymorphism 
 
The excess of coincident SNPs could potentially be due to inheritance, in humans and 
chimpanzees, of polymorphisms that were present in their last common ancestor.  In 
order to attempt to quantify the contribution of ancestral polymorphisms to coincident 
SNPs we performed a number of simulations in which we modeled the genealogy of a 
site in both human and chimp and then calculated the likelihood that these genealogies 
extend back as far as the estimated divergence of human and chimp 5 million years ago; 
we assume these polymorphisms are neutral, since it is not possible to quantify the 
contribution of balanced polymorphisms.  The likelihood is then compared to the 
random expectation for the number of coincident SNPs present in current populations, 
since the excess of coincident SNPs is greater than two fold without incorporating 
context effects, to give an estimation of the contribution of ancestral polymorphism to 
coincident SNPs.  We make a number of assumptions about the human and chimp 
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populations and their demographic history – we assume an average generation time of 
25 years (Eyre-Walker and Keightley 1999), that the current human and chimpanzee 
diversity is 0.001 (Sachidanandam et al. 2001; Venter et al. 2001) and 0.002 (Mikkelsen 
et al. 2005) respectively, and that the number of chromosomes sampled during the 
initial discovery of the SNP is 50 and 2 for human and chimp respectively; the results 
are very similar if the number of chromosomes sampled varies over a realistic parameter 
range.  Furthermore, we assume that the diversity in the common ancestor of human and 
chimpanzee is 1, 5 and 10 times the current human diversity; this is in line with 
expectations that the effective population size of the common ancestor is between 4 and 
10 times that of the current human effective population size (Wall 2003; Burgess and 
Yang 2008).  The likelihood of a common polymorphism being present in both human 
and chimpanzee also depends on the long-term average effect population size along the 
lineages leading from the common ancestor to human and chimp.  The current effective 
population sizes for human and chimp are thought to be around 10,000 (Yu et al. 2001) 
and 20,000 (Hey 2010) respectively, however we have very little information about the 
long-term effective population sizes of these two species, and values could vary 
dramatically depending on whether the decrease from the larger effective population 
size assumed for the common ancestor was linear, exponential or even involved a 
population bottleneck.  Consequently, we modeled average long-term effective 
population sizes of 10,000, 20,000 and 40,000 for both human and chimpanzee. 
 
The results of the simulations are presented in table 2.6.  The contribution of ancestral 
polymorphism to coincident SNPs varies dramatically, depending on assumptions about 
the long-term average effective population size between human, chimp and their 
common ancestor, and the nucleotide diversity present in the common ancestor.  When  
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Common Ancestor 
Diversity 
Human Ne Chimp Ne Contribution to 
coincident SNPs (%) 
1x 10000 10000 0.0001 
1x 10000 20000 0.0159 
1x 10000 40000 0.1844 
1x 20000 10000 0.0083 
1x 20000 20000 1.4902 
1x 20000 40000 17.247 
1x 40000 10000 0.1035 
1x 40000 20000 18.472 
1x 40000 40000 213.79 
5x 10000 10000 0.0004 
5x 10000 20000 0.0797 
5x 10000 40000 0.9223 
5x 20000 10000 0.0417 
5x 20000 20000 7.4508 
5x 20000 40000 86.237 
5x 40000 10000 0.5174 
5x 40000 20000 92.358 
5x 40000 40000 1069.0 
10x 10000 10000 0.0009 
10x 10000 20000 0.1594 
10x 10000 40000 1.8446 
10x 20000 10000 0.0835 
10x 20000 20000 14.902 
10x 20000 40000 172.47 
10x 40000 10000 1.0348 
10x 40000 20000 184.72 
10x 40000 40000 2137.9 
 
Table 2.6:  The contribution of ancestral polymorphism to the excess of coincident 
SNPs under different long-term average effective population sizes for human and chimp 
and varying nucleotide diversity in the common ancestor. 
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the long-term average effective population sizes are assumed to be 10,000 in both 
human and chimp, the contribution of ancestral polymorphisms to the excess of 
coincident SNPs is insignificant, with estimates well below 0.001% in all cases.  If the 
average effective population sizes are assumed to be 20,000 for both human and chimp, 
the contribution of ancestral polymorphisms to the excess of coincident SNPs varies 
between ~1.5% and ~14.9%, thus making a reasonable contribution.  However, if we 
assume that the average effective population sizes for both species is 40,000, ancestral 
polymorphisms can explain between ~214% and ~2138% of the excess of coincident 
SNPs.  This scenario is clearly unlikely to be realistic, because we would expect to 
observe far more coincident SNPs than we actually do.  The estimates reported under all 
models are likely to represent maximum values since we have been conservative in our 
estimates of the divergence time between human and chimpanzee (Benton and 
Donoghue 2007), and we have not taken into account the fact that many genealogies 
prior to the species split will not be such that they yield a polymorphism in each 
species, or that the mutation has to occur in a specific part of the genealogy to generate 
two polymorphisms. 
 
Our simulations show that ancestral polymorphisms could make a substantial or 
inconsequential contribution to coincident SNPs, depending on the model of 
demography used in simulations and ultimately the long-term average effective 
population size along the lineages leading to human and chimp from the common 
ancestor.  Unfortunately, as we have little information about the average effective 
population sizes we are unable to rule a contribution to the excess of coincident SNPs 
from ancestral polymorphisms from a theoretical perspective.  However, it seems 
unlikely that ancestral polymorphism can explain much of the excess of coincident 
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SNPs as two additional lines of evidence suggest that this is not the case.  First, we 
repeated the analysis using human and macaque SNPs.  Since these two species 
diverged more than 23-34 million years ago (MYA) (Benton and Donoghue 2007), as 
opposed to the 6-10 MY that separates human and chimp (Benton and Donoghue 2007), 
one would expect very few polymorphisms to be shared between human and macaque.  
However, in this dataset we also see a significant excess of coincident SNPs whether we 
consider all sites (ratio = 1.64 (0.19) p < 0.001), or non-CpG sites (1.51 (0.26) and p < 
0.05).  The excess is not due to problems with our method; we repeated simulations as 
above, using the Hwang and Green model (2004) and setting the level of divergence to 
6%, which is roughly the level of divergence estimated between human and macaque 
(Gibbs et al. 2007).  The observed over expected ratio for all sites is 1.001 (95% 
confidence interval (0.922, 1.080)), which is a slight under-estimate of the number of 
coincident SNPs expected under simple context effects, however the observed over 
expected ratio for non-CpG sites is 0.929 (0.833,1.024), which is an over-estimate of 
the number of coincident SNPs expected under simple context effects.  Second, the 
pattern of coincident SNPs (table 2.1) is inconsistent with ancestral polymorphism.  All 
four of the possible transversion SNPs are approximately equally common amongst 
SNPs in general (proportion of transversions amongst human SNPs: G/T = 0.092, C/A = 
0.091, C/G = 0.088, A/T = 0.075; transitions: C/T = 0.33, G/A = 0.33).  We would 
therefore expect a G-C SNP in chimps to be coincident with a G-C SNP in humans 
approximately equally often as an A-T SNP in humans is coincident with an A-T SNP 
in chimps.  However, we see distinct biases, with coincident A-T/A-T SNPs being much 
more common than the other transversions and a bias towards transversions in general.  
Although we cannot explain this pattern of mutation, it is clearly inconsistent with 
ancestral polymorphisms at neutral sites.  
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2.4.7 Natural Selection 
 
It is also possible for the apparent excess of coincident SNPs to be due to selection; if 
some regions of the genome are under selection, then we expect them to have a low 
density of SNPs, because many SNPs will be removed as they are deleterious.  As a 
consequence, SNPs will be clustered between these regions, causing an apparent excess 
of coincident SNPs.  This seems an unlikely explanation, since the vast majority of our 
data is intergenic and intronic (98% and 99% of the human and chimpanzee SNPs in our 
BLAST databases, respectively), and although selection is known to act within these 
regions, it is thought to only affect a small percentage of sites (Waterston et al. 2002; 
Dermitzakis, Reymond, and Antonarakis 2005; Asthana et al. 2007).  Furthermore, if 
selection was causing an excess of coincident SNPs, we would expect SNPs to be 
clustered generally, but this is not observed (figure 2.1). There is a small excess of 
human SNPs adjacent to the chimpanzee SNP, but this is a consequence of CpG effects 
– the chimpanzee SNP is disproportionately likely to occur within a CpG, which means 
that a human SNP is also likely to occur at the same site, or at an adjacent site.  If we 
remove CpGs, this slight excess of adjacent SNPs disappears (appendix 2.5).  Otherwise 
there is no tendency for SNPs to cluster. 
 
2.4.8 Other context effects 
 
It therefore seems that the majority of the excess of coincident SNPs is a consequence 
of variation in the mutation rate that is not associated with simple context effects, 
variation in context effects between strands or regions of the genome, or natural 
selection.  The question therefore arises as to whether the variation in the mutation rate  
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Figure 2.1. The number of human SNPs at each site of the human-chimpanzee 
alignments used in the analysis. 
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is associated with other contexts that are distant from the target site, degenerate in 
nature, or sufficiently complex to be difficult to discern.  It should be noted that simple 
context effects beyond the adjacent nucleotides (e.g. 1bp removed from the target site) 
are not responsible for the excess.  Although these effects exist (Zhao et al. 2003), they 
are much smaller than the effects of the adjacent nucleotides, which themselves have a 
relatively modest effect if we remove CpGs; e.g., the expected number of non-CpG 
coincident SNPs is 2115 if we ignore adjacent nucleotide effects, and it is 2533 if we 
include these effects.  
 
To investigate whether there are other, more complex context effects, we tabulated the 
frequency of each triplet at each site in the alignments containing coincident SNPs, and 
a similar size dataset of alignments with non-coincident SNPs.  Surprisingly, we found 
significant heterogeneity in triplet frequencies that extends to about 80bp either side of 
the coincident SNP (figure 2.2a); i.e. the relative frequencies of the triplets at sites close 
to the coincident SNP are different to the average across the alignments.  In contrast, if 
we consider alignments without a coincident SNP, but with a chimpanzee SNP, we only 
see significant heterogeneity in triplet frequencies within 10bp either side of the SNP 
(figure 2.2b).  Despite the heterogeneity in triplet frequencies surrounding a coincident 
SNP we could discern very few patterns in the triplets that are over- or under-
represented.  The only conspicuous pattern is an excess of TTT triplets upstream and 
AAA triplets downstream of coincident SNPs.  However, this seems to explain little of 
the overall excess of coincident SNPs.  If we repeat the analysis but remove all cases in  
which there is a run of three or more nucleotides, of any type, with or without SNPs 
within them, from our alignments, we find 8536 alignments with a coincident SNP 
versus an expected number of 4434, taking into account simple context effects  
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Figure 2.2. Heterogeneity in triplet frequencies. Figure gives the log value from a chi-
square test of heterogeneity of triplet frequencies at each site of the human-chimpanzee 
alignment versus the average triplet frequencies across the whole alignment for (a) 
alignments containing a coincident SNP, and (b) alignments without a coincident SNP, 
but with a chimpanzee SNP at the central position. The line marks the point above 
which 5% of the chi-square values are expected to fall by chance alone. The chi-square 
values are not given for the central three sites because the presence of the chimpanzee 
SNP in the centre of the alignment means that triplets cannot be counted at positions 0, 
1 and -1.  
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(ratio = 1.93 (0.02) p<0.0001).  Considering pentamers, rather than triplets, also fails to 
reveal any context that is associated with coincident SNPs, except for the α-polymerase 
pause site motif, TG(A/G)(A/G)(G/T)(A/C), which has been suggested as a 
hypermutable motif (Todorova and Danieli 1997; Templeton et al. 2000).  However, we 
only observe an excess of α-polymerase pause sites immediately downstream of 
coincident SNPs, and the total number of coincident SNPs explained by this motif is 
trivial (2.2%). 
  
2.4.9 Quantification 
 
To quantify the level of cryptic variation in the mutation rate, we fit two models to the 
ratio of the observed number of coincident SNPs over the number expected with simple 
context effects.  In the first model, we assumed that the variation in the mutation rate 
was log-normally distributed; in the second, we assumed that there were two types of 
sites - normal and hypermutable sites.  These models give qualitatively similar estimates 
of the variation, so we only discuss the log-normal model in detail, because this is a 
model with a single parameter (details of the two-rate model are given in appendix 2.1 
and results are in appendix 2.4).  Since our method for controlling for simple context 
effects tends to underestimate the expected number of coincident SNPs when we have 
CpG sites, we concentrate on non-CpG sites.  Also, since we are unsure about the 
contribution of ancestral polymorphisms and substitutions in paralogous sequences to 
the excess of coincident SNPs, we use the original estimate of the observed over 
expected ratio of coincident SNPs (1.98) to represent the maximum range of the effect 
of cryptic variation in the mutation rate.  We fit two sub-models to our data.  In the first, 
we assume that the mutation rate of a site is invariant in both humans and chimpanzees.  
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Under this “static” model we estimate the shape parameter of the log-normal to be 0.83 
(95% CIs of 0.81, 0.84) for non-CpG sites.  However, this model may not be realistic, 
since we might expect sites with high mutation rates to destroy themselves; e.g. if a site 
has a high rate of C->T mutation, then it will rapidly become fixed for T and therefore 
become non-hypermutable.  We therefore also fit a model in which the time a site 
remains at a certain mutation rate depends upon that mutation rate, assuming an average 
divergence between humans and chimpanzees of 0.92% for non-CpG sites (Mikkelsen 
et al. 2005).  Under this model we estimate slightly higher levels of cryptic variation: 
we estimated the shape parameter to be 0.85 (0.83, 0.87) – higher shape parameters 
mean more variation.  The level of variation that these distributions represent is 
considerable; with a shape parameter of 0.85 the fastest 5% of sites mutate at least 16.4-
fold faster than the slowest 5% of sites.  This level of variation in the mutation rate is 
greater than the variation associated with simple context: the variance due to simple 
context, including CpGs, is 0.59, whereas the variance due to cryptic variation at non-
CpG sites is 1.05.  However, this large difference in variance might be due to the model.  
If we consider a simple two-state model in which sites are either hypermutable or 
normal, and constrain the proportion of hypermutable sites to be 2%, the proportion of 
sites that are involved in CpGs in the human genome (Lander et al. 2001), then we 
estimate that hypermutable sites would have to mutate 9.3-fold faster than normal sites 
to explain the excess of coincident SNPs.  This is similar to 10-20 fold higher rate that 
CpGs mutate (Hwang and Green 2004; Mikkelsen et al. 2005). 
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2.5 Discussion 
 
We have shown that there is an excess of sites that have a SNP in both the human and 
chimpanzee genomes.  We demonstrated that this is not due to natural selection, local 
context effects or problems with our method; although our method tends to slightly 
under-estimate the expected number of coincident SNPs across all sites, which may 
contribute to part of the excess, it is conservative under most realistic conditions when 
CpG sites are excluded, where we still observe a massive excess of coincident SNPs.  It 
also seems unlikely that paralogous sequences have contributed significantly to the 
excess of coincident SNPs, since relatively few of our coincident SNPs map to multiple 
locations of the genome, and the average minor allele frequency at coincident SNPs is 
no higher than at other SNP sites.  We have shown that it is theoretically possible that 
ancestral polymorphisms could contribute substantially to the level of coincident SNPs, 
however without a greater knowledge of the demographic history of human and 
chimpanzee and ultimately the long-term average effective population size of the two 
species, it is difficult to make any firm conclusions about these simulations.  
Furthermore, two additional lines of evidence suggest that ancestral polymorphism does 
not contribute substantially to the excess of coincident SNPs; we observe an excess of 
coincident SNPs between two more distantly related species, where shared 
polymorphisms are likely to be extremely rare, and the pattern of mutation is 
inconsistent with ancestral polymorphism at neutral sites contributing all of the excess; 
we see large biases in the proportions of different types of transversions amongst 
coincident SNPs.  Given the caveats above, it therefore seems likely that the majority of 
the excess of human and chimpanzee coincident SNPs is due to variation in the 
mutation rate that is not associated with simple context effects and is cryptic in nature.  
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We also show that triplet frequencies surrounding sites with coincident SNPs are highly 
non-random, but we have been unable to discern any specific motifs in these regions.  
This suggests that there are probably complex context effects that extend some distance 
from the site they affect.  Furthermore, we show that there has to be considerable 
variation in the mutation rate to explain the observed excess of coincident SNPs. 
 
The presence of such cryptic variation in the mutation rate is perhaps not surprising 
given the evidence that some sites in the human mitochondrial genome are 
hypermutable.  Hypermutation had long been suspected based on the excess of 
homoplasies in human mtDNA phylogenies (e.g., see (Meyer, Weiss, and von Haeseler 
1999)) and although such an excess could be due to hypermutation or recombination 
(Eyre-Walker, Smith, and Maynard Smith 1999), two recent analyses have provided 
convincing evidence that the excess is due to hypermutation.  Stoneking (2000) showed 
that mitochondrial mutations in human pedigrees tend to occur at sites that have high 
levels of homoplasy, and Galter et al. (2006) have recently shown that synonymous 
mitochondrial SNPs tend to occur at the same positions in different species.  
 
However, many of the hotspots in mtDNA appear to be due to strand slippage type 
mutational mechanisms (Kunkel and Soni 1988; Malyarchuk and Rogozin 2004), this 
does not appear to be case for the cryptic variation in the mutation rate in nuclear DNA 
that we describe here.  There are two slippage mechanisms that can operate: template 
strand and primer strand dislocation.  Template strand dislocation is controlled for in 
our simple context analysis, and primer strand dislocation is controlled for in the 
analysis of homonucleotide runs.  
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It has also been shown recently that the mutation rate is elevated close to insertion and 
deletion mutations in the nuclear genomes of several eukaryotes, including humans 
(Tian et al. 2008).  However, it seems unlikely that this process is generating the excess 
of coincident SNPs.  Indels appear to increase the rate of mutation, but not at specific 
sites; rather the mutation is elevated close to an indel and this elevation in the mutation 
rate declines over several hundred nucleotides.  This would menifest itself as general 
tendency for SNPs to cluster, which we do not observe (figure 2.1, appendix 2.5); we 
only observe an excess of coincident SNPs and a small excess of adjacent SNPs.  
Furthermore, humans and chimpanzees would both have to have segregating indels in 
the same locality to generate an excess of coincident SNPs.  
 
Although we have observed an excess of coincident SNPs, we do not know the specific 
mechanism that generates the excess.  Consequently, it is interesting to consider 
whether there are SNPs in the human genome that are coincident with SNPs in both the 
chimpanzee and Macaque genomes, as this may shed some light on the time frame over 
which such a mechanism would need to operate, the locations of sites that are 
particularly prone to cryptic hypermutation and ultimately the origin of such events.  
However, due to the limited amount of data available for the Macaque genome, we are 
unable to find any occurrences of SNPs that are coincident across all three species.  This 
is perhaps not surprising, since we only observe a small number of coincident SNPs 
between human and macaque, sites would need to be ~300 more mutable than the 
average site in order to generate just one co-occurrence between human, chimpanzee 
and macaque, assuming a random distribution of such events. 
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Over the last few years, DNA sequence analysis has revealed that the mutation process 
is highly complex, varying between different parts of the genome and between different 
sites.  Unfortunately we do not yet understand many of these patterns.   
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3. The Genomic Distribution and Local Context of Coincident 
SNPs in Human and Chimpanzee 
 
 
3.1 Abstract 
 
We have previously shown that there is an excess of sites that are polymorphic at 
orthologous positions in humans and chimpanzees and that it seems likely that the 
majority of this excess is due to cryptic variation in the mutation rate.  We showed that 
this might be a consequence of complex context effects since we found significant 
heterogeneity in triplet frequencies around coincident SNP sites.  Here we show that the 
heterogeneity in triplet frequencies is not specifically associated with coincident SNPs, 
but is instead driven by base composition bias around CpG dinucleotides.  As a result, 
we suggest that cryptic variation in the mutation rate is truly cryptic, in the sense that 
the mutation rate does not appear to depend on any specific primary sequence context.  
Furthermore, we propose that the patterns around CpG dinucleotides are driven by the 
mutability of CpG dinucleotides in different DNA contexts.  We also show that the 
genomic distribution of coincident SNPs is non-uniform and that there are some subtle 
differences between the distributions of single and coincident SNPs.  Furthermore, we 
identify regions that contain high numbers of coincident SNPs and suggest that one in 
particular, a region containing the gene PRIM2, may be under balancing selection. 
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3.2 Introduction 
 
There is variation in the mutation rate over a number of different scales in the human 
genome; on a local scale there are hypermutable sites (Blake, Hess, and Nicholsontuell 
1992; Zhao et al. 2003; Hwang and Green 2004), and more broadly, large genomic 
regions and whole chromosomes can vary in their mutation rate (Matassi, Sharp, and 
Gautier 1999; Williams and Hurst 2000; Lercher, Williams, and Hurst 2001; Li, Yi, and 
Makova 2002; Gaffney and Keightley 2005).  What makes a region or site have a higher 
or lower mutation rate is poorly understood, except in the case of CpGs where cytosine 
can become methylated and unstable, leading to a higher rate of mutation (Coulondre et 
al. 1978; Bird 1980).  However, understanding the factors that dictate the mutation rate 
is important since they influence human disease and our understanding of evolution.   
 
In the previous chapter we showed that there is an excess of coincident SNPs, sites that 
have a SNP in both humans and chimpanzees, and that this excess could not be 
explained by the known influence of adjacent nucleotides on the mutation rate.  We also 
showed that the excess is not a result of selection; positive selection tends to remove 
variation from the population through rapid fixation of beneficial alleles, and negative 
selection, in which removal of variation may result in a general clustering of single 
SNPs in non-coding regions, was not observed.  Furthermore, the excess of coincident 
SNPs is not a consequence of us mis-inferring mutation rates in different parts of the 
genome; we show that mutation rates correlate in GC-rich and GC-poor regions of the 
genome, and we also observe a significant excess of coincident SNPs in both sequence 
contexts.  We were unable to rule out a contribution from ancestral polymorphism or 
substitutions in paralogous sequences that have been misinferred as SNPs, however it 
 77 
seems unlikely that these two factors contribute substantially to the excess of coincident 
SNPs; we observe a significant excess of coincident SNPs in comparisons with more 
distantly related species (human and macaque), and it is unlikely that SNPs would be 
preserved over this time frame.  Furthermore, the pattern of mutation is inconsistent 
with ancestral polymorphism as we observed a bias in the proportions of different types 
of transversions at coincident SNP sites.  Similarly, we showed that only a small 
percentage of coincident SNP sequences had both SNP alleles present amongst multiple 
matches to the human reference genome and even under a conservative approach of 
removing all coincident SNP sequences that are potential false positives and those that 
do not match to the reference sequence, the observed over expected ratio for coincident 
SNPs only reduces to 1.63 from 1.76 for all coincident SNPs and to 1.81 from 1.98 for 
non-CpG coincident SNPs.  Furthermore, the average minor allele frequency at 
coincident SNP sites is not different to other SNP sites; should a significant number of 
coinicident SNPs be driven by substitutions in paralogous regions, we might expect the 
average minor allele frequency to be higher for coincident SNPs.  We therefore 
proposed that there is cryptic variation in the mutation rate.  However, despite the 
evidence that this variation in the mutation rate is not due to simple context effects (i.e. 
the adjacent nucleotides), we did show that triplet frequencies are significantly 
heterogeneous to approximately 80bp either side of the coincident SNP. 
 
Here, we investigate both the local and genomic context of human and chimp coincident 
SNPs.  Although many of the coincident SNPs we have identified will not be a 
consequence of cryptic variation in the mutation rate, as approximately half are due to 
chance alone and others may be a consequence of ancestral polymorphism or 
substitutions in paralogous sequences, we consider the entire dataset as we have no way 
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of differentiating coincident SNPs which are caused by chance alone, and those caused 
by some other process.  We now find that the heterogeneity in triplet frequencies is not 
specifically associated with coincident SNPs, but is instead associated with patterns of 
base composition around CpG dinucleotides.  As a result, we suggest that cryptic 
variation in the mutation rate is complex, in the sense that the mutation rate does not 
appear to depend on any specific context.  We also show that the genomic locations of 
coincident SNPs are non-uniform, and that there are subtle differences in the 
distributions of single SNPs compared to coincident SNPs across the genome. 
 
 
3.3 Materials and Methods 
 
3.3.1 Coincident SNPs 
 
In our original analysis (chapter 2) we investigated whether human and chimpanzee 
SNPs tended to occur at the same site in the genome by BLASTing all chimpanzee 
SNPs found in dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP/) against a dataset of 
human SNPs from the same resource.  We obtained >300,000 81bp alignments that 
contained both a human and a chimpanzee SNP, and in 11,571 cases the human and 
chimpanzee SNPs occurred at orthologous positions.  We showed that this number was 
significantly more than we would expect to occur by chance if SNPs are randomly 
distributed along our alignments, even after taking into account that certain sites are 
more likely to contain a SNP due to the effects of neighbouring nucleotides on the 
mutation rate. 
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3.3.2 Sequence contexts 
 
In order to investigate heterogeneity in triplet frequencies around coincident SNPs and 
dincucleotides we analysed the 200bp either side of each of the coincident SNPs 
identified in our previous analysis (chapter 2), except for a few changes due to the 
random selection of BLAST alignments, together with an equal number of randomly 
chosen instances of each dinucleotide.  Random dinucleotides were obtained from the 
entire human genome sequence from the Ensembl database 
(http://www.ensembl.org/index.html - build 55).  We split our dataset of coincident 
SNPs into two groups, CpG and non-CpG coincident SNPs.  A SNP was designated as 
CpG if the site, or any of the alleles at the site, would yield a CpG dinucleotide.   
 
To investigate whether triplet frequencies are significantly heterogeneous around 
coincident SNPs and dinucleotides we proceeded as follows. We tabulated the 
frequency of each triplet at each site relative to the coincident SNP or dinucleotide – 
e.g. to investigate heterogeneity in triplets 10bp upstream of coincident SNPs, we 
tabulated the frequency of triplets where the central nucleotide is 10bp upstream of a 
coincident SNP across all our 11,571 sequences containing a coincident SNP.  We then 
summed the number of each triplet across all sites and divided this by the total number 
of sites to yield the average expected number of triplets at all sites.  Whether the 
observed values were significantly different to the expected values was assessed using a 
standard chi-square test.  To investigate whether the heterogeneity in triplet frequencies 
could be explained in terms of trends in base composition we calculated the expected 
frequency of each triplet from the average nucleotide composition at each site; e.g. to 
calculate the expected frequency of CTG at position +10, we would multiply the 
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frequency of C at position +9 by the frequency of T at position +10 and the frequency 
of G at position +11. 
 
To analyse the sequence context around each type of dinucleotide we obtained 2000 
instances of each type of dinucleotide, flanked by 5000bp either side, at random from 
the human genome.  Any sequences that contained possible CpG islands were removed; 
CpG islands were identified by following the method as outlined by Takai and Jones 
(2002).  For each dataset we lined up the sequences so that the dinucleotide of interest 
was present in the central position, and then we calculated the GC content of each 
position across all 2000 sequences.  To calculate the width of the peak (or depression) 
in GC content around dinucleotides we first used the median of the first 1000 GC 
content values (positions -5000 to -4000 with respect to the central dinucleotide in 
alignments) as an indicator of the average GC content.  In all cases the peak in GC 
content begins after the first 1000 nucleotides in the alignments and so we believe that 
this value acts as a good indicator of the average GC content in surrounding sequences.  
We then assign the start of the peak as the point at which greater than 47 out of 50 base 
positions in a row have an average GC content across the 2000 sequences that is higher 
than the median value, labeling the start of the 50bp as the start of the peak.  Similarly, 
the end of the peak is designated in the same way, but running in the opposite direction 
from the end of the sequences.  For a depression in GC content, we required the GC 
content to be below the median value under the same criteria as before. 
 
 
 
 
 81 
3.3.3 Genomic data 
 
Genomic data on telomere and centromere locations, GC content, gene density, 
nucleosome occupancy and single SNP density were downloaded from the UCSC 
genome browser (http://genome.ucsc.edu/).  Data were downloaded per 1MB for 
comparison with coincident SNP data.  Gene density was taken as the number of base 
pairs that were part of an exon in each megabase region.  A365 values were used for 
nucleosome occupancy scores as they are comparable to other methods at identifying 
regions with high nucleosome occupancy (Gupta et al. 2008).  Recombination rate data 
were also averaged across each MB, using data from Kong et al. (2002), as were 
replication-timing scores (S50), which were taken from Chen et al. (2010). 
 
We estimated human and chimp divergence per MB as follows.  Alignments between 
the NCBI36 version of the human genome and the PanTro2 version of the chimp 
genome were downloaded from the UCSC website (http://genome.ucsc.edu/).  
Nucleotides were masked if they were of low quality in the chimp genome (error rate 
above 1/10000); quality scores were unavailable for chromosomes 21 and Y and so 
these were not masked.  We then masked any sequences where divergence scores were 
unexpectedly high; 100bp windows with greater than 10% divergence were masked, 
with sliding windows every 10bp.  Finally, we masked any sequences of less than 20bp 
that were flanked both sides by >40bp flank sequence.  The number of substitutions per 
MB was calculated in regions containing >100kb of unmasked sequence. 
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3.3.4 Balancing selection 
 
In order to investigate balancing selection on the PRIM2 gene, and the 175kb region on 
chromosome 4, we downloaded low-coverage pilot variation data from the 1000 
genomes project (http://www.1000genomes.org) that was released in April 2009.  The 
data were split into three groups (CEU, YRI, JPT+CHB) at each locus and comprised of 
allele frequency data within each population and phased genotype data for each sampled 
site.  We obtained phased haplotypes from the dataset for each region and then used the 
Neighbour-Joining method in PHYLIP (Felsenstein 2005) to construct a phylogenetic 
tree within each population.  For PRIM2, CEU was sampled across 57 individuals and 
contained 3974 SNPs, YRI was sampled across 56 individuals and contained 1548 
SNPs and the combined populations of JPT+CHB were sampled across 59 individuals 
and contained 1660 SNPs.  For the region on chromosome 4, CEU was sampled across 
57 individuals and contained 1070 SNPs, YRI was sampled across 56 individuals and 
contained 318 SNPs and the combined populations of JPT+CHB were sampled across 
59 individuals and contained 284 SNPs. 
 
To calculate the significance of the Tajima’s D values we performed a coalescent 
simulation using MS (Hudson 2002) with the same number of haplotypes as found in 
each population, assuming a stationary population size and either no recombination or a 
constant recombination rate that was calculated using the Pairwise program in LDhat 
(McVean, Awadalla, and Fearnhead 2002).  We repeated this procedure 1000 times for 
each population at each locus and calculated the Tajima’s D statistic in each case; the p-
value was the number of times the Tajima’s D value generated in each of the 1000 
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coalescent simulations was greater than the observed value for each population at each 
locus. 
 
 
3.4 Results 
 
3.4.1 Local context of coincident SNPs 
 
In the previous chapter we found a significant excess of SNPs in the human genome 
that also contained a SNP at the orthologous position in chimpanzee; we refer to these 
as coincident SNPs.  Furthermore, we showed that there is significant heterogeneity in 
triplet frequencies that extends to about 80bp either side of coincident SNPs.  We did 
this by tabulating the frequency of each triplet at each site relative to the coincident SNP 
across our sequences containing coincident SNPs.  The triplet frequencies at each site 
were then compared to the average frequencies across all sites using a chi-square test.  
To investigate this pattern further we divided our original data set into CpG and non-
CpG coincident SNPs and repeated the analysis as above.  For non-CpG coincident SNP 
sequences (4517 cases) the frequency of triplets within approximately 10bp either side 
of the coincident SNP are significantly different to the average triplet frequencies across 
all positions in the sequences (Figure 3.1a).  This pattern is entirely driven by runs of A 
and T nucleotides; if we remove sequences where the coincident SNP falls at the start or 
the end of a mononucleotide triplet of any kind, the peak in triplet heterogeneity 
disappears outside of the neighbouring nucleotides (Figure 3.1b).  It should be noted at 
this point that mononucleotide runs are not the cause of the excess of coincident SNPs, 
since removing SNPs that form part of a run of 3 or more nucleotides still leaves a large  
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a) 
 
b) 
 
 
Figure 3.1.  Heterogeneity in triplet frequencies around non-CpG coincident SNPs.  
Figure gives the log chi-squared value of the heterogeneity of triplet frequencies against 
the average triplet frequencies across the whole alignment for (a) all alignments 
containing a non-CpG coincident SNP and (b) alignments where the SNP is not part of 
a mononucleotide run of 3 or more nucleotides.  The horizontal line marks the 5% 
significance value for the chi-square test. 
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excess of coincident SNPs (see chapter 2).  There therefore appears to be no 
heterogeneity in triplet frequencies around non-CpG coincident SNPs when mono-
nucleotide runs are removed. 
 
For CpG coincident SNP sequences (5930 cases) the heterogeneity of triplet frequencies 
extends up to ~100bp either side of the coincident SNP (Figure 3.2a).  However, if we 
take the same number of CpGs, which do not contain a SNP, from unique sequences at 
random from the human genome we observe a very similar pattern (Figure 3.2b).  This 
indicates that the pattern around CpG coincident SNPs is entirely dominated by the 
pattern around CpG dinucleotides, whether they contain a SNP or not, and thus there are 
no local context effects associated specifically with coincident SNPs.  As such, 
variation in the mutation rate in the human genome that was inferred from the excess of 
coincident SNPs is truly cryptic on a local scale, in the sense that there do not appear to 
be any non-random patterns of nucleotides in the surrounding sequence. 
 
3.4.2 Patterns around CpG and other dinucleotides 
 
Although we have shown that there are no local nucleotide contexts associated 
specifically with coincident SNPs, it is interesting to consider what is driving the 
patterns in triplet heterogeneity around CpG dincleotides that do not contain a SNP.  In 
order to investigate this we estimated the frequencies of triplets we would expect to see 
given the single nucleotide compositions at each position in the sequences containing 
CpG dinucleotides.  Interestingly, we found that the peak all but disappeared (Figure 
3.3a).  Furthermore, if we plot the GC content across alignments at each position, there 
is a similar peak around the central CpG dinucleotide (Figure 3.3b).  This implies that  
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a) 
 
b) 
 
 
Figure 3.2.  Heterogeneity in triplet frequencies.  Figure gives the log chi-squared value 
of the heterogeneity of triplet frequencies against the average triplet frequencies across 
the whole alignment for (a) all alignments containing a CpG coincident SNP and (b) 
sequences that contain a CpG dinucleotide but no SNP. The horizontal line marks the 
5% significance value for the chi-square test. 
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a) 
 
b) 
 
Figure 3.3.  Nucleotide patterns around CpG dinucletides that do not contain a SNP.  
Figure (a) gives log chi-squared values across alignments when single nucleotide 
frequencies are used to predict triplet frequencies at each position and (b) shows the GC 
content at each position in the alignment. 
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there is a general increase in GC content around CpG dincleotides in the human 
genome, a pattern has also been previously observed in a study by Elango et al (2008), 
and that this explains the pattern of triplet heterogeneity in regions around CpGs.   
 
The question therefore arises as to whether there are patterns in nucleotide content 
around other non-SNP containing dinucleotides in the human genome.  To answer this, 
we selected 2000 cases of each type of dinucleotide at random from the human genome, 
flanked by 5000bp either side.  We then lined up the sequences so that the nucleotide of 
interest was present in the central positions and then considered the GC content across 
the sequences at each position.  Sequences were only considered if they did not contain 
possible CpG islands (see methods).  However, as it is likely that some dinucleotides 
are part of mono-nucleotide and dinucleotide runs, we selected only dinucleotides that 
were not part of two or more of the same dinucleotides or where the first or second base 
of the dinucleotide was not part of a mononucleotide triplet.  As expected, we find an 
increase in GC content around CpG dinucletides that runs from -231bp to 199bp (with  
the dinucleotide at position zero), but also a peak in GC content around GpC 
dinucleotides that runs from -77bp to 90bp, which are shown in figures 3.4a and 3.4b 
respectively.  Furthermore, there is a decrease in GC content around TA dinucleotides 
that extends from -95bp to 80bp (Figure 3.4c).  The specific widths of the peaks are 
clearly determined by the number of sequences used, however they are useful in 
comparisons of different dinucleotides, and all clearly show a context effect.  
Consequently, it appears that there are strong nucleotide patterns acting on a very local 
scale in the human genome.  There are also peaks in GC content around GGs and CCs, 
and troughs in GC content around AAs and TT, however for GGs and CCs this is 
caused by sequences in which a CpG or GpC is found immediately adjacent to the  
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Figure 3.4a.  GC content around CpG dinucleotides 
 
 
 
 
Figure 3.4b.  GC content around GpC dinucleotides. 
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Figure 3.4c.  GC content around TpA dinucleotides. 
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central dincleotide, and for AAs and TTs where TA or AT is found immediately 
adjacent to the central dinucleotide.  If these sequences are removed, the patterns 
disappear.  There are no patterns in GC content around other dinucleotides. 
 
 
3.4.3 Genomic distribution of coincident SNPs 
 
To investigate the genomic distribution of coincident SNPs we split the human genome 
into regions of 1MB and tallied the number of coincident and single (non-coincident) 
SNPs found in each region. Regions with no SNPs were excluded from further analysis; 
these are typically found in the heterochromatic regions near the centromere.  On 
average there were 8014 and 3.91 simple and coincident SNPs per MB respectively, 
6838 and 1.68 of which were non-CpG.  If coincident SNPs occurred at random across 
the human genome, then we would expect the number of coincident SNPs in each 1MB 
region to be Poisson distributed and to have a variance equal to the mean.  However, the 
observed variance, 13.27, is far in excess of this, and using a chi-square test we find that 
the number of coincident SNPs per MB is significantly overdispersed (p<0.001); for 
example the third quartile is 2.5 fold higher than the first quartile, whereas it would be 
expected to be 1.67 fold higher if coincident SNPs were distributed at random.  
Therefore, coincident SNPs are non-uniformly distributed across the human genome.  It 
is possible that the distribution of coincident SNPs is not Poisson distributed across the 
human genome if there is variation in the level of sampling that has occurred between 
different regions.  However, this would lead to an excess of coincident SNPs through 
general clustering of single SNPs, which we do not observe when considering the 
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distribution of distances between human and chimpanzee SNPs in the original analysis 
(see chapter 2). 
 
The distribution of single SNPs is also known to be non-uniform (Venter et al. 2001), 
and we find that the density of coincident SNPs has a significantly positive correlation 
with the density of single SNPs (r2 = 0.065, p<0.001 for all SNPs and r2 = 0.037, 
p<0.001 for non-CpG SNPs); this is perhaps not surprising given that SNP densities 
must drive the locations of coincident SNPs to a certain extent, since at least half of 
coincident SNPs are thought to be due to chance alone, as single SNPs coincide at 
random (chapter 2).  However, the correlation between the density of single and 
coincident SNPs is not strong, and the lack of a strong correlation is not due to high 
sampling error in coincident SNP density; as we have shown above, the observed 
variance in the density of coincident SNPs is substantially greater than we expect from 
sampling error alone – i.e. the distribution of coincident SNP density is overdispersed.  
We can estimate the approximate proportion of the variance in coincident SNP density 
that is due to sampling error as follows; since we expect the number of coincident SNPs 
in each genomic region to be Poisson distributed, the average sampling variance is 
likely to be of the order of the mean number of coincident SNPs per MB; this is 
approximately 30% of the total variance in the density of coincident SNPs.  Given that 
the correlation between the density of single SNPs only explains 6.5% of the density in 
coincident SNPs, it is evident that the poor correlation is not due to sampling error in 
the density of coincident SNPs. 
 
To investigate the variation in coincident SNP density in more depth we compared the 
frequency of coincident SNPs in each 1MB to some key genomic features (table 3.1).  
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There is no significant correlation between the density of coincident SNPs and the 
distance to the centromere, the distance to the nearest telomere or the nucleosome 
association, the gene density, replication timing or GC content of a region.  There is, 
however, a significantly positive correlation between coincident SNP density and 
recombination rate (r = 0.107, p<0.001).  This may reflect the significant correlation 
that exists between the density of single SNPs and the rate of recombination ((Hellmann 
et al. 2003; Hellmann et al. 2005); in our dataset r =0.234, p<0.001), and the fact that 
approximately half of all coincident SNPs appear to be due to chance alone.  To 
investigate this further we performed a partial correlation of coincident SNP density 
against the rate of recombination controlling for the single SNP density and found that 
the correlation is still significantly positive (r = 0.048, p=0.011).  However, despite a 
significant correlation, very little variation in coincident SNP density is explained by 
recombination rates as the correlation has a very low r2 value of 0.002.  It is also 
interesting to note that there are significant correlations between single SNP densities 
and the same set of genomic features as mentioned above (table 3.2), suggesting that 
there are subtle differences between the distributions of coincident and single SNPs in 
the human genome.   
 
It is puzzling that the density of single SNPs does not significantly correlate with 
replication timing, since it has been previously shown that primate divergence rates are 
higher in late replicating regions, suggesting that they have a higher mutation rate 
(Stamatoyannopoulos et al. 2009; Chen et al. 2010).  Furthermore, Stamatoyannopoulos 
et al. (2009) showed that replication also correlates with SNP density over a scale of 
100kb, although different SNP and replication timing datasets were used in this 
analysis.  In an attempt to explain this discrepancy we divided human SNP density by  
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Feature r p 
SNP Density 0.256 <0.001 
Distance to 
Telomere 
-0.022 0.226 
Distance to 
Centromere 
0.011 0.565 
Recombination 
Rate 
0.107 <0.001 
Nucleosome 
Association 
0.004 0.832 
Gene Density -0.022 0.230 
GC Content -0.006 0.741 
Replication Timing 0.004 0.838 
 
Table 3.1:  The correlation between the number of coincident SNPs per MB and 
various genomic features. 
 
 
Feature r p 
Distance to 
Telomere 
-0.171 <0.001 
Distance to 
Centromere 
-0.047 0.012 
Recombination 
Rate 
0.234 <0.001 
Nucleosome 
Association 
0.187 <0.001 
Gene Density 0.064 0.001 
GC Content 0.184 <0.001 
Replication Timing 0.008 0.673 
 
Table 3.2:  The correlation between the number of single SNPs per MB and various 
genomic features. 
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the average divergence between human and chimp per MB to give an estimation of the 
effective population size (Ne) for each region and compared this to replication timing; 
we find a significant negative correlation (r=-0.200, p<0.001).  We then performed a 
partial correlation between single SNPs and replication timing, whilst controlling for 
Ne, and we observe a significant positive correlation (r=0.276, p<0.001), suggesting that 
a negative relationship between Ne and replication timing density may be canceling out 
a relationship between diversity and replication timing.  Furthermore, if we perform a 
partial correlation between coincident SNP density and replication timing, whilst 
controlling for Ne, we observe a significant positive correlation (r=0.102, p<0.001), 
although replication timing explains very little of the variance in the distribution of 
coincident SNPs (~1%). 
 
3.4.4 Regions in the human genome with high numbers of coincident SNPs 
 
There are two 1MB regions in the human genome that contain considerably more 
coincident SNPs than any other region and are outliers in the distributions of both all 
and non-CpG coincident SNPs.  These regions are chromosome 4, 190mb - 191mb, 
which contains 57 coincident SNPs, and chromosome 6, 57mb - 58mb, which contains 
100 coincident SNPs.  The region on chromosome 4 falls very close to the end of the 
chromosome and contains no known genes, however 53 coincident SNPs are found in 
the region running from 190712230 to 190887438 (www.hapmap.org), which is 
approximately 175kb in length.  A gene called PRIM2, which codes for the large DNA 
primase subunit, dominates the region on chromosome 6 (Shiratori et al. 1995).  The 
smaller primase subunit is encoded by PRIM1 and DNA primase is a polymerase that 
plays an important role in DNA replication by synthesizing small RNA primers, which 
 96 
can then be used as starting points for the production of Okasaki fragments by the 
lagging strand polymerase during discontinuous replication (Roth 1987).  Primase also 
acts to prevent leading strand synthesis outpacing lagging strand synthesis by acting as 
a transient brake by halting the progress of the replication fork (Lee et al. 2006).  
PRIM2 is located at 57,290,381-57,621,334 (www.hapmap.org) and contains 86 
coincident SNPs, all of which are intronic.  The high number of coincident SNPs in 
PRIM2 and near the telomere of chromosome 4 could be due to a concentration of 
cryptically hypermutable sites, however they could also be due to long-term balancing 
selection maintaining polymorphisms between species.  It is also possible that the high 
concentration of coincident SNPs are a result of segmental duplications that increase the 
chances of chimpanzee SNPs being coincident with human SNPs if there are two or 
more almost identical regions on the human genome that the sequences surrounding 
SNPs could match to.  It is important to note that this is not the cause of the significant 
excess of coincident SNPs in general, since we showed in chapter 2 that paralogous 
sequences do not contribute substantially to the excess of human and chimpanzee 
coincident SNPs.  Similarly, balancing selection cannot explain the excess of coincident 
SNPs across the whole genome, since we also showed that there is an excess of 
coincident SNPs between human and macaque; the large divergence between the two 
species would mean that balancing selection would be extremely unlikely (see chapter 
2).   
 
To investigate the matter further we downloaded SNP data from the 1000 genome 
project (http://www.1000genomes.org) for the three Hapmap populations that have 
already been sequenced.  The region in the PRIM2 locus, which has a high 
concentration of coincident SNPs, also has a relatively high density of single SNPs in  
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Figure 3.5.  The nucleotide diversity across the region containing PRIM2 for the CEU 
population.  The figure shows a sliding window of nucleotide diversity every 25kb, with 
window size of 50kb as a line graph corresponding to the right hand axis, with the 
coincident SNP density as a bar chart corresponding to the left hand axis. 
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all three human populations (figure 3.5 for the European population, appendix 3.1 for 
other populations); however the region with the very highest density of coincident SNPs 
has a relatively low density of single SNPs within the PRIM2 locus.  Tajima’s D is 
significantly positive in the PRIM2 locus in all three human populations (D = 2.310 in 
Europeans, 1.296 in Yorubans, and 1.253 in East Asians, p<0.0001 assuming a constant 
rate of recombination).  It could be argued that since SNP calling is conservative, many 
rare variants will have been missed, possibly leading to an artificially high Tajima’s D 
statistic for the region.  However, when we perform a sliding window analysis, 
calculating the Tajima’s D statistic in each window of width 200kb every 100kb 
(overlapping windows), we clearly see a peak in the statistic above that observed in  
surrounding regions (figure 3.6 for the European population, appendix 3.2 for other 
populations).  There might therefore be some evidence of balancing selection acting in 
this locus, particularly in the European population.  However, under balancing selection 
we might expect to see groups of divergent haplotypes, and this is not what we observe 
if we construct phylogenetic trees of inferred haplotypes in each population (results not 
shown). 
 
In contrast, the region on chromosome 4 with a high concentration of coincident SNPs 
has one of the lowest densities of single SNPs in the region, especially for the African  
and East Asian populations (figure 3.7 for the Yoruba population, appendix 3.3 for the 
other populations).  Furthermore, Tajima’s D is 1.654 for the European population, 
0.827 for the East Asian population and 0.647 for the Yoruban population in the region 
with the highest concentration of coincident SNPs, running from 190712230 to 
190887438 on chromosome 4.  Although the Tajima’s D scores are all significantly 
positive assuming a constant rate of recombination (p<0.01 for all populations), only the  
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Figure 3.6.  The Tajima’s D statistic across the region containing PRIM2 for the CEU 
population.  The figure shows a sliding window of nucleotide diversity every 100kb, 
with window size of 200kb. 
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Figure 3.7.  The nucleotide diversity across the region on chromosome 4 for the YRI 
population.  The figure shows a sliding window of nucleotide diversity every 25kb, with 
window size of 50kb as a line graph corresponding to the right hand axis, with the 
coincident SNP density as a bar chart corresponding to the left hand axis. 
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European population has a Tajima’s D in excess of one and in all three populations, the 
Tajima’s D statistic is considerably lower than those observed at PRIM2, possibly 
making PRIM2 a more likely candidate for balancing selection.  Furthermore, as with 
PRIM2, if we construct phylogenetic trees of inferred haplotypes in each population, we 
do not see distinct groups of divergent haplotypes (results not shown). 
 
The PRIM2 region is not part of any known segmental duplications.  However, for the 
175kb region on chromosome 4 that contains a high density of coincident SNPs, there 
are two regions that have undergone segmental duplication which contain a total of 20 
coincident SNPs and span approximately 70kb (Bailey et al. 2001; Bailey et al. 2002).  
The average sequence identity between these two regions and their corresponding 
duplications is approximately 96.56%.  Under our criteria for detecting coincident SNPs 
in homologous sequences between human and chimpanzee (requiring a match of at least 
96 out of 101 sites for alignments containing coincident SNPs) and assuming that the 
number of mismatches per alignment is Poisson distributed, we expect that on average 
46% of the chimpanzee sequences would not match to the associated duplicated region 
in humans.  This allows us to conclude that approximately 42 of the 53 coincident SNPs 
found in the 175kb region are correctly matched, which is still considerably above 
average, and therefore that segmental duplications are not having a great impact on the 
numbers of coincident SNPs in this region. 
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3.5 Discussion 
 
In the previous chapter we provided evidence for cryptic variation in the mutation rate 
in the human genome by showing that there is a significant excess of SNPs that are 
present at orthologous positions in human and chimp.  We also suggested that there are 
complex context effects associated with coincident SNPs by showing there was 
significant heterogeneity in triplet frequencies up to ~80bp either side of coincident 
SNPs.  However, we show here that this pattern is not specific to coincident SNPs and 
is instead present around CpG dinucleotides, regardless of whether the dinucleotide 
contains a SNP.  To that end, it seems that cryptic variation in the mutation rate is not 
dependent upon specific local context effects that are associated with coincident SNPs 
and that the general excess of coincident SNPs is not driven by local context effects; 
indeed no single context can explain more than a very small fraction of coincident 
SNPs.  
 
The distribution of coincident SNPs across the genome is non-uniform such that some 
parts of the genome have higher densities of SNPs than others. However, this variation 
is not strongly correlated to any obvious genomic feature.  There are a small number of 
regions that have a very high number of coincident SNPs, and we studied these in more 
detail to investigate whether balancing selection might be involved.  We obtained 
inconclusive results.  Although the PRIM2 region has a high nucleotide diversity and 
Tajima’s D is significantly positive, the region with the very highest density of 
coincident SNPs did not have a particularly high diversity.  Furthermore, a phylogenetic 
tree of haplotypes did not reveal evidence for any deep branches, which might be 
indicative of long term balancing selection.  The region on chromosome 4 with a high 
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density of coincident SNPs actually has rather low diversity for the genomic region in 
which it resides.  Other studies have shown that genome wide testing for balancing 
selection has thus far been fruitless, leading to a suggestion that it is either rare or hard 
to identify (Bubb et al. 2006).  Interestingly, the MHC locus, a region that is thought to 
be undergoing strong balancing selection (Hughes and Nei 1988), has an average of 
11.4 coincident SNPs per MB, which is far above the genome-wide average of 3.91, but 
markedly below the densities found at PRIM2 and the 175kb region on chromosome 4. 
 
Finally, the patterns around CpG dinucletides are driven almost entirely by GC content, 
which increases from ~200bp either side of the dinucleotide up to a peak immediately 
adjacent to the dinucleotide.  This distance-decaying pattern is almost identical to that 
seen in a study by Elango et al. (2008).  We also observe a similar pattern in sequences 
surrounding GpC dinucleotides, albeit to a smaller extent, whilst the inverse is true of 
TpA dinucleotides, with the GC content decreasing towards the two central bases. The 
pattern in GpC dinucleotides is also evident in the work of Elango et al. (2008); 
however they did not draw attention to this pattern since it operates over a limited scale 
and they were interested in larger scale processes.  It seems likely that the increase in 
local GC content around CpGs is caused by a process suggested by Fryxell and 
Zuckerkandl (2000) in which CpG dinucleotides mutate more rapidly in AT rich regions 
due to an increased rate of DNA duplex melting.  Cytosine deamination occurs ~143 
times more often on ssDNA than it does on dsDNA (Frederico, Kunkel, and Shaw 
1990), thus the mutability of CpGs is closely linked to the melting temperature of the 
surrounding DNA.  A 10% decrease in GC content reduces the melting temperature of a 
sequence by 4.1oC, and thus increases the deamination of methylated cytosine by 2-fold 
(Fryxell and Zuckerkandl 2000).  This process could also explain the increase in GC 
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content around GpCs, as Fryxell and Moon (2005) note that unmethylated GpCs 
undergo deamination at lower rates in GC rich regions due to reduced DNA melting.  
Furthermore, we may expect TpA dinucleotides to be present in AT-rich regions if they 
are remnants of former CpGs that have mutated at high rates in the past.  An alternative 
explanation is that biased gene conversion (BGC) alters the base composition around 
CpG dincleotides (Elango et al. 2008).  BGC is a mechanism in which base mismatches 
formed during recombination and the repair of double strand breaks in heterozygous 
individuals are preferentially repaired to GC over AT nucleotides (Marais 2003).  This 
process may decrease the mutability of CpG dinucleotides near to recombination events 
if deaminated cytosines are preferentially repaired or if CpGs end up in less mutable GC 
rich contexts as a result of BGC.  However, this does not readily explain why the local 
increase in GC content is so much more conspicuous for CpG as opposed to GpC 
dinucleotides, and why patterns are absent around CC and GG dinucleotides. 
Furthermore, it is not obvious how BGC could generate a decrease in GC content 
around TpA dinucleotides, as regions between areas undergoing high levels of 
recombination, in which A and T nucleotides are relatively more likely to accumulate, 
are likely to be much larger than the ~200bp over which the pattern appears to exist.  In 
order to differentiate between the two potential mechanisms more formally we tested 
for the presence of peaks in GC content around CpGs in regions that do not undergo 
recombination on the Y chromosome in H. Sapiens.  As there is no recombination in 
these regions, and thus no BGC, we should see no differences in base composition 
across the sequences if the patterns around CpGs are caused by BGC.  We repeated the 
procedure outlined above by obtaining 2000 sequences from the Y chromosome and 
calculating the GC content at each position across the alignments.  It has been reported 
that certain regions of the human Y chromosome undergo gene conversion (Skaletsky et 
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al. 2003) and so these regions were not included in the analysis.  For sequences 
containing CpG dinucleotides from the Y chromosome in H. sapiens there is a peak of 
GC content that extends from -160bp to 186bp, showing that the pattern exists 
independently of recombination.  It therefore seems that the melting temperature of 
different sequences can drive local biases in base composition around certain 
dinucleotides in the human genome. 
 
We have shown that there are no obvious sequence contexts surrounding coincident 
SNPs, which we have inferred to be caused by cryptic variation in the mutation rate.  
Furthermore, we have failed to find any genomic feature that correlates strongly to the 
density of coincident SNPs.  What then might cause some sites to have much higher 
mutation rates than others?  It seems likely that it is caused by DNA topology and 
packaging, but until we understand these processes in the germ-line we may struggle to 
understand this phenomenon further. 
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4.  Human tri-allelic sites: evidence for a novel form of 
mutation? 
 
 
4.1 Abstract 
 
Most SNPs in the human genome are bi-allelic, however there are some sites that are 
tri-allelic.  We show here that there are approximately twice as many tri-allelic sites as 
we would expect by chance.  This excess does not appear to be caused by sequencing 
errors, natural selection or mutational hotspots that result in a single mutation.  Instead, 
we propose that the excess of tri-allelic sites is driven by new mutations inducing 
another mutation either within the same individual, or subsequently during 
recombination.  We provide evidence for this model by showing that the rarer two 
alleles at tri-allelic sites tend to cluster on phylogenetic trees of human haplotypes. 
However, we find no association between the density of tri-allelic sites and the rate of 
recombination, which leads us to suggest that tri-allelic sites might be generated by the 
simultaneous production of new two mutations within the same individual on the same 
genetic background.  Under this model we estimate that simultaneous mutation 
contributes approximately 3% of all distinct SNPs.  We also show that there is a two-
fold excess of adjacent SNPs.  Approximately half of these seem to be generated 
simultaneously since they have identical minor allele frequencies.  We estimate that the 
mutation of adjacent nucleotides accounts for a little less than 1% of all SNPs.  
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4.2 Introduction 
 
Although the density of bi-allelic SNPs in the human genome is reasonably low, there 
are some sites that have three (tri-allelic sites) or even four nucleotides segregating in 
the human population.  We show here that there are approximately twice as many tri-
allelic sites as we would expect by chance.  There are at least three types of mutational 
mechanisms that could potentially generate such an excess of tri-allelic sites.  First, 
some sites may be hypermutable, and if the mutation rate of at least two pathways (e.g. 
C->T and C->A) is elevated at such sites, then there will be an excess of tri-allelic sites. 
The mutation rate of a site is known to depend upon the adjacent nucleotides, the best 
known example being the CpG dinucleotide (Coulondre et al. 1978; Bird 1980) at 
which both the frequency of transition and transversion mutations is elevated.  
However, other adjacent nucleotides also influence the mutation rate (Blake, Hess, and 
Nicholsontuell 1992; Zhao et al. 2003; Hwang and Green 2004).  Furthermore, we 
showed in chapters 2 and 3 that there is variation in the mutation rate that does not 
dependent upon the identity of the adjacent nucleotides, or any specific context. 
 
Second, it is possible that two of the alleles at a tri-allelic site are generated 
simultaneously within a single individual.  Point mutations are generally assumed to 
involve the production of a single new allele per mutation event at a rate of which is 
governed by the effects mentioned above.  However, it is not difficult to imagine 
mechanisms that might induce mutations on both strands of the DNA duplex; for 
example, the presence of a base mismatch may itself be unstable, so we might go from a 
G-C base pair to a G-A, which then may mutate to C-A; if DNA replication reads 
through this mismatch, the G allele will have mutated to both C and T.  Alternatively, 
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the mutation may occur across both strands of the duplex at the same time, possibly as a 
result of a chemical or radiation event.  Thirdly, in a similar manner, we might imagine 
a single SNP inducing subsequent mutations if base mismatches are formed during 
recombination in heteroduplex DNA. 
 
Here we attempt to identify the process causing the excess of tri-allelic sites by 
analysing sequence data around tri-allelic sites. 
 
 
4.3 Materials and Methods 
 
4.3.1 Tri-allelic sites 
 
The expected number of tri-allelic sites in nuclear DNA was estimated as follows.  We 
downloaded human SNP data from the Environmental Genome Project (NIEHS SNPs 
2008) and the SeattleSNPs project (SeattleSNPs 2008).  High quality sequence data 
were used to identify SNPs (Q > 25), and each SNP reported was confirmed in multiple 
individuals and/or multiple reactions.  Assuming the same Q value for re-sequencing, 
the error rate is 1x10-5.  We masked all CpG and coding sites; coding sites were 
removed since it is difficult to calculate the expected number of tri-allelic sites in 
coding sequences because of selection.  Sites were designated as CpG if the site, or any 
of the SNPs at the site, would yield a CpG dinucleotide. We started by tallying the 
number of each type of nucleotide within each intron and across all genes, ignoring any 
regions that were not scanned for variation.  We then calculated the frequency of each 
type of SNP, 
! 
µX "Y  where X and Y are either A,C,T or G, by orientating the SNP using 
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orthologous chimpanzee sequences and then dividing the number of human sites where 
X was inferred to be the ancestral allele and Y was inferred to be the derived state by 
the total number of X sites.  For example, 
! 
µA"G  was estimated by dividing the number 
of sites where the inferred mutation was from A to G (i.e. A was the allele present at the 
orthologous chimpanzee position and G was the second allele at the SNP site) by the 
total number of sites that were A.  Orthologous chimpanzee sequences were found and 
downloaded using Ensembl Biomart (http://www.ensembl.org/biomart/martview/), and 
then aligned to human sequences using FSA 
(http://math.berkeley.edu/~rbradley/papers/manual.pdf), which incorporates Exonerate 
(Slater and Birney 2005) and MUMmer (Kurtz et al. 2004).  We were unable to find a 
small number of orthologous chimpanzee sequences and there were occasional gaps in 
alignments.  In total, ~94% of human SNP sites had an orthologous nucleotide in 
chimpanzee; the ancestral state was inferred from the major allele at sites with no 
orthologous chimp nucleotide.  At tri-allelic sites, two mutations were assumed to have 
occurred.  The expected number of tri-allelic sites (
! 
Emt ) was then found by multiplying 
each mutation rate by the total frequency of nucleotides with the same allele (
! 
n(X) ): 
 
! 
Emt = n(X) . ((" µX #Y .µX #Z1) + (µX #Y .µX #Z 2) + (µX #Z1.µX #Z 2))  (4.1) 
 
where the summation is across X, and Z1 and Z2 are either A,C,T or G, and X, Y, Z1 
and Z2 are all different nucleotides in each case.   
 
We also downloaded >5000 complete human mitochondrial sequences from GenBank 
(http://www.ncbi.nlm.nih.gov) and aligned the protein coding sequences.  Sequences in 
which genes were of different length to the consensus were removed, leaving 4764 
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complete alignments.  We considered four-fold synonymous sites only.  The expected 
number of tri-allelic sites in mitochondrial sequences was found in much the same way, 
using the same formula as that used for nuclear DNA (equation 4.1).  However, in this 
case the ancestral state was inferred from the major allele at each site, as orientation of 
SNPs using the chimp sequence is impossible because of the large divergence between 
humans and chimps for mtDNA.  Although the use of frequency data will lead to some 
level of misinference, this is likely to be very small because when the population size is 
stationary the level of misinference is expected to be ~7% for 5000 sequences.  mtDNA 
also shows a skew towards rare alleles, which will further reduce the level of 
misinference.  
 
4.3.2 Distribution of single SNPs 
 
The expected distances between SNPs were estimated by randomly distributing SNPs 
within each intron across the intron sequence.  SNPs were not allowed to fall on CpG 
dinucleotides, as these would have been discarded as CpG SNPs (as stated above). The 
expected number of tri-allelic sites was the number of times a site was hit by two SNPs 
multiplied by a factor K, which reflects the fact that when two mutations occur at the 
same site they will not necessarily generate a tri-allelic SNP; for example, if two 
transitions occur at the same site.  Let the proportion of SNPs that are transitions be fts 
and the proportion of transversions that are G<->T or C<->A be ftv1 and the proportion 
that are G<->C or A<->T be ftv2.  Then, the expected number of tri-allelic sites is 2x2. fts 
(ftv1 + ftv2 ) + 2x2. ftv1 . ftv2 , where x is the density of SNPs, and the expected number of 
times two SNPs are expected to fall at the same site is x2.  Thus K = 2(fts (ftv1 + ftv2 )+(2 
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ftv1 . ftv2 )).  In the human genome fts = 0.66, ftv1  = 0.183 and ftv2  = 0.163 
(http://www.ncbi.nlm.nih.gov/), which means that K=0.516. 
 
The expected number of tri-allelic SNPs incorporating the effects of adjacent 
nucleotides on the rate of mutation was calculated using equation 4.1, but by summing 
X over triplets rather than nucleotides.  For example, if the site in question is TTT, then 
the three possible mutations are TTT->TCT, TTT->TGT and TTT->TAT and the 
relative frequency of each SNP is pTTT-C, pTTT-G and pTTT-A respectively.  The likelihood 
of a tri-allelic SNP being observed at this site is then simply:  
 
TriTTT = (pTTT-C x pTTT-A) + (pTTT-C x pTTT-G)+ (pTTT-G x pTTT-A) 
 
This probability is then multiplied by the total number of TTT sites and repeated in a 
similar fashion across all triplet types to give the total number of tri-allelic sites 
expected.  The process was repeated using estimated mutation rates from each gene 
rather than across all sites in the dataset.  This incorporates the effects of any regional 
variation in triplet mutation rates. 
 
4.3.3 Cryptic Variation 
 
In order to investigate the effects of cryptic variation in the mutation rate on the number 
of tri-allelic sites we used the method described in chapter 2, but we only considered 
non-CpG human tri-allelic SNPs against chimpanzee non-CpG bi-allelic SNPs.  We did 
not correct for the effects of adjacent nucleotides on the mutation rate since there is not 
enough data to estimate this for tri-allelic sites and the effects are small for bi-allelic 
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sites.  As such, the expected number of coincident SNPs is simply the total number of 
alignments divided by the number of positions in the alignment that were not part of a 
CpG dinucleotide. 
 
4.3.4 Origin of tri-allelic SNPs 
 
To test whether tri-allelic SNPs in autosomal data could have been produced by a 
simultaneous mutation event or by an event linked to recombination we considered 
whether the minor alleles were significantly closer together on a phylogenetic tree of 
human haplotypes than would be expected by chance.  For each tri-allelic site we took 
the 100 bi-allelic SNPs either side from each of the individuals sampled in the 
Environmental Genome Project and SeattleSNPs studies, not including the tri-allelic 
SNP itself.  Where there were not 100 SNPs either side of the tri-allelic site within each 
gene, we used extended data either side of the tri-allelic site up to a total of 200 SNPs 
where possible.  We then used PHASE (Stephens, Smith, and Donnelly 2001) to 
construct haplotypes from the variation data.  The bi-allelic sites were bootstrapped 
1000 times and each bootstrap dataset used to build a phylogenetic tree using the 
Neighbour-Joining method in Phylip (Felsenstein 2005).  The tri-allelic site was then 
placed back on this tree.  The distances between the minor alleles in the tri-allelic site 
were found by summing the lengths of branches on each tree separating the terminal 
nodes containing the alleles; if either one of the minor alleles was not a singleton, the 
distances between every pair of haplotypes containing the minor alleles was averaged. 
The expected distance between minor alleles was estimated by randomly placing two 
mutation events on two branches of each tree inferred from the bootstrapped data 
according to the inferred length of the branches; simulations in which the two mutations 
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fell on the same branch, or on the two branches descending from the root, were 
discarded since they would not generate a tri-allelic SNP.  Minor alleles were 
designated as those at the lowest frequency and the average distance between them was 
calculated as before.  The process was repeated across the 1000 bootstrapped trees for 
each tri-allelic SNP, and an estimated p-value was calculated as the proportion of trees 
in which the observed distance between minor alleles was smaller than the distance 
between the minor alleles of the simulated data.  Fisher’s combined probability test was 
used to calculate whether the p-values across all tri-allelic sites were significant. 
 
In order to test whether the randomization procedure and analysis of phylogenetic trees 
was satisfactory we also derived the expected distance between a random pair of non-
adjacent bi-allelic SNPs from within the set of haplotypes generated for each tri-allelic 
SNP, and then calculated whether these mutations fell significantly closer on the 
phylogenetic tree of haplotypes than we would expect by chance.  In each case, 
phylogenetic trees were reconstructed as before, excluding the two randomly chosen bi-
allelic SNPs.  Where a single haplotype contained both minor alleles for the two SNPs 
chosen, the allele at lower frequency was used, thus generating three different alleles 
across all haplotypes for comparison.  We found no significant difference between the 
real data and the simulated data (p=0.28) for the distances between minor alleles at the 
bi-allelic sites.  We therefore conclude that our analysis procedure for phylogenetic 
trees is satisfactory and does not lead to artificial clustering of SNPs. 
 
A second test was performed to judge whether the minor alleles of tri-allelic sites 
tended to cluster on a phylogenetic tree of haplotypes in the population.  The distances 
between minor alleles of tri-allelic sites were calculated as above, however on this 
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occasion they were compared to the distances between minor alleles of tri-allelic sites 
that were generated by coalescent simulations.  For each tri-allelic site the 
recombination rate was calculated using the Pairwise program in LDhat (McVean, 
Awadalla, and Fearnhead 2002), considering all haplotypes in the population and 
assuming a constant rate of recombination.  A coalescent simulation was then 
performed using MS (Hudson 2002), which incorporated a model of demographic 
history as outlined by Adams and Hudson (2004) and the recombination rate and 
population structure for each particular tri-allelic site.  Individuals were considered to be 
either African or non-African in the simulation.  Finally, the program Seq-Gen 
(Rambaut and Grassly 1997) was used to generate haplotypes for each population under 
a finite sites model, with the mutation rate set such that the average nucleotide diversity 
would be 0.0015 (-s option). This is slightly higher than the average nucleotide diversity 
in humans, but was increased to reduce computing time.  The process was repeated for 
each tri-allelic site until 100 data sets had been generated that contained a tri-allelic site; 
for each of these simulated tri-allelic sites we extracted the same number of bi-allelic 
SNPs as were present in the original data.  Each set of sequences was then used as 
above, with the tri-allelic site removed, to generate a phylogenetic tree; the tri-allelic 
site was then placed back on the tree and the distance between minor alleles computed 
as above.  The distribution of distances were then compared to the distribution of 
distances from the bootstrapped trees of the original data; the p-value was calculated by 
randomly pairing a value from the original boostrapped data, with a value from the 
coalescent simulations; the p-value was the number of times the former was less than 
the latter.  The coalescent simulations depend upon the demographic model, but ethnic 
information for the DNA samples was only available for 60 of the 113 tri-allelic sites; 
we therefore only considered these. 
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In order to test whether tri-allelic SNPs are linked to recombination we calculated the 
average recombination rate across each gene in our data set using data from Kong et al. 
(2002).  We split the genes into quartiles based on average recombination rate and 
tested whether the density of tri-allelic sites was significantly different between the 
upper and lower quartiles using a z test. 
 
The expected number of tri-allelic SNPs that fall within immediately adjacent SNPs was 
calculated by multiplying the frequency of tri-allelic SNP sites by the frequency of 
immediately adjacent SNP sites (2 per pair of SNPs) within each intron. 
 
4.3.5 Quantification 
 
We estimate the relative contributions of single and simultaneous mutation events to the 
production of variation as follows. We assume the mutations are neutral, the population 
is stationary in size and the organism being considered is diploid.  First, let us consider 
single bi-allelic SNPs.  The expected number of bi-allelic sites in a sample of n 
sequences is: 
! 
Ss = 2Neµs P(t,n)
t= 0
"
# + 2Neµd . 2 P(t,n). (1$ P(t,n))
t= 0
"
#  (4.2) 
where µs is the rate of single mutations, µd is the rate for simultaneous double mutations 
during the mitotic phase of germ line development,  and P(t,n) is the probability of 
observing a mutation that was produced t generations in the past in a sample of n 
sequences.  Note that only simultaneous mutation events during mitosis are likely to 
generate two mutations that can both be inherited; this is because only one meiotic 
product generates an egg in females so only one mutation from a simultaneous event 
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during meiosis will be inherited.  Furthermore, human females typically only have one 
offspring at a time; hence, only one product from a simultaneous event in male meiosis 
will be transmitted.  The first summation denotes the probability of observing a SNP 
produced by a normal mutational event, and the second summation denotes the 
probability of observing a bi-allelic SNP that was originally produced by a simultaneous 
event, with one allele being lost through genetic drift and therefore only contributing a 
bi-allelic SNP to the population.   
 
The expected number of tri-allelic SNPs is approximately: 
! 
St = 2Neµd P(t,n)2
t= 0
"
#   (4.3) 
This is only an approximation because it assumes that the frequencies of the two 
mutations are independent, whereas they are not; for example, if one allele goes to 
fixation then the other allele can no longer exist. However, this approximation is likely 
to be good since the new mutations will generally be rare. 
 
The probability of observing a SNP in the population, 
! 
P(t,n), can be split into two 
components; the probability that a SNP is segregating in the population, 
! 
y( j, t,N), 
where j is the number of copies of the new allele in the population of size N, and the 
probability that it is sampled in our data, 
! 
z(n) . We can estimate 
! 
y( j, t,N) using a 
transition matrix approach as follows.  We initially introduce a single mutation into our 
population: 
! 
y(1,0,N) =1 and 
! 
y( j,0,N) = 0 for j>1.  The probability of the mutation 
being at a frequency j given that we had i copies in the previous generation can be 
calculated from the binomial distribution: 
! 
X(i, j,N) = n!j!(n " j)!
i
2N
# 
$ 
% 
& 
' 
( 
j
1" 2N " i2N
# 
$ 
% 
& 
' 
( 
2N" j
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so 
! 
y( j, t +1,N) = y(i,t)X(i, j,N)
i=1
2N"1
#  
The chance of sampling a SNP is: 
! 
z(n) =1" ( j2N )
n " (1" j2N )
n  
where n is our sample size, (j/2N)n is the chance that one of the minor alleles gets 
sampled in all cases, and (1-j/2N)n is the chance that the other allele gets sampled in all 
cases.  The likelihood of observing the SNP is therefore: 
! 
P(t,n) = y( j,t,N). z(n)
j=1
2N"1
#  
 
Both equations 4.2 and 4.3 involve infinite sums; to determine a reasonable limit of this 
summation we note that ∑P(t,n) should be equal to ∑(2/i) as given by Watterson’s 
classic formula for the number of neutral polymorphisms segregating in a sample of 
sequences (Watterson 1975):  
! 
Sw = 4Nµ
1
ii=1
2N"1
#  
 
The convergence of ∑P(t,n) depends upon the number of chromosomes sampled; we 
required that ∑P(t,n) was within 1% of ∑(2/i). 
 
From equations 4.2 and 4.3 it is straightforward to estimate the relative rates of single 
and simultaneous mutation, µs and µd, from the observed numbers of bi-allelic and tri-
allelic sites, Ss / St. 
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4.4 Results 
 
4.4.1 Excess of tri-allelic sites 
 
We used data from 896 nuclear genes that had been resequenced in between 90 and 95 
human individuals to search for tri-allelic sites.  After removing CpG and coding sites 
we had a total of 36,702 transitions, 20,375 transversions and 113 sites that had three 
alleles segregating in the human population (appendix 4.1).  This is significantly greater 
than the 61.15 tri-allelic sites expected by chance if mutations are randomly distributed 
across non-CpG sites (ratio of observed over expected = 1.85, with a standard error of 
0.17, p < 0.001 under the null hypothesis that the ratio is one).  We also searched for tri-
allelic SNPs at four fold synonymous sites in human mitochondrial genes in 4764 
complete sequences.  We found 1125 transitions, 173 transversions and 126 tri-allelic 
sites.  In this case we found no significant excess of tri-allelic sites above that expected 
by chance (observed over expected = 1.20, p > 0.05).  We do not consider the results 
from mtDNA further.  The excess of tri-allelic SNPs in nuclear DNA could be 
potentially caused by one of four processes; sequencing errors, natural selection, 
increased rates of mutation at single nucleotides or another form of mutation that may 
include mismatches at recombination or a primary mutation inducing a second mutation 
on the strand opposite. 
 
4.4.2 Sequencing Error 
 
It is possible that some tri-allelic sites are the result of sequencing error and this may 
lead us to over-estimate the excess of tri-allelic SNPs, however this seems unlikely for 
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the following reasons.  There are only two ways in which sequencing error could 
generate the excess; first, if polymorphic sites tend to be more prone to sequencing 
error, and second if some sites tend to be prone to sequencing error and two of the three 
alleles at a tri-allelic site are generated by error.  However, there is no evidence and no 
reason to believe that sites that are polymorphic tend to be more prone to sequencing 
error, and very few of our tri-allelic sites have two singleton mutations, as we would 
expect if two alleles at tri-allelic sites were generated by error.  However, to investigate 
the matter further we performed an additional analysis.  Should the excess of tri-allelic 
sites be due to sequencing error we would expect to see a higher frequency of singletons 
at tri-allelic sites than we do at bi-allelic sites in the observed data.  To test this, we 
selected one of the minor alleles at each tri-allelic site at random, since bi-allelic sites 
only contain two alleles, and then compared the frequency of singletons at randomly 
chosen alleles at tri-allelic sites with the frequency of singletons found at bi-allelic sites; 
we bootstrapped the data 1000 times to obtain an average singleton frequency and 
confidence intervals at tri-allelic sites.  The frequency of singletons at bi-allelic sites is 
0.347 (95% confidence interval: (0.342,0.352)) and the average frequency of singletons 
at tri-allelic sites is 0.345 (0.257,0.434), which are not significantly different (p=0.44).  
Furthermore, we have contacted the researchers who produced the data and they 
confirm that the validation process is more rigorous for tri-allelic sites due to their rarity 
and interesting nature.  Tri-allelic sites are confirmed on both strands of the DNA 
duplex and additional PCR reactions are performed to show that the tri-allelic site is 
present in at least two different amplicons (Rieder 2010).  Thus, there is no evidence 
that the excess of tri-allelic sites is caused by sequencing error. 
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4.4.3 Natural selection 
 
Selection is expected to lead to an apparent excess of tri-allelic sites because SNPs will 
not tend to segregate within regions under selection, and therefore SNPs will appear to 
be clustered between these areas.  Firstly, this is unlikely to be the case here as all of the 
sequences considered are intronic, and although selection is known to act in these 
regions, it is thought to only affect a small percentage of sites (Waterston et al. 2002; 
Dermitzakis, Reymond, and Antonarakis 2005; Asthana et al. 2007).  Furthermore, if 
selection were responsible for the excess of tri-allelic SNPs we would expect to see 
SNPs clustering more generally.  However, if we look at the distances between SNPs, 
and compare this to the results from simulations in which SNPs are randomly 
distributed, then we see no evidence of clustering except an excess of tri-allelic sites and 
an excess of immediately adjacent SNPs (Figure 4.2).  We consider the excess of 
adjacent SNPs separately below.  The distances between SNPs suggest that selection is 
not impacting on the number of tri-allelic sites present. 
 
4.4.4 Mutation Hotspots 
 
The excess of tri-allelic SNPs could be a result of local variation in the mutation rate in 
the human genome.  It has previously been shown that the mutation rate varies as a 
function of local context effects, particularly depending upon the adjacent nucleotides 
(Blake, Hess, and Nicholsontuell 1992; Zhao et al. 2003; Hwang and Green 2004).  
Such variation in the mutation rate could lead to an increased number of tri-allelic SNPs 
if some sites have an elevated mutation in two or more pathways; e.g. if both C->T and 
C->A occur at higher rates.  To investigate whether neighbouring nucleotide effects  
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Figure 4.2.  Observed over expected values for the distance to the nearest neighbour 
SNP within each intron. 
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could cause the excess of tri-allelic sites, we estimated the probability of observing a 
SNP at the central nucleotide of each triplet, ignoring CpGs, and used these to estimate 
the expected number of tri-allelic sites.  If we estimate the probabilities across all our 
genes we infer the expected number of tri-allelic sites to be 61.88; this is only slightly 
larger than the estimate ignoring adjacent nucleotide effects, and is significantly less 
than the number observed (observed/expected = 1.83, standard error = 0.17, p < 0.001).  
If we estimate probabilities within genes, thus controlling for any regional variation in 
mutation rates within chromosomes, this expectation increases slightly to 69.03, but this 
is still highly significantly different from the observed number (p < 0.001).  Local 
context effects are therefore not the cause of the excess of tri-allelic sites.  We do not 
consider the effects of nucleotides further away as these have been shown to have a 
much smaller effect on mutation rates than adjacent nucleotides (Krawczak, Ball, and 
Cooper 1998; Zhao et al. 2003), which themselves have little impact on the expected 
number of tri-allelic SNPs. 
 
It is also possible that the excess of tri-allelic SNPs is caused by CpG alleles that were 
subsequently lost from the population.  If we consider a CpG site that mutates at a high 
rate to produce a TpG and an ApG; if the CpG is then lost from the population and 
either the TpG or ApG then mutates to a GpG, this generates a tri-allelic site which was 
in part caused by the increased mutation rate associated with a CpG.  In order to test for 
this we repeated the analysis and excluded all sites preceded by a C or followed by a G; 
we find that the effect is still significant (observed/expected = 1.77, standard error = 
0.18, p<0.001).  Therefore, CpGs that have been lost are not causing the excess of tri-
allelic sites. 
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However, we have previously shown that the mutation rate varies across the human 
genome in a cryptic nature that is not associated with any specific context effect 
(chapters 2 and 3).  This was demonstrated by showing that there is an excess of sites 
with a SNP at the orthologous position in humans and chimpanzees (coincident SNPs).  
Such cryptic variation could potentially lead to an excess of tri-allelic sites, should at 
least two mutational pathways be elevated at particular sites (e.g. a transition and a 
transversion).  However, we note that this cryptic variation seems to largely elevate the 
rate of mutation of a single mutational pathway; there is a large excess of cases in which 
an X<->Y SNP in humans is coincident with an X<->Y SNP in chimps, but little or no 
excess of X<->Y in humans and X<->Z in chimpanzees (where X,Y and Z can be 
A,T,G or C).  Cryptic variation would therefore not tend to generate tri-allelic sites.  
However, to investigate the matter further we considered whether tri-allelic sites in 
humans also tended to have a SNP at the orthologous position in chimpanzee, and 
calculated the number expected assuming that chimpanzee SNPs and tri-allelic sites 
were randomly distributed relative to one another.  As an excess of tri-allelic SNPs 
requires an increased level of mutation along two pathways, we would expect the ratio 
of coincident tri-allelic SNPs to their expected number to be far in excess of that found 
for coincident single SNPs.  Because we are not interested in the excess of tri-allelic 
sites per se we can take advantage of tri-allelic sites found in dbSNP; there are ~50,000 
examples. These were BLASTed against a dataset of chimpanzee SNPs to yield a data 
set of 548 alignments of 81bp with the chimpanzee SNP in the central position and the 
human tri-alllelic SNP elsewhere within the alignment.  Of these alignments, 17 have 
the human and chimpanzee SNPs in the same position, as opposed to the 6.96 we would 
expect were the SNPs distributed at random (observed over expected ratio = 2.44); this 
is not significantly different from the ratio for non-CpG single SNPs in which local 
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context effects are ignored, which is 2.40 (chapter 2).  There is therefore no evidence 
that cryptic variation in the mutation rate tends to generate an excess of tri-allelic sites. 
 
There are a number of additional mutation hotspot mechanisms that could cause an 
excess of tri-allelic sites, which need to be considered.  First, it has been suggested that 
sequences adjacent to indel events may have elevated rates of mutation; this is most 
evident up to 100bp from the indel, but effects decline away from indels across several 
hundred base pairs (Tian et al. 2008).  It is unlikely that an increase in the rate of 
mutation in these areas could cause the excess of tri-allelic SNPs in our data because if 
the effect were sufficiently large, we would expect to see a clustering of SNPs in certain 
parts of the genome.  It is clear from figure 4.1 (discussed in the section on natural 
selection) that this is not the case.  Furthermore, alpha-polymerase pause sites are also 
thought to mutate at a higher than normal rate (Todorova and Danieli 1997), and could 
cause an excess of tri-allelic sites.  In our data however, there is only one occurrence of 
the motif associated with a pause site in the region immediately upstream of tri-allelic 
sites and thus the motif does not impact on our results. 
 
4.4.5 Recombination and simultaneous mutation 
 
The evidence above suggests that it is not particular sites that tend to produce tri-allelic 
SNPs, so maybe tri-allelic sites are generated by a mechanism which can occur at all 
sites with a similar probability, but one in which one mutation generates the second 
mutation.  There are at least two related potential mechanisms.  First, it is possible that a 
mutation could induce a subsequent mutation, possibly through the formation of 
heteroduplex DNA during recombination.  The lack of an excess of tri-allelic sites in 
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mitochondrial DNA, in which recombination is rare or absent, would be consistent with 
this model.  Second, it might be possible that two mutations occur within a single DNA 
duplex; for example, a G=C base pair might become an A=C mismatch, which then 
becomes an A=G.  If replication runs through this mismatch before it is repaired we 
would end up with the G=C allele being mutated to A=T and C=G; so two new 
mutations have been generated within a single event. Alternatively, it may be possible 
that both strands of DNA are mutated simultaneously, perhaps as a result of a chemical 
or radiation event.  This process of simultaneous mutation would need to occur in the 
mitotic phase of germ line development in order for the two new alleles to be potentially 
transmitted to the next generation.  We refer to these as the “recombination” and 
“simultaneous mutation” models respectively. 
 
In order to investigate whether one of these two mechanisms generates the excess of tri-
allelic sites we can potentially test a prediction that both models make for recombining 
data; they both predict that new mutations should cluster together on a phylogenetic tree 
of human haplotypes.  We expect this clustering under the simultaneous mutation model 
because we hypothesise that both new mutations will be produced on the same genetic 
background.  The clustering is also expected under the recombination model because 
the first mutation should induce the second mutation equally as often on the original 
haplotype as it does on another haplotype in the population.  To investigate whether we 
could detect clustering in recombining autosomal loci we took each of our tri-allelic 
sites and 200 bi-allelic SNPs surrounding the site where possible; using the bi-allelic 
SNPs we constructed haplotypes and inferred the phylogenetic relationships between 
them.  We then calculated the average distance between haplotypes containing the 
minor alleles.  Amongst our 113 tri-allelic sites we find 6 cases in which the minor 
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alleles are significantly closer to each other at the 5% level than if mutations are placed 
on the phylogenetic trees at random, approximately what we would expect by chance 
alone; however if we combine probabilities across all tri-allelic sites we find significant 
evidence for proximity of the minor alleles (p<0.05).  Nevertheless, comparing the 
observed distances between minor alleles with those generated by randomly placing 
mutations on the same phylogenetic tree may not be the most appropriate way to 
detect clustering.  There may be some genealogies that tend to produce tri-allelic sites by 
double mutation, where the minor alleles tend to be clustered together on deeper 
branches of the phylogenetic tree.  As a consequence, the method above may average 
across several genealogies if there has been recombination and so produce an average 
genealogy that does not tend to lead to an excess of tri-allelic sites.  Thus we performed 
coalescent simulations under a realistic demographic model, with the rate of 
recombination estimated from the bi-allelic sites, to generate a set of simulated tri-allelic 
sites for each observed tri-allelic site.  We then compared the observed distances 
between the minor alleles of tri-allelic sites with those produced from the coalescent 
simulations.  We only knew the ethnicities of the individuals sequenced for 60 of the tri-
allelic sites and so could only perform simulations for those sites because of the need to 
incorporate demography; in 12 cases the minor alleles are significantly closer to each 
other at the 5% level than those generated from coalescent simulations.  If we combine 
probabilities across all 60 tri-allelic sites we find highly significant evidence of proximity 
(p<0.001).  This is consistent with both the simultaneous mutation and recombination 
pathways. 
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In principle it is possible to differentiate between the recombination and simultaneous 
models by considering non-recombining nuclear DNA, such as the non-recombining 
portion of the Y-chromosome (NRY).  In the NRY, under the simultaneous mutation 
hypothesis we expect both mutations to appear at the same time on the same genetic 
background in about half the tri-allelic sites, the other half being a consequence of 
chance alone.  The simultaneous generation of two mutations will manifest itself as two 
new alleles emanating from a single node in the phylogenetic tree of human haplotypes.  
Unfortunately, to our knowledge only a single non-CpG tri-allelic SNP has been 
reported for the NRY; this is an A,T,C tri-allelic SNP termed M116 (Underhill et al. 
2001).  In this case, the two minor alleles, T and C, are found in different haplogroups 
and as such cannot have been caused by a simultaneous mutation event. This does not 
disprove that tri-allelic sites are produced by simultaneous mutation since we infer that 
about 50% of tri-allelic sites are due to chance alone (see above). 
 
Alternatively, we may be able to differentiate between the two models by considering 
the prediction that under the recombination model, tri-allelic SNPs and recombination 
rates should be correlated.  We have already shown that there is no excess of tri-allelic 
sites in human mitochondrial DNA and clearly there is a prediction under the 
recombination model that there should be no excess in non-recombining sequences.  
However, in mtDNA a lack of tri-allelic sites does not necessarily point to tri-allelic 
SNPs being generated during recombination, as there are many other factors that 
differentiate the mutation process in mtDNA and nDNA that could be equally likely to 
generate the result.  Consequently, we tested for a correlation between tri-allelic SNPs 
and recombination rates in the autosomal datasets. We separated our data set of introns 
from genes into quartiles based on the average recombination rate across the gene (rates 
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taken from Kong et al. (2002)) and found that there was no significant difference 
between the number of tri-allelic SNPs per sampled site in genes that were in the upper 
and lower 25% of recombination rates (p = 0.77).  We also tested for a correlation 
between recombination rate and the presence/absence of a tri-allelic site across genes 
using logistic regression; there was no evidence of a significant correlation (p=0.99).  It 
should be noted at this point that our test for a correlation between tri-allelics SNPs and 
recombination may not include all gene conversion events, as the genetic map only 
measures crossover rates and our hypothetical recombination mechanism would also 
apply to gene conversion events.  However, as gene conversion and crossover hotspots 
tend to coincide (Jeffreys and May 2004), it is likely that the result would be mirrored 
when considering gene conversion as an indicator of tri-allelic SNP density.  There is 
therefore no evidence that tri-allelic sites are linked to recombination.  This leads us to 
believe that the simultaneous mutation model most likely explains the excess of tri-
allelic SNPs in the human genome. 
 
4.4.6 Adjacent mutations 
 
As we noted above, besides an excess of tri-allelic sites there is also an excess of 
adjacent SNPs.  It has been previously noted that adjacent substitutions are more 
common than you would expect by chance (Averof et al. 2000) and it has been 
suggested that this is due to the simultaneous mutation of adjacent nucleotides.  To 
investigate whether this is the case we compared the absolute difference in minor allele 
frequency (MAF) between adjacent SNPs.  If adjacent SNPs are produced 
simultaneously then we expect many adjacent SNPs to have identical MAF since they 
can only differ in frequency if they are broken up through recombination.  This is what 
 129 
we observe; approximately half of all adjacent SNPs have identical MAFs (252/506), 
which is consistent with the observation that adjacent SNPs are approximately twice as 
common as expected by chance.  We also note that the absolute difference in MAF 
between adjacent SNPs is significantly smaller than the absolute difference in MAF 
between one of the adjacent SNPs (randomly chosen) and the next non-adjacent SNP 
(p<0.001, average difference in MAF for adjacent SNPs = 0.073, average difference in 
MAF for non-adjacent SNP = 0.107).  Thus, it seems that there is a process that 
produces adjacent SNPs simultaneously, and it therefore seems possible that a similar 
process could also generate tri-allelic sites if a mutation event that causes a doublet 
mutation along a strand can also cause a double mutation across strands, which could 
occasionally occur at the same time.  To investigate this we searched our data for any 
case in which a tri-allelic site was adjacent to another SNP.  We found one case, and 
although this feature is rare, this is significantly higher than the 0.008 we expect by 
chance alone (p < 0.01).  The coincidence of a tri-allelic site and an adjacent SNP could 
be due to either some sites having a greater chance of producing adjacent and tri-allelic 
sites, or due to the generation of both simultaneously. 
 
 
4.5 Discussion 
 
We have shown that there is an excess of sites in the human genome that have three 
alleles segregating in the population.  The excess cannot be explained by sequencing 
errors, natural selection or an increased mutation rate for single events at particular 
sites.  Instead, there is some evidence that a proportion of tri-allelic sites may be caused 
by a single mutation mechanism in which two new alleles are produced at the same or 
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similar time, on the same or similar genetic background; the minor alleles at a tri-allelic 
SNP tend to be closer together on the phylogenetic tree than one would expect by 
chance.  We show that the clustering is unlikely to be caused by a mutational 
mechanism linked to recombination, as there is no association between recombination 
rates and genes that contain tri-allelic SNPs.  We have also shown that there may be an 
association between tri-allelic and immediately adjacent SNPs.  None of these lines of 
evidence is individually particularly strong, but collectively they suggest that a 
proportion of tri-allelic sites are a consequence of simultaneous mutation.  A conclusive 
test can be made using Y-chromosome data, and the 1000 human genome project is 
likely to provide sufficient information to resolve the problem since the project will 
produce long non-recombining Y-chromosome sequences from many males.  However, 
this data is unlikely to be available for another 12 to 18 months (McVean 2009). 
 
Although we do not know the specific mechanism that generates two new alleles at a 
single site, there are a number of potential candidates.  First, it is possible that double 
strand breaks that occur as a result of both endogenous and exongenous factors, could 
result in nucleotides at the same site on opposite strands being more prone to mutation.  
It seems unlikely that this mechanism is the one responsible here, since double strand 
breaks are generally considered to be mutagenic over a larger distance than at single 
sites (Pfeiffer 1998), and we do not observed clustering of mutations in the regions 
surrounding tri-allelic sites.  Second, it is possible that error-prone polymerases could 
increase the likelihood of a second mutation opposite a site that has already undergone a 
mutation.  It is known that Y-family polymerases have a high error rate when 
replicating undamaged DNA (Goodman 2002; Rattray and Strathern 2003) and 
furthermore, particular polymerases are known to preferentially insert non Watson-
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Crick base pairs at lesions (Goodman 2002; Rattray and Strathern 2003).  For example, 
polymerase iota preferentially inserts a guanine opposite a thymine when recruited to a 
lesion site (Johnson et al. 2000); should the original mutation have been A->G, this kind 
of error would lead to an A, G and C being present at the same site across different 
copies of the DNA after replication.  Whether this specific polymerase is involved at tri-
allelic sites is not known, however it is not difficult to imagine that a similar mechanism 
involving other enzymes could play a role.  A similar mechanism has been invoked to 
explain why rates of CpG and non-CpG substitutions are correlated across genes in the 
human genome (Walser, Ponger, and Furano 2008).  The idea is further supported as 
translesion polymerases are known to be highly expressed in germ cells (Rattray and 
Strathern 2003), where the generation of a tri-allelic site would need to occur in order to 
be inherited and become visible in the population.  Third, it may be possible that tri-
allelic sites are generated at dual abasic sites, where the nucleotides on both strands of 
the duplex become lost.  Were replication to encounter such a problem, it could lead to 
two different mutations at the same site.  It has been proposed that the in vivo steady-
state level of abasic sites is between 4,500 and 200,000 for a 3 billion nucleotide 
genome (Nakamura and Swenberg 1999; Atamna, Cheung, and Ames 2000) and even if 
the actual number is at the lower end of these estimates, the rate of depurination could 
be increased by chemical or enzymatic induction, such as free radicals or alkylating 
agents; the latter of which has been shown to accelerate the rate of nucleotide loss by 6-
fold (Wilson and Barsky 2001).  Under normal conditions, the abasic site would be 
incised by AP endonucleases and repaired using the nucleotide opposite as a template, 
however should both nucleotides be lost there would be no template to re-generate the 
original nucleotide.  It has also been shown that endonucleases do not need the base 
opposite for recognition of an abasic site (Wilson et al. 1995).  Fourth, it could 
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potentially be the case that two mutations on opposite strands are caused by chemical or 
radiation event attacking both strands simultaneously, however in the case of the latter it 
is difficult to see how this could occur in germ line cells that are generally less prone to 
attack by external agents.  Finally, it could be the case that a primary mutation induces a 
mutation at the site opposite if the bond between the two nucleotides is lost and the site 
essentially becomes single stranded DNA (ssDNA).  Cytosine bases have been shown 
to be more prone to deamination and subsequent mutation on ssDNA when adjacent to a 
guanine residue (Frederico, Kunkel, and Shaw 1990) and although we have excluded 
CpG sites in this analysis, a similar process is thought to occur during somatic 
hypermutation where an associated enzyme, activation induced deaminase (AID), 
induces deamination at cytosines in different contexts on ssDNA (Rattray and Strathern 
2003).  However, although a similar mechanism could occur here, we would likely 
observe a general clustering of mutations in the region, which we do not see. 
 
The available evidence suggests that the excess of tri-allelic sites is caused by the 
simultaneous production of two new alleles in a single individual.  If this is the case 
then we can estimate the frequency of this process using equations 4.2 and 4.3.  To a 
first approximation the relative numbers of bi-allelic and tri-allelic SNPs depend upon 
their mutation rates and the relative probabilities of detecting a single SNP (ΣP(t,n)), 
and two SNPs generated simultaneously (ΣP(t,n)2).  Surprisingly we find that ∑
! 
P(t,n)2 
is only about fifteen-fold lower than ∑
! 
P(t,n) when large numbers of chromosomes 
have been sampled (table 4.1); so the chance of sampling two mutations produced in the 
same generation is actually quite high in the data we have analysed. 
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Number of 
Chromosomes 
∑2/i ∑
! 
P(t) ∑
! 
P(t)2 ∑
! 
P(t) / ∑
! 
P(t)2 
4 3.66 3.62 0.017 212.02 
10 5.65 5.58 0.049 112.70 
40 8.51 8.29 0.190 43.73 
100 10.35 9.88 0.419 23.61 
200 11.75 10.90 0.698 15.61 
 
Table 4.1. The summed probabilities that a single SNP is sampled in n chromosomes 
until it is fixed or lost, and the summed probabilities that two mutations produced 
simultaneously are sampled, together with a ratio of the two values across different 
numbers of sampled chromosomes. 
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We can use equations 4.2 and 4.3 to estimate the ratio of the rates of single and 
simultaneous mutation, 
! 
µs /µd  as follows. We infer that approximately half of all tri-
allelic sites are a consequence of simultaneous mutation, hence 
! 
Sd  = 51.13 and 
! 
Ss  = 
57077.  In our data between 180 and 190 chromosomes have been sampled so ∑
! 
P(t) / 
∑
! 
P(t)2 is between 16.05 and 16.54 and hence 
! 
µs /µd  is between 65.6 and 67.7; so 
single mutations occur approximately 65 times more frequently than simultaneous 
mutations and since each simultaneous event produces two new mutations, we estimate 
that about 3% of all distinct SNPs are generated in this fashion. 
 
We have also shown that there is an excess of adjacent SNPs, and that at least half of 
these adjacent SNPs appear to be generated simultaneously.  If we assume that the 
doublet mutations remained linked throughout their life – i.e. there is no recombination 
between them, then we can directly estimate the rate of adjacent mutation (µa) by 
considering the ratio of single SNPs to adjacent SNPs; using this approach we estimate 
! 
µs /µa  as 225.6, assuming that approximately half of all immediately adjacent mutations 
occur simultaneously.  As adjacent mutation events contribute two new SNPs, we 
estimate that about 0.89% of all distinct SNPs are generated in this fashion.  So 
although adjacent SNPs are slightly more common than tri-allelic sites, the rate at which 
they are produced is actually lower, and this is because the probability that two 
independent SNPs survive to be sampled is considerably lower than the probability that 
two linked SNPs survive (table 4.1).  Of course, this figure depends on the rate of 
recombination between adjacent SNPs; should this rate be extremely high, there will be 
almost no linkage between adjacent SNPs, if it is low, adjacent SNPs will behave in the 
manner of single SNPs.  In this case it is reasonable to suggest that the latter is most 
probably more realistic.  Our estimate of the ratio of single over doublet mutation rates 
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of 225.6 is closer to the ~1000 estimated by Kondrashov (2003) than the ~10 estimated 
by Averoff et al. (2000).  We believe that our estimate is likely to be most accurate as it 
uses the most direct approach to compare mutation rates in neutral sequences. 
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5. The local context and genomic distribution of cancer 
mutations 
 
 
5.1 Abstract 
 
Recently the genome sequences from four cancer cells have been published, along with 
the genome from a non-cancer tissue from the same individual, allowing the 
identification of new somatic mutations in the cancer.  The data comes from two acute 
myeloid leukemia (AML) cells, a small-cell lung cancer (SCLC) cell and a skin cancer 
cell.  Here we investigate the patterns of mutation in the cancer tissues as well as the 
distribution of those mutations at a number of different scales; we compare these to the 
patterns seen in the germ-line.  The pattern of mutation in SCLC and skin cancer is 
dominated by mutations associated with specific mutagens, as others have shown 
before.  Interestingly one of the two AML cancers shows a very similar pattern to the 
SCLC, suggesting that it might have been caused by similar mutagens.  In contrast the 
second AML cancer shows a pattern that is very similar to that observed in the germ-
line.  The rate of mutation at individual sites is affected by the identity of the adjacent 
nucleotides in all cancers, and these patterns are very similar to those observed in the 
germ-line, except in the skin cancer genome, where patterns of mutation are very 
different to the germ-line.  All cancer genomes show substantial variation in the number 
of mutations per MB, and these patterns are quite strongly correlated between SCLC 
and skin cancers, and between the two AML genomes; all cancers are significantly 
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correlated to the germ-line.  We find no evidence that genes associated with cancers are 
found disproportionately in regions with high mutation rates.  Finally we show that the 
mutation rate differs between chromosomes for all cancers; echoing the results at a MB 
scale, mutation rates were most strongly correlated between skin and SCLC, and 
between AML genomes, and also the germ-line. 
 
 
5.2 Introduction 
 
Mutations can be divided into those that occur in the germ-line and those that occur in 
the soma.  Germ-line mutations contribute to future generations and are the basis of 
inherited genetic disease as well as being the raw material of evolutionary change.  In 
contrast, somatic mutations do not contribute to future generations but can give rise to 
cancers and most probably contribute to ageing (Vijg 2000; Finkel, Serrano, and Blasco 
2007).  It has been estimated that on average each of us receives approximately 50-100 
new germ-line mutations from our parents (Kondrashov 1995; Lynch 2010), but this is 
completely dwarfed by the number of somatic mutations a cell will accumulate during 
its life-time within an individual; it is thought that cells in proliferating tissue are likely 
to have accumulated 10,000s of new somatic mutations by the time an individual 
reaches mid-life (Lynch 2010).  Cancers are no different to other somatic tissue and 
accumulate thousands of mutations by the time a diagnosis is made.  Recently the 
sequence from four cancer genomes have been published, along with the genome from 
non-cancer tissue from the same individual, allowing the identification of new somatic 
mutations in the cancer.  The data comes from two acute myeloid leukemia (AML) 
genomes (Ley et al. 2008; Mardis et al. 2009), henceforth referred to as AML1 and 
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AML2 respectively, a small-cell lung cancer (SCLC) genome (Pleasance et al. 2009b) 
and a skin cancer genome (malignant melanoma) (Pleasance et al. 2009a).   
 
In the germ-line transitions occur approximately 2 times as frequently as transversions, 
and GC->AT changes occur much more often than the reverse (Gojobori, Li, and Graur 
1982; Li, Wu, and Luo 1984; Blake, Hess, and Nicholsontuell 1992).  In contrast, it has 
been shown that lung and skin cancer genomes show evidence of the mutagenic 
mechanisms that are thought to cause these diseases; the lung cancer genome shows a 
large excess of GC->TA transversions (Pleasance et al. 2009b), which is thought to be 
associated with tobacco smoke carcinogens (Pfeifer et al. 2002), and the skin cancer 
shows a very large excess of CG->TA transitions (Pleasance et al. 2009a), which are 
thought to be a consequence of UV light (Pfeifer, You, and Besaratinia 2005).  The 
pattern of mutation has not been studied in the AML genomes.   
 
The rate of mutation at a site is also known to depend on the identity of the 
neighbouring nucleotides in the germ-line, the most dramatic example being CpG 
dinucleotides, which are 10-15 times more mutable than other nucleotides (Coulondre et 
al. 1978; Bird 1980).  However, the mutation rate varies by at least 2-3 fold at all other 
sites as a function of the adjacent nucleotides (Hess, Blake, and Blake 1994; Zhao and 
Boerwinkle 2002; Hwang and Green 2004).  Strong context effects have also been 
noted in the skin cancer genomes; for example, 92% of C->T transitions in skin cancer 
occur at sites proceeded by another pyrimdine, compared to the ~50% expected by 
chance (Pleasance et al. 2009a).  This pattern is consistent with the action of ultra-violet 
light in generating pyrimidine dimers, and also the impacts of reactive oxygen species 
that preferentially target CCN and NCA triplets, where the central base is mutated and 
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N is any nucleotide (Pfeifer, You, and Besaratinia 2005).  Again, no neighbouring 
nucleotide analysis has been performed on the mutations in AML genomes.   
 
Finally, the mutation rate has been shown to vary in the germ-line at both a 
chromosomal (Lercher, Williams, and Hurst 2001; Li, Yi, and Makova 2002; Gaffney 
and Keightley 2005) and a sub-chromosomal scale (Wolfe, Sharp, and Li 1989; Wolfe 
and Sharp 1993; Matassi, Sharp, and Gautier 1999; Gaffney and Keightley 2005).  The 
reasons for this variation are poorly understood, however, the fact that some regions of 
the genome can have high mutation rates opens up the possibility that some genes tend 
to be involved in cancer simply because the genomic region in which they are located 
has a high mutation rate. 
 
Here we perform a comparative analysis of the mutation patterns observed in the four 
cancer genomes and in the germ-line.  The four genomes provide a unique opportunity 
to fully compare and contrast the mutation signatures associated with three different 
types of cancer, and also those present in two different individuals suffering from the 
same disease: AML.  We consider the patterns of mutation at three scales; first at single 
nucleotides, incorporating the effects that adjacent and adjacent-but-one nucleotides 
have on the rate of mutation, and also at a 1MB scale and on a chromosomal level.  We 
chose a scale of one megabase since Gaffney and Keightley (2005) have shown that this 
is the scale over which the germ-line rates vary on a sub-chromosomal level.  Our 
overall aims are two-fold.  First, we hope that studying the patterns of mutation in the 
germ-line and somatic tissue will allow a greater understanding of why the mutation 
rate varies across the genome.  Second, we wish to test whether certain genes are 
involved in cancer because they have high rates of mutation. 
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5.3 Materials and Methods 
 
5.3.1 Germ-line mutation rates 
 
Germ-line mutation rates were calculated as follows.  We downloaded human SNP data 
from the SeattleSNPs project (SeattleSNPs 2008) and Environmental Genome Project 
(NIEHS-SNPs 2008), and removed all coding sites.  SNPs were orientated using 
orthologous chimpanzee sequences that were downloaded using Ensembl Biomart 
(www.ensembl.org/biomart/martview/) and aligned to human sequences using FSA 
(http://math.berkeley.edu/~rbradley/papers/manual.pdf), which incorporates Exonerate 
(Slater and Birney 2005) and MUMmer (Kurtz et al. 2004).  We were unable to find a 
small number of orthologous chimpanzee sequences (~6% of human SNPs); the major 
allele was used to infer the ancestral state in these cases.  To calculate single nucleotide 
mutation rates we tallied the number of each type of nucleotide across the human 
sequence data, ignoring any regions that were not scanned for variation, and then 
calculated the frequency of each type of SNP, 
! 
µX "Y  (where X and Y are either A, G, T 
or C), by dividing the number of SNPs where the ancestral allele was X by the total 
number of X nucleotides in the human sequence data.  For example, 
! 
µA"G  was estimated 
by dividing the number of sites where the inferred mutation was from A to G (i.e. A 
was the allele present at the orthologous chimpanzee position and G was the second 
allele at the SNP site) by the total number of sites that were A.  A similar approach was 
used to incorporate the effects of neighbouring nucleotides; triplet mutation rates, 
! 
µNXN "NYN  (where N is either A, G, T or C), were calculated by dividing the total number 
of SNPs that were NXN to NYN by the total number of triplets that were NXN in the 
human sequence data.  Reverse complement triplets and mutations were considered to 
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be the same (e.g. TTT>C and AAA>G are considered to be equivalent and were 
summed).  To isolate the independent effects of neighbouring nucleotides, triplet rates 
were divided by the overall rate for mutation of the central nucleotide, regardless of 
context – e.g. TTT>C was divided by the rate of T>C, which is the average rate of T>C 
mutations across triplets. 
 
To estimate patterns of mutation in the germ-line on a 1 MB and chromosomal scale, 
we estimated the divergence between the human and chimpanzee genomes as follows.  
Alignments using the GRCh37 version of the human genome and PanTro2 version of 
the chimp genome were downloaded from the UCSC website (http://genome.ucsc.edu/) 
and nucleotides were masked where the quality score was less than 40 in the 
chimpanzee genome (representing an error rate of 1/10000).  Quality scores were 
unavailable for chromosomes 21 and Y, and so they did not undergo quality score 
masking.  In order to minimize the possibility of non-homologous sites contributing to 
divergence data, we masked any regions that contained more than 10% divergence 
across 100bp, with sliding windows every 10bp.  We also repeated the analysis using a 
5% divergence threshold and obtained very similar results.  Finally, we removed any 
regions of less that 20bp that were flanked both sides by more than 40bp of gap 
sequence, as we could not be confident in the reliability of these regions.  Substitution 
density per megabase (MB) was then calculated only in regions that contained at least 
100kb of unmasked sequence.  Any regions below this threshold were excluded from 
further analysis; these were typically heterochromatic regions near centromeres.  
Chromosome mutation rates were calculated by dividing the number of substitutions per 
chromosome by the total number of unmasked nucleotides. 
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5.3.2 Cancer mutations 
 
SCLC and skin cancer mutations were downloaded from the supplementary sections of 
the respective papers (Pleasance et al. 2009a; Pleasance et al. 2009b).  The two AML 
genomes were obtained via dbGaP (http://www.ncbi.nlm.nih.gov/gap/), through dbGaP 
accession number phs000159.v1.p1.  For SCLC and skin cancer, the data included 
mutations that were found only in the cancer cells, with any positions that were already 
present in dbSNP also removed.  To ensure consistency across datasets, we also took 
the same approach for the AML genomes, removing mutations present in normal cells, 
dbSNP and the Watson and Venter genomes.  For AML1, the data remaining is the 
same as that published in the genome paper, however, for AML2 the original study also 
removed some SNPs found in the 1000 genomes project 
(http://www.1000genomes.org).  These were not removed in our analysis, to maintain 
consistency across the cancer genomes, however the mutation patterns are very similar 
for AML2 on all scales both with and without these SNPs (correlation considering 
neighbouring nucleotide effects, r = 0.995, p<0.01; correlation on 1MB scale: r = 0.947, 
p<0.01; correlation on chromosome scale: r = 0.992, p<0.01).  Mutation rates for the 
central nucleotide of a triplet were calculated by dividing the number of occurrences of 
each triplet-mutation type by the number of occurrences of the reference triplet in the 
NCBI36 genome sequence (downloaded from the UCSC website).  For example, the 
mutation rate of TTT>C was calculated by tallying the number of times TTT>C was 
observed in the cancer genome, and dividing this by the number of times TTT occurred 
in the NCBI36 reference sequence.  Again, to determine the independent effects of 
neighbouring nucleotides, triplet rates were divided by the overall rate of mutation for 
the central nucleotide (as above).  Reverse complement triplets and mutations were 
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considered to be the same (e.g. TTT>C and AAA>G are considered to be equivalent).  
The locations of mutations in cancer genomes were converted from the NCBI36 
genome to the GRCh37 genome for comparison with divergence data via the ‘convert’ 
tool on the UCSC genome browser.  The numbers of mutations per MB were tallied and 
regions for which we had no human-chimpanzee divergence data were removed.  
Chromosome mutation rates were calculated by dividing the number of mutations found 
in each chromosome by the total number of valid bases (A/T/C/G) in the NCBI36 
reference sequence for each chromosome. 
 
5.3.3 Context Effects 
 
To investigate the variance in the mutation rate associated with adjacent and adjacent-
but-one nucleotides we proceeded as follows.  We calculated the mutation rate for all 
pentamers; e.g. for TTTTT we tabulated the number of times the central nucleotide had 
undergone each type of mutation and divided this by the total number of TTTTTs 
surveyed; we also calculated the sampling variance associated with this rate as the 
number of TTTTTs with a mutation divided by the square of the number of TTTTTs, 
i.e. we assume that the number of TTTTTs with a mutation is a Poisson variate.  We 
then calculated the variance in the mutation rate for each triplet-mutation combination.  
For example, if we are interested in the variance associated with the adjacent-but-one 
nucleotides, we calculate mean and variance in the mutation rate for XTTTY>N, where 
X, Y and N can be any nucleotide; for adjacent nucleotides we would consider 
TXTYT>N.  We performed this calculation for each triplet-mutation combination.  We 
normalized the variance associated with each triplet-mutation combination by dividing 
it by the square of the mean mutation rate for the triplet-mutation combination – in 
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essence we are dividing the mutation rate of each of the pentamers, by the mean rate 
across pentamers that contain the relevant triplet (e.g. all pentamers with TTT in the 
middle). We also calculated the average normalized sampling variance, which is 
subtracted from the total variance to yield an estimate of the systematic variance 
associated with the adjacent, or adjacent-but-one nucleotides for a particular triplet.  We 
then averaged this estimate of the systematic variance across triplets-mutation classes to 
yield an estimate of the average variance associated with either adjacent or adjacent-
but-one nucleotides. 
 
5.3.4 Coincident SNPs 
 
We calculated whether there is an excess of human and chimpanzee coincident SNPs 
that occur at the same position as cancer mutations as follows.  We obtained the 
genomic locations of coincident SNPs from previous work (chapter 2) and extracted 
flanking sequence in each case.  We then retained only those sequences where a cancer 
mutation was present within 500bp either side of the central coincident SNP; this left us 
with 603 1001bp alignments.  The expected number of sites that contain both a 
coincident SNP and a cancer mutation was calculated by the same method as described 
in chapter 2, incorporating the effects of neighbouring nucleotides on the mutation rate. 
 
5.3.5 Genomic features 
 
To investigate what factors might influence the distribution of cancer mutations we 
considered whether the density per MB was correlated to a number of variables.  
Genomic data on the locations of telomeres and centromeres, GC content, gene density 
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and nucleosome association were downloaded from the UCSC website 
(http://genome.ucsc.edu/).  Gene density was calculated as the number of nucleotides 
present within an exon, scaled up to the number of nucleotides per MB.  We used A365 
values to study the influence of nucleosome occupancy on the distribution of cancer 
mutation across the genome; although these values come from a skin melanoma cell 
line, they are highly correlated at the 1MB scale with scores from mammary cells 
(Dennis and MEC scores) (A365 and Dennis, r = 0.971, p<0.01; A365 and MEC, r = -
0.932, p<0.01).  Recombination rates per MB were obtained from Kong et al. (2002).  
As some genomic features were only available with reference to the NCBI36 genome, 
the divergence analysis (see above) was repeated using human NCBI36 sequences for 
use in the comparisons. 
 
To compile a list of genes present in hypermutable regions, we downloaded entrez gene 
data from the UCSC website for each specific region.  We then checked each gene 
against the OMIM database (http://www.ncbi.nlm.nih.gov/Omim/) for cancer 
association; details listed in the paper are taken directly from the OMIM website. 
 
 
5.4 Results 
 
5.4.1 The pattern of mutation 
 
We used data of single nucleotide variants (SNVs) from each cancer genome; these are 
differences between the cancer genome and the reference human genome.  From these 
we removed any variants found in the genome of the normal, non-cancerous cells from 
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the same individual, along with the any SNVs that matched SNPs in public databases.  
We removed SNPs in public databases, as other have done, to mitigate against the 
possibility that the individual carries an SNV that is a SNP segregating in the human 
population, which is not detected in the normal tissue (i.e. a false negative) but is called 
in the cancer tissue.  We assume the remaining SNVs are new somatic mutations that 
have accumulated in the cancer cell lineage, though many may have accumulated before 
the tissue became cancerous.  This left 22,910 SNVs in the SCLC genome, 33,345 
SNVs in the skin cancer genome, and 31,650 and 36,641 SNVs in the AML1 and 
AML2 genomes respectively. 
 
The rates of mutation for each cancer type and for the germ-line are shown in figure 5.1.  
In the germ-line, transitions are elevated relative to transversions as expected, with all 
types of transversions mutating at a similar rate.  As has been mentioned before 
(Pleasance et al. 2009b), the pattern of mutation in the SCLC genome is dominated by 
G/C->T/A transversions, which are thought to be a consequence of tobacco smoke 
carcinogens (Pfeifer et al. 2002).  As a result, the correlation between mutation rates in 
the SCLC genome and those observed in the germ-line is not significant (r=0.32, 
p=0.54); however if G/C->T/A transversions are removed the rates become comparable 
to those observed in the germ-line, with transitions occurring more often than 
transversions, and the correlation between SCLC and germ-line mutation rates becomes 
significant (r=0.912, p=0.01).  Surprisingly, one of the AML genomes (AML1) also 
shows a strong excess of G/C->T/A transversions, suggesting that this leukemia might 
have been caused by a similar mutagen to the lung cancer.  Again, the correlation 
between AML1 and germ-line mutation rates is non-significant (r=0.031, p=0.954); 
however if G/C->T/A transversions are removed the mutation rates become similar to  
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a)        b) 
    
c)      d) 
     
e) 
 
Figure 5.1.  Single nucleotide mutation rates for a) SCLC, b) Skin cancer, c) AML1, d) 
AML2 and e) the germ-line.  Transitions (C>T and T>C) are shown in the two left hand 
columns and transversions are shown in the four right hand columns. 
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those in the germ-line and the r-value of the correlation increases to 0.967, which is 
significant (p<0.01).  In contrast, mutation rates in the AML2 genome strongly correlate 
with germ-line mutation rates (r=0.981, p<0.01).  The correlation between skin cancer 
mutation rates and the germ-line is also significant (r=0.905, p=0.01), however this 
appears to be driven by an excess of G/C->A/T transitions in both genomes, which is 
massively over-represented in skin cancer most likely as a consequence of UV light.  If 
G/C->A/T transitions are removed the correlation becomes non-significant (r=-0.024, 
p=969), and it appears that G/C->T/A transversions are over-represented in skin cancer, 
possibly due to the effects of reactive oxygen species at CCN and NCA triplets.  T/A-
>C/G transitions are also under-represented in the skin cancer genome as they occur at 
similar rates to transversions. 
 
The above results imply that the mutational processes occurring in AML2 cells are very 
similar to those in the germ-line on this scale, whereas the specific effects of UV light 
and reactive oxygen species have an effect on mutation rates in skin cancer. 
 
Furthermore, the mutation patterns in SCLC and AML1 are very similar, suggesting 
that they may be caused by the same, or a similar, carcinogen.  Indeed, partial 
correlations between the mutation rates of different cancers are all non-significant after 
controlling for germ-line rates, except for between SCLC and AML1 (table 5.1).   
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 SCLC Skin cancer AML1 AML2 
SCLC  0.246 0.981* 0.617 
Skin cancer   0.306 0.705 
AML1    0.657 
AML2     
 
Table 5.1.  Partial correlation coefficients between different cancer genomes for single 
nucleotide mutation rates whilst controlling for germ-line mutation rates.  * shows 
significance at the 5% level. 
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5.4.2 Local context effects of cancer mutations 
 
The identities of the adjacent nucleotides are known to influence the mutation rate in the 
germ-line (Hess, Blake, and Blake 1994; Zhao and Boerwinkle 2002; Hwang and Green 
2004).  To investigate whether similar patterns are evident in cancer genomes we 
estimated the rate of each mutation as a function of the adjacent nucleotides and 
compared them to germ-line rates.  However, since effects at single nucleotides 
dominate many mutations, we normalized triplet mutation rates (where the central 
nucleotide is the one that mutates) by dividing by the corresponding single nucleotide 
rate and thus focused on the residual effects associated with context.  For example, the 
normalized mutation rate for the triplet TTT->TCT was found by dividing the triple rate 
by the T/A->C/G mutation rate.  Furthermore, we also take the log value of each 
normalized mutation rate for comparisons between cancer cells and the germ-line, in 
order to reduce the effects of CpG transitions that mutate at a much higher rate than 
other triplets. 
 
We do not find a significant correlation between the neighbouring nucleotide effects in 
the skin cancer mutations and those observed in the germ-line (r=0.041, p=0.694). This 
is not surprising since it is known that the mutagenic processes causing skin cancer have 
strong context effects; UV light generates pyrimidine dimers and reactive oxygen 
species target CCN->CAN and NCA->NAA triplets (Pfeifer, You, and Besaratinia 
2005).  However, when C/G->T/A transitions occurring at dipyrimidines either on the 
5’ or 3’ side are removed, along with mutations associated with reactive oxygen species, 
the correlation between skin cancer and germ-line mutation rates is still non-significant 
(r=-0.020, p=0.864).  In the previous section it was noted that both G/C->T/A 
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transversions and G/C->A/T transitions are over-represented in skin cancer cells, and it 
is only when these mutation classes are removed that the correlation between skin 
cancer and germ-line mutation rates becomes significant (r=0.257, p=0.040).  
Furthermore, T/A->C/G transitions were found to be under-represented in skin cancer 
cells, and if these mutations are removed, together with G/C->T/A transversions and 
G/C->A/T transitions, the correlation between skin cancer and germ-line mutation rates 
becomes much stronger (r=0.467, p=0.001).  This indicates that the effects of adjacent 
nucleotides in skin cancer cells are much more far-reaching than just the effects 
associated with UV light and reactive oxygen species.  In contrast, SCLC, AML1 and 
AML2 triplet mutation rates all correlate significantly with germ-line rates across all 
triplets (SCLC: r=0.716, p<0.01; AML1: r=0.650, p<0.01; AML2: r=0.746, p<0.01), 
however there are some obvious outliers.  The rate of GCG>GGG and CTA>CAA 
mutations are much higher in the SCLC genome than expected from germ-line rates, 
whereas TCT>TTT and ACA>AAA show an increased rate of mutation in AML1 and 
AML2.  Interestingly this effect in AML1 is not observed in SCLC suggesting that 
AML1 may have a similar, but not identical molecular origin.  It is not known what 
might be driving these effects. 
 
Although triplet mutation rates for three cancer genomes correlate significantly with 
germ-line mutation rates after accounting for single mutation rates, there are many 
similarities between cancer genomes.  We performed partial correlations between each 
pair of cancer genomes whilst controlling for germ-line rates and found significant 
correlations in all but one case (SCLC and skin cancer) (table 5.2).  This implies that 
although germ-line patterns may be repeated in somatic tissues, there are also some  
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 SCLC Skin cancer AML1 AML2 
SCLC  0.177 0.380* 0.428* 
Skin cancer   0.417* 0.373* 
AML1    0.745* 
AML2     
 
Table 5.2.  Partial correlation coefficients between different cancer genomes for log 
triplet mutation rates whilst controlling for log germ-line mutation rates.  * shows 
significance at the 5% level. 
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features that are unique to somatic/cancer cells, which result in different mutational 
signatures.  
 
As well as neighbouring nucleotide effects, it is known that the identity of more distant 
nucleotides affect the mutation rate at a particular site in normal cells, even as far as 
200bp away (Zhao and Boerwinkle 2002; Elango et al. 2008).  To investigate whether 
cancer mutations show similar patterns, we estimated the variance in the mutation rate 
associated with the adjacent and adjacent-but-one-nucleotides, controlling for the 
influence of the other, for each triplet (e.g. comparing the variance in the rate associated 
with TNCNT with NTCTN).  In all cases we found the ratio of the variance associated 
with the adjacent nucleotide relative to that associated with the adjacent-but-one to be 
significantly greater than one (p<0.01 for all cases).  In SCLC, the average ratio of the 
variances is 2.78, for skin cancer it is 3.20, and for AML1 and AML2 it is 1.82 and 2.12 
respectively, i.e. the adjacent nucleotides generate roughly 2-3 fold more variance in 
rate than the adjacent-but-one nucleotides.  These values are all roughly consistent with 
those observed in the germ-line (Zhao and Boerwinkle 2002). 
 
5.4.3 Coincident SNPs 
 
It has previously been shown that there is an excess of SNPs in the human genome that 
also contain a SNP at the orthologous position in chimpanzee, and it has been inferred 
from this that some sites undergo mutation at higher rates than can be explained by the 
effects of adjacent nucleotides (chapter 2).  To test whether this might be the cause of 
some mutations in cancer genomes, we compared the positions of cancer mutations 
from all cancer types with the locations of human and chimpanzee coincident SNPs; this 
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resulted in 603 alignments of 1001bp with the human-chimpanzee coincident SNP 
present in the central position and the cancer mutation elsewhere within the alignment.  
Of these alignments, one has a coincident SNP and a cancer mutation in the same 
position, compared to the 1.28 we would expect taking into account the effects of 
adjacent nucleotides on the mutation rate.  As a consequence, it appears, on the basis of 
this very limited evidence, that the process driving the excess of human and chimpanzee 
coincident SNPs is not causing cancer mutations.  
 
5.4.4 Genomic distribution of cancer mutations 
 
To investigate the genomic distribution of cancer mutations we tallied the number of 
mutations per megabase (MB) for each dataset and compared the distributions to those 
found between human and chimpanzee genomes, which we take to be the pattern found 
in the germ-line, averaged over the divergence of the two species.  On average there 
were 7.85, 11.55, 10.94 and 12.55 mutations per MB in the SCLC, skin cancer, AML1 
and AML2 genomes respectively.  If cancer mutations are randomly distributed across 
the genome we would expect the number per MB to be Poisson distributed and have a 
variance equal to the mean.  However, in all cases the variance is significantly greater 
than the mean and so the number of mutations per MB is significantly over-dispersed 
(the observed variances are as follows: SCLC = 37.09, p<0.01; skin cancer = 53.26, 
p<0.01; AML1 = 76.40, p<0.01; AML2 = 1273.81, p<0.01).  The density of mutations 
in each of the cancer genomes is weakly but significantly correlated to that found in the 
germ-line (SCLC: r=0.129, p<0.01; skin cancer: r=0.195, p<0.01; AML1: r=0.195, 
p<0.01; AML2: r=0.335, p<0.01); the correlation is of very similar strength for all 
cancers except AML2, which shows a stronger correlation.  As expected, given the 
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rather weak correlations we observe, there is significant variation in the density of 
mutations in cancer genomes which cannot be attributed to the germ-line pattern; if we 
randomly distribute the same number of mutations observed in each cancer across the 
genome, weighted by the density of mutations per MB observed between human and 
chimps, we find the observed variance to be significantly greater than in the simulated 
data (p<0.01 for all cancers). 
 
There are also significant partial correlations between the densities of mutations in the 
different cancer genomes after controlling for human and chimp divergence rates (table 
5.3).  For most comparisons these correlations are weak, except between the two AML 
genomes and between SCLC and skin cancer.  Most of the correlation between the two 
AML genomes can be explained by high rates of mutation around centromeres, some 
telomeres and five other 1MB regions (discussed later).  If these MBs are removed the 
r-value is reduced to a modest 0.101, which is still significant (p<0.001), but explains 
little of the variance in either dataset.  In the case of SCLC and the skin cancer, there are 
no obvious outliers.  This implies that many patterns are consistent across the two 
different cancers on this scale, even though the effects of specific carcinogens vary. 
 
To investigate the distribution of cancer mutations in more detail we compared the 
density per MB with a number of key genomic features using step-wise multiple 
regression, retaining only those features that contributed significantly to the regression 
model.  The features investigated were the distance to the telomere, the distance to the 
centromere, the GC content, the human and chimpanzee divergence, the gene density, 
the recombination rate and the nucleosome association rate (table 5.4).  The multiple 
regression model for SCLC explains approximately 24% of the total variance in the  
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 SCLC Skin cancer AML1 AML2 
SCLC  0.399* 0.024 -0.101* 
Skin cancer   0.105* 0.001 
AML1    0.674* 
AML2     
 
Table 5.3.  Partial correlation coefficients between different cancer genomes for the 
frequency of mutations per MB whilst controlling for human and chimp divergence.  * 
shows significance at the 5% level. 
 
 
Feature SCLC Skin 
Cancer 
AML1 AML2 
Telomere -0.092 NS -0.039 NS 
Centromere NS NS -0.052 -0.065 
GC content -0.307 0.050 -0.059 NS 
Divergence 0.170 0.279 0.193 0.262 
Gene Density -0.048 -0.071 NS -0.039 
Recombination NS -0.059 -0.048 -0.139 
Nucleosome Association NS -0.101 NS 0.124 
r 0.490 0.355 0.216 0.311 
p <0.01 <0.01 <0.01 <0.01 
 
Table 5.4.  Multiple regression analysis of key genomic feature for each cancer type.  
Features used are distance to the telomere (telomere), distance to the centromere 
(centromere), GC content, Human and Chimp divergence rates (Divergence), gene 
density, recombination rate (recombination) and nucleosome association rate 
(nucleosome association).  Partial correlations whilst controlling for all other significant 
features are shown for each genomic feature. 
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distribution of SCLC mutations, whereas this figure is 21.7%, 4.7% and 11% for skin 
cancer, AML1 and AML2 respectively.  Taking the data together, it appears there are 
many features that may explain at least part of the distribution of cancer mutations, 
however in many cases the low partial correlation scores suggest that some features 
have limited explanatory power.  First, as expected given the correlations above, human 
and chimp divergence is included within the regression model for all cancer types, and 
partial correlations suggest that it has a significant impact on the distribution of cancer 
mutations.  This implies that some regions in the human genome are more mutable than 
others, and that this remains true in cancer genomes regardless of other mutational 
pressures.  Second, gene density is included in the model for all cancers except AML1; 
however, although the effect is significant in all the other cancers it has little predictive 
power by itself.  The partial correlations are negative in all cases, showing that there are 
less cancer mutations in genic regions.  This is probably due to a number of factors – 
the higher rate of transcription-linked repair processes, as highlighted in some of the 
original cancer genome papers (Pleasance et al. 2009a; Pleasance et al. 2009b), and 
negative selection.  Third, cancer mutations are negatively correlated with 
recombination rates in the SCLC, AML1 and AML2 genomes, making a significant 
contribution to the predictive power of the regression model, particularly in the case of 
AML2.  As cancer mutations occur in somatic tissues it is highly unlikely that the 
recombination process itself has a direct impact on mutagenesis since somatic 
recombination is thought to be very rare (Paques and Haber 1999).  However, the 
correlation may be driven by other underlying factors that have not been considered 
here.  All other features have either a non-significant, limited or contradictory (i.e. they 
differ between cancers) contribution to the regression model in each case and across all 
cancers.  For example, there is a significant negative partial correlation between SCLC 
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and GC content when controlling for all other features in the final regression model, but 
this is only mirrored in part in AML1, not at all in AML2 and is positively correlated in 
skin cancer.  This result may reflect the differing causes of each type of cancer.  
Furthermore, nucleosome association rate is strongly negatively correlated to skin 
cancer mutation density and strongly positively correlated to AML2 mutation density.  
This might not seem surprising, since the nucleosome binding scores come from a skin 
melanoma cell line; however, nucleosome binding scores are highly correlated between 
the melanoma cell line and a mammary gland cell line (see methods).  Finally, a 
prominent feature not picked up by the regression analysis is the propensity of AML 
mutations to be located immediately adjacent to centromeres.  Although distance to the 
centromere is included in the regression analysis, it is not a significant indicator as the 
mutation density does not decline with distance from the centromere outside of the first 
few MBs.  However, the effect is very strong with 11.8% and 27.8% of mutations 
occurring within the 2.58% and 2.37% of sequence that immediately flanks the 
centromeres in AML1 and AML2 respectively. 
 
5.4.5 Outlier regions and implications for cancer 
 
There are some megabase regions in cancer genomes that contain a very high density of 
mutations.  Appendix 5.1 contains a list of regions that fall outside of four standard 
deviations from the mean (on the order of 0.01% of the data assuming a normal 
distribution), together with any genes located in those regions for each cancer.  As the 
AML genomes are dominated by mutations in centromeric and telomeric regions, these 
have been removed before outliers are identified, and all functional gene information in 
the following section was taken from the OMIM website 
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(http://www.ncbi.nlm.nih.gov/omim).  In the SCLC genome none of the 1MB regions 
with high numbers of mutations overlap with the other three datasets outside of the 
centromeric regions.  Within the SCLC outliers there are two regions that stand out: 
chromosome X: 61MB-62MB and chromosome 6: 57MB-58MB, both of which are 
located close to the centromere.  The region on the X contains no genes whereas the 
region on 6 contains four genes.  Furthermore, 42 of the mutations from chromosome 6: 
57MB-58MB fall within a 100KB region just downstream of PRIM2, which is involved 
in DNA replication.  This is a region we have previously shown to contain a high 
density of sites at which both humans and chimpanzees have a SNP (chapter 3).  In the 
skin cancer genome there are again no highly mutated regions that overlap with other 
cancer genomes outside of those close to centromeres.  There are, however, two regions 
that contain genes that are associated with cancer; genomic alterations in GPC5 have 
been implicated in lymphomas, lung cancers and squamous cell carcinoma, whereas 
loss-of-function in TLR4 has been linked with more rapid relapse after treatment for 
breast cancer.  In the two AML genomes there are five 1MB regions that have high rates 
of mutation in both AML1 and AML2.  Furthermore, the high numbers of mutations 
within these regions actually fall within smaller areas of 100-200KB, which are 
consistent across both genomes.  Within these five regions there are many genes linked 
to cancer.  In one MB region in the MHC locus there is AGER, which codes for a 
receptor that has been shown to decrease growth and metastases of cancer cells when 
blocked in mice, HLA-DRA, which is linked with thromboembolic complications in 
cancer patients, and TAP1, which was found to contain a mutation in SCLC cell lines.  
In other highly mutable regions of the AML genomes, PRR4 has been linked to breast 
cancer, ETV6 is a known tumour suppressor gene and LYPD1 is a tumour suppressor 
gene that has a role in triggering apoptosis.  Furthermore, highly mutable regions 
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unique to either AML genome also contain cancer genes.  In AML1, MASL1 is related 
to the oncogene MAS1, and HLA-G has been shown to have a high level of 
transcription in malignant melanoma cells.  In AML2, MMP21 was detected at unusual 
levels in cancer cells, BCCIP is known to interact with the breast cancer gene BRCA1 
and has been shown to inhibit growth of some breast and brain tumour cells, whereas 
HIST2H4A, which codes for histone H4, was found to be lost in monoacetylated and 
trimethylated forms in cancer cells. 
 
The occurrence of many cancer genes in regions that are undergoing high rates of 
mutation in cancer genomes may suggest that some genes are involved in disease 
phenotypes simply because they mutate at higher rates.  To test this we downloaded a 
census of human cancer genes from the Cancer Genome Project 
(http://www.sanger.ac.uk/genetics/CGP) that was originally compiled by Futreal et al. 
(2004).  Genes were only included in this list if they have been causally implicated in 
oncogenesis, have mutations that have been presented in at least two independent 
reports from primary patient material and are mutated in areas outside of methylated 
promoter regions.  Changes in expression level alone are not sufficient for genes to be 
included in this dataset.  For each cancer genome we then tested for a correlation 
between the number of cancer mutations per MB and whether there was a gene 
implicated in that specific cancer present in the MB using a logistic regression.  In all 
four cases the result was non-significant (SCLC: p=0.31, skin cancer: p=0.46, AML1: 
p=0.31, AML2: p=0.414), and results are similar using t-tests.  However, it may be the 
case that many regions in the genome cannot be causally implicated in cancer as they 
contain either no genes, or genes that are not part of pathways that can lead to cancer 
progression.  As a result, we repeated the analysis as before, considering the number of 
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mutations and whether there were genes specific to each cancer type in each region, 
however in this case we only included those regions that contain genes associated with 
at least one type of cancer; we again found the result to be non-significant in all cases 
(SCLC: p=0.90, skin cancer: p=0.25, AML1: p=0.94, AML2: p=0.50), with similar 
results obtained from t-tests.  This suggests that particular genes are not repeatedly 
associated with cancer simply because they have a high mutation rate.  However, since 
the genetic complexity and full array of causative cancer genes are not yet understood, 
the results cannot be assumed to be definitive. 
 
5.4.6 Chromosomal mutation rates 
 
There is significant variation in chromosomal mutation rates across all four datasets, 
which can be seen in figures 5.2a-d as not all 95% confidence intervals overlap for each 
chromosome.   This is consistent with the pattern of germ-line mutation inferred from 
the divergence between human and chimpanzee (Mikkelsen et al. 2005).  For SCLC, 
skin cancer and AML1, the mutation rates of the sex chromosomes fall within the 
confidence intervals for the mutation rate of at least one autosome.  This is markedly 
different from human and chimpanzee divergence, where the Y chromosome mutates at 
a higher rate than the autosomes, and the X chromosome at a lower rate (Mikkelsen et 
al. 2005).  However, this is not unexpected as cancer mutations in these datasets are 
occurring in somatic cells, so all chromosomes undergo the same number of 
replications.  This is in contrast to events in the germ-line where the Y chromosome 
undergoes more mutations than the autosomes, which undergo more mutations than the 
X chromosome due to relative time spent in males that undergo more cell divisions 
(Haldane 1947).  Conversely, for AML2 the mutation rate on the Y chromosome is  
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Figure 5.2a.  Chromosome mutation rates for the SCLC genome. Error bars represent 
95% confidence intervals. 
 
 
 
 
Figure 5.2b.  Chromosome mutation rates for the skin cancer genome. Error bars 
represent 95% confidence intervals. 
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Figure 5.2c.  Chromosome mutation rates for the AML1 genome. Error bars represent 
95% confidence intervals. 
 
 
 
 
Figure 5.2d.  Chromosome mutation rates for the AML2 genome. Error bars represent 
95% confidence intervals. 
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 SCLC Skin cancer AML1 AML2 Divergence 
SCLC  0.406 0.230 -0.261 -0.092 
Skin cancer   0.068 0.017 0.115 
AML1    0.644* 0.285 
AML2     0.520* 
Divergence      
 
Table 5.5.  Correlation coefficients between different cancer genomes for the frequency 
of mutations per chromosome. * shows significance at the 5% level. 
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significantly higher than the autosomes and X chromosome, which is not easily 
explained given the somatic nature of the mutations.  Furthermore, there are only two 
significant correlations when we compare the autosomal mutation rates of the four 
cancer genomes, and the germ-line rates (table 5.5).  Firstly, AML2 correlates 
significantly with the germ-line rates, which is perhaps not surprising given that they 
also correlation significantly on the MB scale, and for the most part, show similarities in 
mutation patterns when considering neighbouring nucleotides and single nucleotides.  
Secondly, AML1 chromosome mutation rates correlate significantly with AML2 rates, 
which remains significant after controlling for human and chimp divergence rates 
(r=0.605, p=0.004).  Again, this is not surprising since there is a strong correlation on 
the MB scale and for neighbouring nucleotide rates. 
 
 
5.5 Discussion 
 
The recent sequencing of four cancer genomes provides a unique opportunity to study 
the patterns of mutation on various scales occurring in different cancers (SCLC, skin 
cancer and AML in this case), but also within a type of cancer (AML).  We observe 
some striking similarities and differences between the cancer genomes, and between the 
cancer genomes and the germ-line at the three scales we have considered.  It is 
important to appreciate that given just four cancer genomes it is currently not possible 
to determine whether the differences we observe represent systematic differences 
between cancers and the somatic tissue they developed from, or random differences 
between individuals.  However, the analysis of the AML genomes suggests that the 
differences between the cancer genomes are likely to be due systematic differences 
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rather than random differences between individuals, since these genomes show strong 
correlations in their patterns of mutation at all scales, differing only in the high rate of 
C>A mutations in AML1. 
 
We assume, as others have done, that most mutations are ‘passengers’ effectively 
hitchhiking along with a small handful of ‘driver’ mutations that have a causal 
relationship with cancer (Greenman et al. 2007).  In fact, although it has been suggested 
that one of the steps in the development of cancer might be the loss of some DNA repair 
enzymes and hence the increase in the mutation rate (Loeb, Bielas, and Beckman 2008), 
it seems likely that the vast majority of mutations that are observed in the cancers tissue 
accumulated prior to the development of cancer.  The rate of somatic mutation has been 
estimated to be 0.77 x 10-9 per site per cell division, and this is expected to generate of 
the order of 10,000s of mutations in dividing cells in a mature adult (Lynch 2010). 
 
At the single and neighbouring nucleotide scale, mutations are often a consequence of 
specific carcinogens associated with different cancer types.  Mutations in SCLC bear 
the hallmarks of the mutagens present in tobacco smoke, with an over-representation of 
C>A mutations, whilst mutations in the skin cancer genome are often at dipyrimidines, 
as one would expect from UV radiation, or show the patterns associated with reactive 
oxygen species.  However, there also appears to be more variation in the rate of 
different types of mutation in the skin cancer cell above that associated with specific 
carcinogens.  Mutations in AML are different; in AML1 there is an over-representation 
of C>A mutations, whereas in AML2, most mutation rates are similar to those found in 
the germline, implying that mutation patterns in the two different AML genomes – both 
of subtype M1 – may have different causes.  Intriguingly, the patterns of mutation in the 
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AML1 genome are very similar to those observed in the SCLC genome.  The most 
obvious interpretation of this is that the mutation patterns in the AML1 and SCLC 
genomes are being caused by the same carcinogens, namely those found present in 
tobacco smoke.  Tobacco smoke has been linked to many types of cancer (Doll 1996; 
Kuper, Boffetta, and Adami 2002), and some studies have shown a significant, albeit 
weak, association between cigarette smoking and myeloid leukemias (Kinlen and Rogot 
1988; Wakabayashi et al. 1994).  However, there are also studies showing no significant 
link (Adami et al. 1998; Stagnaro et al. 2001), making the association not entirely clear.  
Alternatively, it could be that very similar carcinogens are involved in both cases, rather 
than the effects being specific to tobacco smoke.  The comparable mutation patterns 
could also be enhanced as a consequence of similar deficiencies in replication and repair 
enzymes in the two cancer cells; in this case this could involve Y family polymerases 
that are implemented in cases where bulky adducts attach to DNA nucleotides (Loeb 
and Monnat 2008).  Unfortunately the smoking history of the individual from which 
AML1 was taken is unknown, so the cause of cancer in this case remains unidentified.   
 
The influence of neighbouring nucleotides appears to be fairly consistent across all 
cancer genomes, except for the skin cancer genome, which shows no similarity to the 
germ-line.  It seems likely that neighbouring nucleotide effects are a consequence of 
biases in the replication or repair machinery, so the consistency across tissues is 
possibly not surprising. 
 
On a larger scale there is significant variation in the numbers of mutations per megabase 
above that expected given human and chimp divergence rates, and some regions appear 
to be hyper-mutable.  The specific effects of carcinogens do not appear to explain this 
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pattern, since the rate of mutation at the 1MB scale is only weakly correlated to GC 
content in two of the cancer genomes, and in the two cancers in which the correlation is 
at all strong (SCLC and skin cancer) one might expect the correlation to be in the 
opposite direction (SCLC: r=-0.350, p<0.01, Skin cancer: r=-0.352, p<0.01; AML1: r=-
0.069, p<0.01; AML2: r=0.003, p=0.861).  Furthermore, across the three different types 
of cancer, 1MB regions with very high mutation rates appear to occur in different 
regions of the genome.  However, the two AML genomes share many mutation 
hotspots, mostly at centromeres and telomeres, but also at five other 1MB locations in 
the genome.  In addition, within the five regions that do not fall near to the centromere 
or telomere, there are even smaller 100-200kb regions that contain the majority of the 
mutations that are the same in both AML1 and AML2.  It seems unlikely that these 
have arisen by chance, thus implying a causative process at this scale.  Note that we do 
not have enough mutations per MB to explore the density in mutations at a finer scale 
than 1MB, however further cancer genomes will allow us to do this.  Several of the 
regions with the highest mutation rates contain a number of genes that have been linked 
to some form of cancer in the literature, suggesting that some genes may be associated 
with cancer simply because they are in mutation hotspots and are therefore more likely 
to mutate.  However, we find no evidence that regions containing genes specific to each 
type of cancer have higher mutation rates than other regions in the genome, even 
amongst regions containing genes associated with other cancers.   
 
When considering all 1MB regions we see at least marginally significant correlations 
between most cancers, possibly driven by background mutations, and indeed all four 
cancer genomes correlate significantly with human and chimp divergence on the same 
scale.  This points to the idea that impaired replication and repair mechanisms may play 
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a part in all cancers as mutation patterns at the 1MB scale are similar to those expected 
in the germ line.  Two of the correlations between cancer genomes are particularly 
strong; there is a strong correlation between AML1 and AML2, however when outlier 
regions are removed the correlation is drastically reduced, and between SCLC and skin 
cancer, which occurs in spite of the lack of correlation among outlier regions.  It is 
possible that the variation in the mutation rate at the 1MB scale is a consequence of 
processes such as chromatin openness or nucleosome binding, and this would readily 
explain why the cancer types do show differences with each other and with the germ-
line.  However, it is not clear that chromatin state should vary wildly between different 
tissues (Ozsolak et al. 2007), and nucleosome occupancy scores from skin melanoma 
cells (A375), mammary epithelial cells (MEC) and mammary gland cells (Dennis) 
correlate strongly (A375 vs MEC: r=-0.932, p<0.01; A375 vs Dennis: r=0.971, p<0.01; 
Dennis vs MEC: r=-0.982, p<0.01). 
 
Finally, on the chromosome level, and specifically for the autosomes, there are very 
little similarities between cancer types and all correlations are non-significant.  
Furthermore, correlations between three of the cancer genomes (SCLC, skin cancer and 
AML1) and human and chimp divergence are non-significant.  Conversely, the 
chromosome mutation rates of the two AML genomes correlate significantly, and 
AML2 correlates significantly with human and chimp divergence, perhaps reinforcing 
the notion that most mutations in the AML2 genome are occurring in a similar way to 
that expected in normal cells. 
 
The genetic basis of cancer appears to be very complex, and there is still much that is 
unknown.  Here, we show that although there is significant variation between rates of 
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mutation on the local, 1MB and chromosomal scale within each genome, there are also 
similarities between different cancer types.  However, this picture may be muddied 
further if there is also significant heterogeneity between cancer cells in a single 
individual (Fox, Salk, and Loeb 2009).  
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6. Discussion and Conclusions 
 
6.1 The impact of mutations 
 
The rate of mutation in the human genome is estimated to be ~2 x 10-8 per site per 
generation (Nachman and Crowell 2000; Kondrashov 2003; Xue et al. 2009), although 
it is clear that this rate varies considerably over a number of different scales and 
contexts (Ellegren, Smith, and Webster 2003).  The importance of understanding this 
variation is far reaching; mutations can result in deleterious effects at certain sites and in 
certain regions of the genome, possibly causing genetic diseases or cancer.  
Appreciating which particular contexts and regions are likely to undergo more mutation 
events may lead to a greater diagnostic ability and an understanding of why certain 
genes and mutations are involved in disease.  Furthermore, an understanding of 
variation in the mutation rate can aid in the description of how and why species evolve; 
the use of mutation rates as molecular clocks and the subsequent analysis of 
phylogenetic trees through comparative sequence analysis, together with an 
understanding of diversity levels within populations, shed much light on our history. To 
correctly infer phylogeny and particularly the timescale over which evolution occurs, it 
is necessary to understand variation in the mutation rate.  Considering variation in the 
mutation rate is also important when unlocking the secrets of the genome; mutation 
patterns are key to identifying functional regions, understanding why other regions are 
conserved and quantifying processes such as recombination and repair.  In this thesis we 
considered further patterns of sequence variation that cannot be explained with current 
knowledge of the processes that drive differing mutation rates.  This has led us to a 
general conclusion that there is much more variation in the mutation rate in the human 
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genome, both in the germ-line and the somatic tissues, than was thought.  Here, I will 
summarise the results obtained in this thesis, highlighting the broader issues that emerge 
from our analyses.  
 
6.2 Cryptic variation in the mutation rate 
 
In chapter 2 we showed that there is more variation in the mutation rate of single sites 
than is currently expected, given what is known about the effects of neighbouring 
nucleotides on the rate of mutation; we refer to this as ‘cryptic variation’.  This result 
was inferred from the excess of sites in the human genome that also have a SNP in the 
orthologous position in chimpanzee above that expected at random.  As we controlled 
for local context as well as other known mutational patterns and natural selection, it 
seems that the causes of this variation in the mutation rate could not be explained by 
previous knowledge.  However, we must be cautious in quantifying the impact of 
cryptic variation in the mutation rate since we were unable to rule out a contribution to 
the excess of coincident SNPs from ancestral polymorphisms and substitutions in 
paralogous sequences that occurred before the split of human and chimp, although it 
seems unlikely that these features contribute substantially to the excess of coincident 
SNPs.  One interesting feature of this variation is that due to the nature of its detection, 
it only impacts single sites in isolation, rather than particular regions of the genome, 
ruling out any small-scale regional effects as a cause.  This is further supported by 
results in chapter 3 where we fail to find a strong correlation between coincident SNP 
densities and any other feature on the genomic scale.  Outside of the specific actions of 
replication and repair activity, it is difficult to imagine a process that could operate in 
such a fashion, although DNA topology and packaging could certainly be a candidate if 
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specific sites are more important than others in controlling the structure of DNA.  Of 
course, some coincident SNPs will be a consequence of known factors, and indeed there 
is some evidence that balancing selection may maintain a small subset of 
polymorphisms at the same position in both humans and chimp.  However, the general 
pattern of excess does not resolve with the introduction of a single causative 
mechanism.  It may well be interesting to consider whether there is an excess of 
coincident SNPs between different pairs of species, or indeed between more distantly 
related species, as this may give an indication of the evolutionary distance at which the 
causative process is preserved and possibly lead to greater insights into cryptic variation 
in the mutation rate.   
 
The strength of cryptic variation in the mutation rate could potentially be as large as that 
associated with the CpG effect.  It has been estimated that roughly 1/3 of all disease 
causing germ-line mutations are associated with increased rates of mutation at CpG 
sites (Cooper and Youssoufian 1988; Cooper and Krawczak 1990).  It therefore may 
seem plausible that hypermutable sites that are associated with cryptic variation may 
also contribute a similar amount to genetic disease mutations.  Of course, this is merely 
speculation as the processes that cause cryptic variation in the mutation rate may well 
be very different to those associated with CpG hypermutation, particularly as the latter 
seems to have nothing to do with replication and is instead a consequence of 
deamination at methylated cytosines (Coulondre et al. 1978; Bird 1980).  However, 
since we have shown that the excess of coincident SNPs exists for both CpG and non-
CpG mutations, it is difficult to rule this out.  Unfortunately, coincident SNPs are not 
associated with any specific context, either on a local of genomic scale, and so unlike 
mutations occurring as a result of adjacent nucleotides, it may be very difficult to 
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identify particular sites that are more or less likely to undergo mutation and thus aid in 
clinical detection.  Indeed, our only attempt thus far to link diseases with cryptic 
variation in the mutation rate was performed by comparing the locations of cancer 
mutations to human and chimpanzee coincident SNP sites, and in this case we found no 
excess of such events above that expected by chance.  However, this does not preclude 
the effects of cryptic variation in the mutation rate in causing genetic disease, as the 
sample sizes we used were very small and do not allow a definitive conclusion.  
Furthermore, the process may also vary between germ-line and somatic tissues.  
 
Cryptic variation in the mutation rate is potentially a problem in evolutionary genetics 
since it can affect the ability to estimate evolutionary distances and in particular to 
accurately infer the ancestral state; this has been found to be a problem when classifying 
CpG and non-CpG mutations (Gaffney and Keightley 2008). 
 
6.3 Simultaneous mutation 
 
In chapter 4 we showed that approximately 3% of all distinct SNPs arise as a 
consequence of simultaneous mutation across the two strands of a DNA helix, either in 
a single process, or by two tightly linked events in which the first mutation causes the 
second on the opposite strand.  It is generally assumed that a single mutation event 
generates a single new allele in the population.  However, we showed that there are an 
excess of sites in the human genome that contain three alleles, and that the minor alleles 
at these sites tend to cluster on phylogenetic trees of individuals in the population.  It is 
possible that the excess of tri-allelic sites could be generated by mismatches occurring 
in heteroduplex DNA during recombination, however we showed that there is no 
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association between recombination rate and sites that have three alleles.  A similar 
process is thought to occur between adjacent nucleotides on the same strand (Averof et 
al. 2000), however we estimate that this process has a smaller impact on diversity in the 
human population, generating slightly less that 1% of all distinct SNPs. 
 
The importance of simultaneous mutation in the process and analysis of evolution may 
be far reaching.  Failing to account for the generation of two new alleles in a single 
event may lead to mis-inferences in phylogenetic analysis of populations; minor alleles 
will not necessarily be grouped together using standard approaches of phylogenetics.  
Although this is only likely to become a problem in small SNP datasets, it is not known 
whether simultaneous mutation events tend to cluster in certain parts of the genome 
where this issue could become more important.  Furthermore, it is possible that 
simultaneous mutation events in coding regions may allow for a more rapid exploration 
of evolutionary pathways than single mutations occurring sequentially.  Two new 
alleles generated at a non-synonymous site could result in two different amino acids, the 
effects of which may be dramatically different. 
 
6.4 Cancer Mutations 
 
In chapter 5 we showed that the patterns of mutations in different types of cancer cells 
are complex.  In general, cancer mutations show the strongest similarity to germ-line 
mutations when considering the effects of neighbouring nucleotides and at the 1MB 
scale.  However, at the single nucleotide level, most of the cancers considered showed 
patterns of mutation associated with specific carcinogens, for example, many skin 
cancer mutations occurred at dipyrimidines as a consequence of UV light (Pfeifer, You, 
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and Besaratinia 2005).  Most interestingly, one of the acute myeloid leukemia (AML) 
genomes showed very similar patterns of mutation to those observed in the small cell 
lung cancer genome.  The most obvious explanation for this is that AML in this case 
may have been a consequence of tobacco smoke.  However, as the smoking history of 
the patient is unknown, we cannot rule out other causes.  At larger scales (1MB and 
whole chromosomes), there are substantial differences between the distributions of 
mutations in different types of cancer for the most part, although some cancers also 
show similarities.  Perhaps the most insightful aspect of the analysis at this level is the 
comparison of two individuals with the same type of cancer, AML; mutations in these 
two genomes show the strongest correlation, perhaps implying that the differences in 
the patterns of mutation between cancers are likely to be systematic rather than 
stochastic, although we must be cautious in making firm conclusions with a limited 
number of datasets. 
 
Most mutations in cancer are thought to be passengers that have no causal affect on the 
disease.  However, it is possible that some genes are involved in cancer simply because 
they are in regions of the genome that mutate at higher levels than others.  We 
performed an analysis to test this theory and found little support, however since the full 
array of genes associated with each type of cancer is unknown, we cannot come to any 
firm conclusions.  It is clear that cancer in a very complex disease, with varying patterns 
of mutation across different cancers, but also many similarities. 
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6.5 Variation in the mutation rate    
 
There have been many studies over the past 60 years that have analyzed patterns of 
mutation in the human genome and subsequently detailed the various ways in which a 
site can vary in its rate of mutation.  Variation has been observed on numerous levels: at 
single sites, as a consequence of local context, on a regional scale and between different 
chromosomes.  Perhaps the largest variation in the rate of mutation occurs at the 
smallest scale, the single nucleotide, however it is unknown the extent to which this 
variation is explained by processes associated with primary sequence context.  Here, we 
have shown that there is far more variation at this scale than was previously thought.  
This has far reaching implications in the study of evolution and disease, since it may 
change the interpretation of the levels of conservation we might expect amongst 
homologous sequences, alter the way we look for selection, or point to hypermutable 
sites that are implicated in disease.  Although we do not currently understand the 
underlying mechanisms that generate cryptic variation in the mutation rate, more data 
and analysis may lead to answers in the future.  It would be interesting to compare 
coincident SNP distributions to other features of DNA structure, both within primates 
and across a wider range of species.  Furthermore, we have shown that nucleotide 
changes may arise at this scale through a novel form of mutation where two new alleles 
are generated in a single, or tightly linked series of events.  Although potential 
underlying mutational mechanisms that could lead to this result are well established, it 
has not previously been shown that they could generate variation in this way and at this 
frequency.  The process of simultaneous mutation could be further understood with the 
use of Y chromosome sequence data that is obtained in an unbiased fashion; this would 
allow a greater understanding of the processes that cause tri-allelic SNPs.  Similarly, it 
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may be interesting to consider whether simultaneous mutation events occur non-
randomly across the genome, and what impact this might have on evolution.    
 
We have also shown that the patterns of mutation can vary in cancer genomes beyond 
that observed in the germ line.  This brings up an interesting question as to whether 
there is more variation in the mutation rate between cells from different tissues, in 
different individuals and under differing conditions.  Although cancer genomes are 
likely to represent an extreme, due to the likely increased level of mutation, the data 
does serve to highlight that there is much more we don’t know about the scale of 
variation in the mutation rate.  The sequencing of more cancer genomes will 
undoubtedly lead to a greater understanding of the disease and patterns of mutation.  A 
comparison of more individuals with the same type of cancer may allow us to assess the 
cause of variation, and subsequent comparison to other forms of cancer may identify 
important differences. 
 
More recent advances in sequencing technology have made large sequences projects 
more feasible, indeed projects like the environmental genome project 
(www.egp.gs.washington.edu/) and the 1000 genomes project (www.1000genomes.org) 
will generate masses of data for further analysis.  This, together with practical 
laboratory analysis, may finally allow the scientific community to understand the full 
nature of mutation and its underlying processes.    
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Appendices 
 
Appendix 2.1.  A description of the two-state model for quantifying cryptic variation in 
the mutation rate. 
 
Let us assume that a proportion, α, of sites are hypermutable and that they mutate at a 
rate β, whereas normal sites mutate at a rate of β*. Let us assume that hypermutable 
sites are always hypermutable. The average rate of mutation in the sequence is therefore 
 
! 
µ ="# + (1$")#*        (A2.1) 
 
If we arbitrarily set the average rate of mutation to one then we can express β* in terms 
of α and β. 
 
! 
"* =
1#$"
1#$         (A2.2) 
 
Let the average probability of detecting a SNP in humans and chimpanzees be µh and µc 
respectively, then the expected number of coincident SNPs is 
 
! 
P ="µhµc# 2 + (1$")µhµc#*2       (A2.3) 
 
If there is no variation in the mutation rate then the expected number of coincident 
SNPs is 
 
! 
P0 = µhµc         (A2.4) 
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So the observed number of SNPs over the number expected with no variation is 
 
! 
Z = PP0
="# 2 + (1$")#*2      (A2.5) 
 
The expected excess of coincident SNPs therefore depends upon the proportion of sites 
that are hypermutable and the ratio β/β*. The observed excess of coincident SNPs at 
non-CpG sites is 1.98; we therefore set α to a range of values and solved equation A2.5 
for  β/β*.  The results are shown in appendix 2.4. 
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Appendix 2.2 
a) 
 C/T G/A C/A G/T C/G A/T 
C/T 1120 1 103 46 101 53 
G/A 3 1105 53 99 77 60 
C/A 117 54 294 0 46 23 
G/T 57 138 0 308 35 13 
C/G 79 89 34 30 167 1 
A/T 57 56 28 20 0 561 
b) 
 C/T G/A C/A G/T C/G A/T 
C/T 2.23  0.99 1.12 1.23 1.04 
G/A  2.17 1.30 0.96 0.91 1.20 
C/A 1.13 1.15 5.12  1.51 1.30 
G/T 1.25 1.34  5.38 1.14 0.71 
C/G 1.05 1.17 1.23 1.09 2.78  
A/T 1.07 1.07 1.69 1.16  14.90 
 
Appendix 2.2. The pattern of coincident SNPs for non-CpG sites. a) Gives the number 
of times a particular SNP in humans is found opposite a particular SNP in chimpanzees. 
b) The observed number of SNPs over the number expected with simple context effects. 
Note, some of the observed values are greater than when we included CpG 
dinucleotides. This is because we re-ran the analysis and when a chimp SNP had 
matched multiple human sequences we chose a sequence in which the human SNP was 
not involved in a CpG.  The tables show that there is an excess of coincident SNPs 
above that expected given simple context effects, particularly along the leading 
diagonal, for non-CpG sites. 
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Appendix 2.3  
 
 All sites Non-CpG sites 
GC 
content 
Observed Expected Ratio Observed Expected Ratio 
Lower 
quartile 
2793 1420 1.97 
(0.04) 
1633 752 2.17 
(0.05) 
Upper 
quartile 
2890 1862 1.55 
(0.03) 
606 367 1.65 
(0.07) 
 
Appendix 2.3. The observed and expected numbers of coincident SNPs in the 
alignments with high or low GC content. Standard errors are given for the ratio.  There 
is a significant excess of coincident SNPs in both the upper and lower GC quartile 
datasets. 
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Appendix 2.4 
 
α β/β* 
0.001 33 
0.002 24 
0.01 12 
0.02 9.2 
0.1 5.9 
0.2 5.9 
 
Appendix 2.4. The results from the simple two-rate model presented in appendix 2.1.  
The results are similar to those obtained from the log-normal model detailed in the main 
text and consequently we focus solely on that model. 
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Appendix 2.5 
 
 
Appendix 2.5. The number of human SNPs at each site of the human-chimpanzee 
alignments used in the analysis excluding CpG sites. The slight deficit of human SNPs 
adjacent to the chimpanzee is due to the fact that the adjacent sites are more likely to be 
inferred to be within a CpG because the chimp SNP might contain either C or G. For 
example, if the human SNP at +1 is G/A and the chimp SNP is C/G this would be called 
a potential CpG site and excluded.  The graph shows an excess of coincident SNPs at 
position zero, with the frequency of human SNPs at all other positions being relatively 
uniform, showing that there is no tendency for single SNPs to cluster. 
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Appendix 2.6 
 
a) 
 
b) 
 
Appendix 2.6. The rate of mutation for each triplet on the coding strand (delete) plotted 
against its reverse complement for (a) all genes and (b) genes expressed in the testes.  
The graphs show that the relative rates of mutation are similar on the coding and non-
coding strand in all genes and those expressed in the testes, and consequently the excess 
of coincident SNPs is not a result of strand asymmetry in the pattern of mutation. 
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Appendix 2.7 
 
 
Apendix 2.7. The rate of mutation for each triplet in the GC-rich alignments (x-axis) 
versus the rate of mutation in the GC-poor alignments (y-axis).  The graph shows that 
the relative rates of mutation are similar in GC-rich and GC-poor alignments, and thus 
the excess of coincident SNPs is not a consequence of mis-inferring triplet mutation 
rates in different contexts. 
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Appendix 3.1 
 
a) 
 
b) 
 
Appendix 3.1: The nucleotide diversity across the region containing PRIM2 for (a) the 
CHB+JPT and (b) the YRI populations.  The figure shows a sliding window of 
nucleotide diversity every 25kb, with window size of 50kb as a line graph 
corresponding to the right hand axis, with the coincident SNP densities as a bar chart 
corresponding to the left hand axis.  The region with the highest density of coincident 
SNPs also has a relatively high single SNP density in most cases.
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Appendix 3.2 
 
a) 
 
b) 
 
Appendix 3.2:  The Tajima’s D statistic across the region containing PRIM2 for (a) the 
CHB+JPT and (b) the YRI populations.  The figure shows a sliding window of 
nucleotide diversity every 100kb, with window size of 200kb.  The region containing 
PRIM2 has a higher Tajima’s D statistic than most surrounding regions, and thus 
PRIM2 may be under balancing selection. 
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Appendix 3.3 
 
a) 
 
b) 
 
Appendix 3.3: The nucleotide diversity across the region on chromosome 4 for (a) the 
CHB+JPT and (b) the CEU populations.  The figure shows a sliding window of 
nucleotide diversity every 25kb, with window size of 50kb as a line graph 
corresponding to the right hand axis, with the coincident SNP densities as a bar chart 
corresponding to the left hand axis.  The region on chromosome 4 with a high 
concentration of coincident SNPs has one of the lowest densities of single SNPs in the 
region 
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Appendix 4.1 
 
Appendix 4.1:  Tri-allelic SNP locations and allele frequencies.  Genomic locations are 
from Ensembl release 56 (www.ensembl.org/Homo_sapiens). 
 
Gene Chr Genomic 
Location 
Major 
Allele 
Freq. Minor 
allele 
Freq. Minor 
allele 
Freq. 
 
ABCB1 7 87134535 G 170 C 14 A 2 
ABCB4 7 87081432 T 164 G 4 A 2 
ABCC1 16 16169574 G 167 C 10 A 1 
ADH5 4 99994622 G 161 C 14 T 1 
ALDH1A2 15 58249834 C 168 A 21 T 1 
ALOX5AP 13 31331915 G 75 A 11 C 8 
APOH 17 64220092 C 70 G 18 A 2 
APP 21 27503569 C 162 T 17 A 7 
APP 21 27270116 G 162 C 1 A 1 
ATRX X 76842900 G 173 A 3 T 2 
BNIP3 10 133785129 T 116 G 53 C 1 
BRCA1 17 41218426 C 174 G 1 T 1 
CASP9 1 15844131 C 178 G 1 T 1 
CCND1 11 69462202 C 167 T 3 A 2 
CCNI 4 77974190 C 164 G 13 A 3 
CD247 1 167412070 C 173 T 8 A 1 
CD27 12 6557735 T 176 G 3 C 1 
CHUK 10 101961390 A 87 T 5 G 2 
CP 3 148894357 A 184 C 5 G 1 
CTNND2 5 11822213 C 188 T 1 A 1 
CTNND2 5 11496373 G 122 C 65 A 3 
CYP2C8 10 96797158 G 174 A 5 T 1 
CYP4F2 19 15996483 C 67 T 3 G 1 
CYP4V2 4 187115996 T 126 G 63 A 1 
DCN 12 91542527 A 79 G 14 T 1 
DCN 12 91540103 A 74 G 15 T 3 
DDB1 11 61080839 T 183 A 2 C 1 
DNAJC3 13 96442178 T 167 C 11 G 2 
ECE1 1 21604667 A 185 G 2 T 1 
EIF2AK2 2 37353832 C 169 A 6 T 1 
ERCC3 2 128042109 G 178 T 1 A 1 
ERCC4 16 14025590 C 138 G 22 A 4 
ERCC8 5 60195619 G 161 A 15 T 4 
F9 X 138613499 G 91 A 2 T 1 
F9 X 138616642 C 49 A 43 G 2 
FANCA 16 89875207 G 174 T 1 A 1 
FANCA 16 89814818 C 91 A 65 T 2 
FANCD2 3 10105399 C 173 T 10 A 1 
FGF1 5 141980820 C 136 A 33 G 1 
FGF20 8 16858885 G 104 A 50 T 26 
FGF20 8 16858876 A 177 C 2 T 1 
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Appendix 4.1:  Tri-allelic SNP locations and allele frequencies.  Genomic locations are 
from Ensembl release 56 (www.ensembl.org/Homo_sapiens).  Table continued from 
previous page. 
 
Gene Chr Genomic 
Location 
Major 
Allele 
Freq. Minor 
allele 
Freq. Minor 
allele 
Freq. 
 
FGF5 4 81193146 G 171 A 6 T 1 
FGF5 4 81197802 C 183 T 2 A 1 
FGFR1 8 38292902 A 163 C 4 G 1 
GAD2 10 26518418 T 128 C 39 A 9 
GAS6 13 114542957 G 69 C 16 A 9 
GCLC 6 53373276 G 167 C 2 A 1 
GPX7 1 53070740 A 184 G 3 C 1 
GSR 8 30566786 C 162 T 11 A 7 
GSTA4 6 52843758 A 160 T 24 C 4 
HPGD 4 175423755 A 57 T 21 C 4 
IGFBP7 4 57904663 C 115 T 37 G 10 
IL4R 16 27356680 G 89 A 2 T 1 
LIPE 19 42930288 T 79 A 4 C 1 
MAPK1 22 22139890 A 115 G 32 C 1 
MAPK9 5 179696997 T 141 C 39 G 8 
MAPT 17 44065708 A 172 C 7 T 1 
MB 22 36007803 G 182 T 5 A 3 
MCM6 2 136628183 C 164 A 10 G 2 
MDM2 12 69214894 C 164 T 14 G 2 
MMP12 11 102735103 C 139 T 45 A 2 
MMP16 8 89217739 G 173 A 12 T 1 
MNAT1 14 61241111 G 163 A 14 C 3 
MSH6 2 48032937 C 135 T 40 G 1 
MUC5B 11 1161713 G 96 C 93 A 1 
MUC5B 11 1280099 T 187 C 2 A 1 
MYBPC3 11 47365372 G 172 T 1 A 1 
NBN 8 90950688 G 177 C 2 T 1 
ORC2L 2 201802566 G 174 C 1 A 1 
OXSR1 3 38209896 G 177 A 7 T 6 
PARP2 14 20822219 G 152 T 14 C 2 
PCSK9 1 55507314 G 85 T 8 A 1 
PIK3R5 17 8789532 G 87 C 4 A 1 
PKM2 15 72506120 G 154 T 1 A 1 
PLA2G4A 1 186896603 A 106 G 67 C 1 
PLA2G6 22 38521077 G 160 A 7 T 1 
PMS1 2 190690517 A 135 C 10 G 3 
PNKP 19 50368116 G 139 T 32 C 1 
PNKP 19 50366164 G 129 T 42 A 5 
PON1 7 94943123 A 86 C 7 G 1 
PON3 7 94992644 T 85 C 8 A 1 
PPARG 3 12434070 G 76 C 4 A 4 
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Appendix 4.1:  Tri-allelic SNP locations and allele frequencies.  Genomic locations are 
from Ensembl release 56 (www.ensembl.org/Homo_sapiens).  Table continued from 
previous page. 
 
Gene Chr Genomic 
Location 
Major 
Allele 
Freq. Minor 
allele 
Freq. Minor 
allele 
Freq. 
 
PRDX3 10 120937828 C 168 A 5 T 1 
PRKCB 16 24056018 C 125 A 64 T 1 
PRKDC 8 48801948 G 171 C 2 T 1 
PRKDC 8 48791668 G 176 C 1 T 1 
PSD4 2 113945902 C 53 T 38 A 3 
PSD4 2 113947847 G 88 T 5 A 1 
PSD4 2 113951924 C 62 A 25 T 7 
PTCH2 2 45303959 C 157 T 4 G 1 
RAD17 5 68694169 G 88 A 85 C 1 
RB1 13 48947469 T 166 G 7 A 1 
REV3L 6 111626944 G 176 T 1 A 1 
RIPK1 6 3104135 T 84 G 5 C 3 
SCARA3 8 27509262 G 184 A 4 C 2 
SLC6A3 5 1400241 C 172 T 2 A 2 
SNCA 4 90673770 C 116 G 49 T 21 
STAT4 2 191898949 G 62 A 30 T 2 
SULT1E1 4 70718924 C 165 T 8 A 1 
SULT2A1 19 48374950 G 175 T 12 A 1 
TDP1 14 90499324 C 165 G 24 A 1 
TGFBR2 3 30674339 G 147 A 2 T 1 
TGM2 20 36792842 T 109 A 71 C 2 
TNFRSF8 1 12170425 G 166 T 12 A 2 
TNFRSF9 1 7987558 G 164 T 1 A 1 
TRIM5 11 5699801 T 141 G 24 A 1 
TUBA3C 13 19752039 C 182 A 5 T 1 
UGT2B4 4 70347172 T 145 G 23 A 2 
UHRF1 19 4928699 G 102 C 77 A 1 
VLDLR 9 2629029 A 66 C 16 G 8 
WRN 8 31023686 G 149 A 30 T 1 
XPA 9 100438652 T 149 G 26 C 1 
XRCC1 19 44053360 T 164 C 3 A 3 
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Appendix 5.1 
 
Appendix 5.1:  Outlier regions for the frequency of cancer mutations per MB.   
* indicates those genes associated with at least one form of cancer in the OMIM 
database (http://www.ncbi.nlm.nih.gov/omim). 
 
Cancer Chromosome Region 
(MB) 
Number of 
mutations 
Genes 
SCLC X 61-62 77 None 
SCLC 6 57-58 58 ZNF451 
BAG2 
RAB23 
PRIM2 
SCLC 4 136-137 40 None 
SCLC 3 95-96 39 None 
SCLC 8 138-139 39 None 
SCLC 12 128-129 36 TMEM132C 
SCLC 2 79-80 36 SNAR-H 
SCLC 8 112-113 35 None 
SCLC 14 41-42 35 None 
SCLC 5 24-25 35 CDH10 
SCLC 8 88-89 34 CNBD1 
DCAF4L2 
SCLC 14 42-43 34 LRFN5 
SCLC 2 81-82 33 None 
SCLC 8 111-112 33 None 
SCLC 4 135-136 33 PABPC4L 
SCLC 1 239-240 33 CHRM3 
Skin cancer 7 119-120 50 KCND2 
Skin cancer 13 93-94 47 GPC5* 
GPC6 
Skin cancer 7 57-58 47 ZNF479 
LOC642006 
ZNF716 
Skin cancer 7 53-54 46 POM121L12 
Skin cancer 3 68-69 44 FAM19A1 
FAM19A4 
Skin cancer 9 120-121 42 ASTN2 
TLR4* 
Skin cancer 12 61-62 41 None 
Skin cancer 3 162-163 41 None 
Skin cancer 8 47-48 41 BEYLA 
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Appendix 5.1:  Outlier regions for the frequency of cancer mutations per MB.   
* indicates those genes associated with at least one form of cancer in the OMIM 
database (http://www.ncbi.nlm.nih.gov/omim).  Table continued from previous page. 
 
Cancer Chromosome Region 
(MB) 
Number of 
mutations 
Genes 
AML1 6 32-33 97 C4A 
C4B 
CYP21A2 
TNXB 
ATF6B 
FKBPL 
PRRT1 
PPT2 
EGFL8 
AGPAT1 
RNF5 
RNF5P1 
AGER* 
PBX2 
GPSM3 
NOTCH4 
C6orf10 
BTNL2 
HLA-DRA* 
HLA-DRB5 
HLA-DRB6 
HLA-DRB1 
HLA-DQA1 
HLA-DQB1 
HLA-DQA2 
HLA-DQB2 
HLA-DOB 
TAP2 
PSMB8 
TAP1* 
PSMB9 
PPP1R2P1 
HLA-DMB 
HLA-DMA 
BRD2 
HLA-DOA 
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Appendix 5.1:  Outlier regions for the frequency of cancer mutations per MB.   
* indicates those genes associated with at least one form of cancer in the OMIM 
database (http://www.ncbi.nlm.nih.gov/omim).  Table continued from previous page. 
 
Cancer Chromosome Region 
(MB) 
Number of 
mutations 
Genes 
AML1 6 29-30 84 OR2W1 
OR2B3 
OR2J3 
OR2J2 
OR14J1 
OR5V1 
OR12D3 
OR12D2 
OR11A1 
OR10C1 
OR2H1 
MAS1L* 
UBD 
SNORD32B 
OR2H2 
GABBR1 
MOG 
ZFP57 
HLA-F 
LOC285830 
IFITM4P 
HCG4 
HLA-G* 
HLA-H 
HCG2P7 
HCG4P6 
HLA-A 
HCG9 
NCRNA00171 
HLA-J 
AML1 3 75-76 67 FAM86D 
MIR1324 
FRG2C 
ZNF717 
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Appendix 5.1:  Outlier regions for the frequency of cancer mutations per MB.   
* indicates those genes associated with at least one form of cancer in the OMIM 
database (http://www.ncbi.nlm.nih.gov/omim).  Table continued from previous page. 
 
Cancer Chromosome Region 
(MB) 
Number of 
mutations 
Genes 
AML1 12 11-12 50 PRR4* 
PRH1 
TAS2R13 
PRH2 
TAS2R14 
TAS2R50 
TAS2R20 
TAS2R19 
TAS2R31 
TAS2R46 
TAS2R43 
TAS2R30 
TAS2R42 
PRB3 
PRB4 
PRB1 
PRB2 
ETV6* 
AML1 2 133-134 48 NCRNA00164 
MIR663B 
GPR39 
LYPD1* 
NCKAP5 
AML1 2 37-38 34 VIT 
STRN 
HEATR5B 
CCDC75 
EIF2AK2 
SULT6B1 
CEBPZ 
C2orf56 
PRKD3 
QPCT 
CDC42EP3 
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Appendix 5.1:  Outlier regions for the frequency of cancer mutations per MB.   
* indicates those genes associated with at least one form of cancer in the OMIM 
database (http://www.ncbi.nlm.nih.gov/omim).  Table continued from previous page. 
 
Cancer Chromosome Region 
(MB) 
Number of 
mutations 
Genes 
AML2 3 75-76 473 See above 
AML2 2 133-134 252 See above 
AML2 13 63-64 149 None 
AML2 6 32-33 106 See above 
AML2 2 132-133 92 POTEE 
LOC440910 
LOC150786 
LOC401010 
TUBA3D 
FAM128A 
LOC150776 
CCDC74A 
C2orf27A 
C2orf27B 
NCRNA00164 
AML2 2 37-38 90 See above 
AML2 4 3-4 89 GRK4 
HTT 
C4orf44 
RGS12 
HGFAC 
DOK7 
LRPAP1 
ADRA2C 
LOC348926 
AML2 9 69-70 81 PGM5P2 
LOC440896 
FOXD4L6 
CBWD6 
ANKRD20A4 
LOC100133920 
AML2 10 127-128 63 LOC100169752 
C10orf122 
C10orf137 
MMP21* 
UROS 
BCCIP* 
DHX32 
FANK1 
ADAM12 
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Appendix 5.1:  Outlier regions for the frequency of cancer mutations per MB.   
* indicates those genes associated with at least one form of cancer in the OMIM 
database (http://www.ncbi.nlm.nih.gov/omim).  Table continued from previous page. 
 
Cancer Chromosome Region 
(MB) 
Number of 
mutations 
Genes 
AML2 12 11-12 62 See above 
AML2 1 149-150 59 LOC388692 
FCGR1C 
HIST2H2BF 
PPIAL4A 
PPIAL4C 
PPIAL4B 
LOC728855 
FCGR1A 
HIST2H3D 
HIST2H4A* 
HIST2H4B 
HIST2H3C 
HIST2H3A 
HIST2H2AA3 
HIST2H2AA4 
HIST2H3A 
HIST2H3C 
HIST2H2BE 
HIST2H2AC 
HIST2H2AB 
BOLA1 
SV2A 
SF3B4 
MTMR11 
OTUD7B 
 
